TWI554555B - A liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display device - Google Patents
A liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display device Download PDFInfo
- Publication number
- TWI554555B TWI554555B TW101123263A TW101123263A TWI554555B TW I554555 B TWI554555 B TW I554555B TW 101123263 A TW101123263 A TW 101123263A TW 101123263 A TW101123263 A TW 101123263A TW I554555 B TWI554555 B TW I554555B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- crystal alignment
- alignment film
- acid
- formula
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 519
- 150000004985 diamines Chemical class 0.000 claims description 170
- 239000000758 substrate Substances 0.000 claims description 118
- 239000003795 chemical substances by application Substances 0.000 claims description 92
- 239000002243 precursor Substances 0.000 claims description 85
- 229920001721 polyimide Polymers 0.000 claims description 50
- 239000004642 Polyimide Substances 0.000 claims description 48
- 238000004519 manufacturing process Methods 0.000 claims description 43
- 239000002904 solvent Substances 0.000 claims description 40
- 150000000000 tetracarboxylic acids Chemical class 0.000 claims description 40
- 125000000962 organic group Chemical group 0.000 claims description 38
- 238000010438 heat treatment Methods 0.000 claims description 37
- 229920000642 polymer Polymers 0.000 claims description 37
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 238000006068 polycondensation reaction Methods 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 241000723347 Cinnamomum Species 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 235000017803 cinnamon Nutrition 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 103
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 77
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- 238000000034 method Methods 0.000 description 69
- 239000000243 solution Substances 0.000 description 65
- 230000000052 comparative effect Effects 0.000 description 57
- -1 cinnamoyl groups Chemical group 0.000 description 49
- 150000001875 compounds Chemical class 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 45
- 230000015572 biosynthetic process Effects 0.000 description 42
- 210000002858 crystal cell Anatomy 0.000 description 41
- 238000003786 synthesis reaction Methods 0.000 description 37
- 239000000203 mixture Substances 0.000 description 36
- 238000005160 1H NMR spectroscopy Methods 0.000 description 33
- 239000002253 acid Substances 0.000 description 31
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 30
- 238000000862 absorption spectrum Methods 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 150000002148 esters Chemical class 0.000 description 27
- 238000011156 evaluation Methods 0.000 description 27
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 26
- 229920000768 polyamine Polymers 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 238000005259 measurement Methods 0.000 description 21
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- 239000003960 organic solvent Substances 0.000 description 19
- 206010047571 Visual impairment Diseases 0.000 description 17
- 239000000178 monomer Substances 0.000 description 17
- 239000012153 distilled water Substances 0.000 description 16
- 108010039918 Polylysine Proteins 0.000 description 15
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 15
- 229920000656 polylysine Polymers 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- 229920005575 poly(amic acid) Polymers 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 13
- 125000000217 alkyl group Chemical group 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 12
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 10
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 10
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000008065 acid anhydrides Chemical class 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- 229910052731 fluorine Inorganic materials 0.000 description 6
- 239000011737 fluorine Substances 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
- 229920006254 polymer film Polymers 0.000 description 6
- 239000000565 sealant Substances 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 6
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical class [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- CTMHWPIWNRWQEG-UHFFFAOYSA-N 1-methylcyclohexene Chemical compound CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 description 4
- LSKONYYRONEBKA-UHFFFAOYSA-N 2-Dodecanone Chemical compound CCCCCCCCCCC(C)=O LSKONYYRONEBKA-UHFFFAOYSA-N 0.000 description 4
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- AMNPXXIGUOKIPP-UHFFFAOYSA-N [4-(carbamothioylamino)phenyl]thiourea Chemical compound NC(=S)NC1=CC=C(NC(N)=S)C=C1 AMNPXXIGUOKIPP-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- 238000006471 dimerization reaction Methods 0.000 description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 4
- 230000010287 polarization Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- CVNKFOIOZXAFBO-UHFFFAOYSA-J tin(4+);tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Sn+4] CVNKFOIOZXAFBO-UHFFFAOYSA-J 0.000 description 4
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 3
- IKMXRUOZUUKSON-UHFFFAOYSA-N 2-(4-nitrophenyl)ethanol Chemical compound OCCC1=CC=C([N+]([O-])=O)C=C1 IKMXRUOZUUKSON-UHFFFAOYSA-N 0.000 description 3
- PPPFYBPQAPISCT-UHFFFAOYSA-N 2-hydroxypropyl acetate Chemical compound CC(O)COC(C)=O PPPFYBPQAPISCT-UHFFFAOYSA-N 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 229920000037 Polyproline Polymers 0.000 description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 108010026466 polyproline Proteins 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 2
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 description 2
- PNBCGVPSRHMZDO-UHFFFAOYSA-N 1-(1-propoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCCOCC(C)OCC(C)OC(C)=O PNBCGVPSRHMZDO-UHFFFAOYSA-N 0.000 description 2
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- JRHNUZCXXOTJCA-UHFFFAOYSA-N 1-fluoropropane Chemical compound CCCF JRHNUZCXXOTJCA-UHFFFAOYSA-N 0.000 description 2
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 2
- ONDSSKDTLGWNOJ-UHFFFAOYSA-N 1-methoxyhexan-2-ol Chemical compound CCCCC(O)COC ONDSSKDTLGWNOJ-UHFFFAOYSA-N 0.000 description 2
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 2
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 2
- HOLGXWDGCVTMTB-UHFFFAOYSA-N 2-(2-aminophenyl)aniline Chemical group NC1=CC=CC=C1C1=CC=CC=C1N HOLGXWDGCVTMTB-UHFFFAOYSA-N 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 2
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 2
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 2
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 2
- KRKAHVGIXIYIGB-UHFFFAOYSA-N 3-chloro-2,2-dimethyldecane Chemical compound CCCCCCCC(Cl)C(C)(C)C KRKAHVGIXIYIGB-UHFFFAOYSA-N 0.000 description 2
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 2
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 2
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 2
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 2
- AIVVXPSKEVWKMY-UHFFFAOYSA-N 4-(3,4-dicarboxyphenoxy)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 AIVVXPSKEVWKMY-UHFFFAOYSA-N 0.000 description 2
- LFBALUPVVFCEPA-UHFFFAOYSA-N 4-(3,4-dicarboxyphenyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C(C(O)=O)=C1 LFBALUPVVFCEPA-UHFFFAOYSA-N 0.000 description 2
- XDYLWBWPEDSSLU-UHFFFAOYSA-N 4-(3-carboxyphenyl)benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C(C(O)=O)=CC=2)C(O)=O)=C1 XDYLWBWPEDSSLU-UHFFFAOYSA-N 0.000 description 2
- NEQFBGHQPUXOFH-UHFFFAOYSA-N 4-(4-carboxyphenyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C=C1 NEQFBGHQPUXOFH-UHFFFAOYSA-N 0.000 description 2
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 2
- QNVNLUSHGRBCLO-UHFFFAOYSA-N 5-hydroxybenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC(O)=CC(C(O)=O)=C1 QNVNLUSHGRBCLO-UHFFFAOYSA-N 0.000 description 2
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 2
- ZPAKUZKMGJJMAA-UHFFFAOYSA-N Cyclohexane-1,2,4,5-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)CC1C(O)=O ZPAKUZKMGJJMAA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000004988 Nematic liquid crystal Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- PAVQGHWQOQZQEH-UHFFFAOYSA-N adamantane-1,3-dicarboxylic acid Chemical compound C1C(C2)CC3CC1(C(=O)O)CC2(C(O)=O)C3 PAVQGHWQOQZQEH-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229940072049 amyl acetate Drugs 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
- WOSVXXBNNCUXMT-UHFFFAOYSA-N cyclopentane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1C(O)=O WOSVXXBNNCUXMT-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 2
- 229940117360 ethyl pyruvate Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 2
- 229940057867 methyl lactate Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 2
- WSKHYOXDVZCOJP-UHFFFAOYSA-N naphthalene-1,6-diamine Chemical compound NC1=CC=CC2=CC(N)=CC=C21 WSKHYOXDVZCOJP-UHFFFAOYSA-N 0.000 description 2
- ZDWYJINCYGEEJB-UHFFFAOYSA-N naphthalene-1,7-diamine Chemical compound C1=CC=C(N)C2=CC(N)=CC=C21 ZDWYJINCYGEEJB-UHFFFAOYSA-N 0.000 description 2
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 2
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002098 polyfluorene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 2
- 150000004060 quinone imines Chemical class 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- ASJCSAKCMTWGAH-WHFBIAKZSA-N (1s,2s)-cyclopentane-1,2-dicarboxylic acid Chemical compound OC(=O)[C@H]1CCC[C@@H]1C(O)=O ASJCSAKCMTWGAH-WHFBIAKZSA-N 0.000 description 1
- FADNCTVVKDWKIX-UHFFFAOYSA-N (2,4-diaminophenyl)methanol Chemical compound NC1=CC=C(CO)C(N)=C1 FADNCTVVKDWKIX-UHFFFAOYSA-N 0.000 description 1
- LYSJSRSBKUIFDF-UHFFFAOYSA-N (2-aminophenyl)-(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 LYSJSRSBKUIFDF-UHFFFAOYSA-N 0.000 description 1
- BWRBVBFLFQKBPT-UHFFFAOYSA-N (2-nitrophenyl)methanol Chemical compound OCC1=CC=CC=C1[N+]([O-])=O BWRBVBFLFQKBPT-UHFFFAOYSA-N 0.000 description 1
- OHLQBRYVKXJYHZ-UHFFFAOYSA-N (3,5-diaminophenyl)methanol Chemical compound NC1=CC(N)=CC(CO)=C1 OHLQBRYVKXJYHZ-UHFFFAOYSA-N 0.000 description 1
- YKNMIGJJXKBHJE-UHFFFAOYSA-N (3-aminophenyl)-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC(N)=C1 YKNMIGJJXKBHJE-UHFFFAOYSA-N 0.000 description 1
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 1
- LDSPUPOZPVNYFP-XCVCLJGOSA-N (4-aminophenyl) (e)-3-(4-aminophenyl)prop-2-enoate Chemical compound C1=CC(N)=CC=C1OC(=O)\C=C\C1=CC=C(N)C=C1 LDSPUPOZPVNYFP-XCVCLJGOSA-N 0.000 description 1
- AAFXQFIGKBLKMC-KQQUZDAGSA-N (e)-3-[4-[(e)-2-carboxyethenyl]phenyl]prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(\C=C\C(O)=O)C=C1 AAFXQFIGKBLKMC-KQQUZDAGSA-N 0.000 description 1
- RHUYHJGZWVXEHW-UHFFFAOYSA-N 1,1-Dimethyhydrazine Chemical compound CN(C)N RHUYHJGZWVXEHW-UHFFFAOYSA-N 0.000 description 1
- NSZYKXMFFCRNJB-UHFFFAOYSA-N 1,2,3,4-tetramethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C)(C(O)=O)C(C)(C(O)=O)C1(C)C(O)=O NSZYKXMFFCRNJB-UHFFFAOYSA-N 0.000 description 1
- DVGGYXXTNYZERM-UHFFFAOYSA-N 1,2,5-oxadiazole-3,4-dicarboxylic acid Chemical compound OC(=O)C1=NON=C1C(O)=O DVGGYXXTNYZERM-UHFFFAOYSA-N 0.000 description 1
- MQQRFOXFIPBFOV-UHFFFAOYSA-N 1,2-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C(O)=O)C1(C)C(O)=O MQQRFOXFIPBFOV-UHFFFAOYSA-N 0.000 description 1
- OURODNXVJUWPMZ-UHFFFAOYSA-N 1,2-diphenylanthracene Chemical compound C1=CC=CC=C1C1=CC=C(C=C2C(C=CC=C2)=C2)C2=C1C1=CC=CC=C1 OURODNXVJUWPMZ-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- SBHHKGFHJWTZJN-UHFFFAOYSA-N 1,3-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C)(C(O)=O)C1C(O)=O SBHHKGFHJWTZJN-UHFFFAOYSA-N 0.000 description 1
- ODJKHOBNYXJHRG-UHFFFAOYSA-N 1,3-dimethylimidazole Chemical compound CN1[CH]N(C)C=C1 ODJKHOBNYXJHRG-UHFFFAOYSA-N 0.000 description 1
- ULAFJDYDLJSYLI-UHFFFAOYSA-N 1,3-diphenylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound C1(=CC=CC=C1)C1(C(C(C1C(=O)O)(C(=O)O)C1=CC=CC=C1)C(=O)O)C(=O)O ULAFJDYDLJSYLI-UHFFFAOYSA-N 0.000 description 1
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- HFHARFNUBJTTGI-UHFFFAOYSA-N 1,3-thiazole-4,5-dicarboxylic acid Chemical compound OC(=O)C=1N=CSC=1C(O)=O HFHARFNUBJTTGI-UHFFFAOYSA-N 0.000 description 1
- UTYAEKVPLFDTTI-UHFFFAOYSA-N 1,4-dioxoanthracene-2,3-dicarboxylic acid Chemical compound C1=CC=C2C=C(C(C(C(=O)O)=C(C(O)=O)C3=O)=O)C3=CC2=C1 UTYAEKVPLFDTTI-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- CRJFHXYELTYDSG-UHFFFAOYSA-N 1-(4-nitrophenyl)ethanol Chemical compound CC(O)C1=CC=C([N+]([O-])=O)C=C1 CRJFHXYELTYDSG-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RQUBQBFVDOLUKC-UHFFFAOYSA-N 1-ethoxy-2-methylpropane Chemical compound CCOCC(C)C RQUBQBFVDOLUKC-UHFFFAOYSA-N 0.000 description 1
- GEUYACYJMUQXCF-UHFFFAOYSA-N 1-ethyl-2-(2-phenylethenyl)benzene Chemical compound CCC1=CC=CC=C1C=CC1=CC=CC=C1 GEUYACYJMUQXCF-UHFFFAOYSA-N 0.000 description 1
- PEBXLTUWFWEWGV-UHFFFAOYSA-N 1-methyl-2-(2-phenylethenyl)benzene Chemical compound CC1=CC=CC=C1C=CC1=CC=CC=C1 PEBXLTUWFWEWGV-UHFFFAOYSA-N 0.000 description 1
- MMBDKCNXVOREEF-UHFFFAOYSA-N 1-methyloctane-1,2,5,6-tetracarboxylic acid Chemical compound CCC(C(CCC(C(C)C(=O)O)C(=O)O)C(=O)O)C(=O)O MMBDKCNXVOREEF-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- ULAJXVNCPQIRQD-UHFFFAOYSA-N 1-n,4-n-bis(3-aminophenyl)benzene-1,4-dicarboxamide Chemical compound NC1=CC=CC(NC(=O)C=2C=CC(=CC=2)C(=O)NC=2C=C(N)C=CC=2)=C1 ULAJXVNCPQIRQD-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- WKRCUUPMCASSBN-UHFFFAOYSA-N 2,2-diethylbutanedioic acid Chemical compound CCC(CC)(C(O)=O)CC(O)=O WKRCUUPMCASSBN-UHFFFAOYSA-N 0.000 description 1
- BTUDGPVTCYNYLK-UHFFFAOYSA-N 2,2-dimethylglutaric acid Chemical compound OC(=O)C(C)(C)CCC(O)=O BTUDGPVTCYNYLK-UHFFFAOYSA-N 0.000 description 1
- WCZNKVPCIFMXEQ-UHFFFAOYSA-N 2,3,5,6-tetramethylbenzene-1,4-diamine Chemical compound CC1=C(C)C(N)=C(C)C(C)=C1N WCZNKVPCIFMXEQ-UHFFFAOYSA-N 0.000 description 1
- CXSDOMQTAJIDQI-UHFFFAOYSA-N 2,3-bis(3-aminophenyl)terephthalic acid Chemical compound NC=1C=C(C=CC=1)C=1C(=C(C(=O)O)C=CC=1C(=O)O)C1=CC(=CC=C1)N CXSDOMQTAJIDQI-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- XVBLEUZLLURXTF-UHFFFAOYSA-N 2,4-dimethylbenzene-1,3-diamine Chemical compound CC1=CC=C(N)C(C)=C1N XVBLEUZLLURXTF-UHFFFAOYSA-N 0.000 description 1
- XQRUEDXXCQDNOT-UHFFFAOYSA-N 2,5-diaminophenol Chemical compound NC1=CC=C(N)C(O)=C1 XQRUEDXXCQDNOT-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- FKUJGZJNDUGCFU-UHFFFAOYSA-N 2,5-dimethylterephthalic acid Chemical compound CC1=CC(C(O)=O)=C(C)C=C1C(O)=O FKUJGZJNDUGCFU-UHFFFAOYSA-N 0.000 description 1
- XQIBGVDOSWYGGA-UHFFFAOYSA-N 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylic acid Chemical compound C1CC2(C(O)=O)CC(=O)C1(C(=O)O)CC2=O XQIBGVDOSWYGGA-UHFFFAOYSA-N 0.000 description 1
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 1
- UPQDHGRRFJDNOG-UHFFFAOYSA-N 2-(1,1-diphenylethyl)propanedioic acid Chemical compound C=1C=CC=CC=1C(C(C(O)=O)C(O)=O)(C)C1=CC=CC=C1 UPQDHGRRFJDNOG-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- WZKHBEGQWSEAJI-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethanol;1-methoxy-2-(2-methoxyethoxy)ethane Chemical compound OCCOCCO.COCCOCCOC WZKHBEGQWSEAJI-UHFFFAOYSA-N 0.000 description 1
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 1
- CRQBUNFZJOLMKC-UHFFFAOYSA-N 2-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C(=CC=CC=2)N)=C1 CRQBUNFZJOLMKC-UHFFFAOYSA-N 0.000 description 1
- JZUMVFMLJGSMRF-UHFFFAOYSA-N 2-Methyladipic acid Chemical compound OC(=O)C(C)CCCC(O)=O JZUMVFMLJGSMRF-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- IIQLVLWFQUUZII-UHFFFAOYSA-N 2-amino-5-(4-amino-3-carboxyphenyl)benzoic acid Chemical group C1=C(C(O)=O)C(N)=CC=C1C1=CC=C(N)C(C(O)=O)=C1 IIQLVLWFQUUZII-UHFFFAOYSA-N 0.000 description 1
- ZGDMDBHLKNQPSD-UHFFFAOYSA-N 2-amino-5-(4-amino-3-hydroxyphenyl)phenol Chemical group C1=C(O)C(N)=CC=C1C1=CC=C(N)C(O)=C1 ZGDMDBHLKNQPSD-UHFFFAOYSA-N 0.000 description 1
- AQHFCRYZABKUEV-UHFFFAOYSA-N 2-chloro-5-methoxybenzoic acid Chemical compound COC1=CC=C(Cl)C(C(O)=O)=C1 AQHFCRYZABKUEV-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- CQTGAEFAFTYQAM-UHFFFAOYSA-N 2-pentylhexanedioic acid Chemical compound CCCCCC(C(O)=O)CCCC(O)=O CQTGAEFAFTYQAM-UHFFFAOYSA-N 0.000 description 1
- TVHXQIGBVCWCIS-UHFFFAOYSA-N 2-phenyl-1,3-thiazole-4,5-dicarboxylic acid Chemical compound S1C(C(O)=O)=C(C(=O)O)N=C1C1=CC=CC=C1 TVHXQIGBVCWCIS-UHFFFAOYSA-N 0.000 description 1
- VSZJLXSVGVDPMJ-UHFFFAOYSA-N 2-phenylterephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C=2C=CC=CC=2)=C1 VSZJLXSVGVDPMJ-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- QVNDSQQNODQYJM-UHFFFAOYSA-N 3,4-diphenylcyclobutane-1,2-dicarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C=2C=CC=CC=2)C1C1=CC=CC=C1 QVNDSQQNODQYJM-UHFFFAOYSA-N 0.000 description 1
- WFNVGXBEWXBZPL-UHFFFAOYSA-N 3,5-diaminophenol Chemical compound NC1=CC(N)=CC(O)=C1 WFNVGXBEWXBZPL-UHFFFAOYSA-N 0.000 description 1
- LXJLFVRAWOOQDR-UHFFFAOYSA-N 3-(3-aminophenoxy)aniline Chemical compound NC1=CC=CC(OC=2C=C(N)C=CC=2)=C1 LXJLFVRAWOOQDR-UHFFFAOYSA-N 0.000 description 1
- NDXGRHCEHPFUSU-UHFFFAOYSA-N 3-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C=C(N)C=CC=2)=C1 NDXGRHCEHPFUSU-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- QSPMTSAELLSLOQ-UHFFFAOYSA-N 3-(4-aminophenyl)aniline Chemical group C1=CC(N)=CC=C1C1=CC=CC(N)=C1 QSPMTSAELLSLOQ-UHFFFAOYSA-N 0.000 description 1
- JOLPMPPNHIACPD-UHFFFAOYSA-N 3-(4-aminophenyl)prop-2-enoic acid Chemical compound NC1=CC=C(C=CC(O)=O)C=C1 JOLPMPPNHIACPD-UHFFFAOYSA-N 0.000 description 1
- ZDBWYUOUYNQZBM-UHFFFAOYSA-N 3-(aminomethyl)aniline Chemical compound NCC1=CC=CC(N)=C1 ZDBWYUOUYNQZBM-UHFFFAOYSA-N 0.000 description 1
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 1
- ABFYEILPZWAIBN-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine;hydrochloride Chemical compound Cl.CN(C)CCCN=C=N ABFYEILPZWAIBN-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- OQOCRVBUYRQQPS-UHFFFAOYSA-N 3-[2-(3-aminophenyl)ethyl]aniline Chemical compound NC1=CC=CC(CCC=2C=C(N)C=CC=2)=C1 OQOCRVBUYRQQPS-UHFFFAOYSA-N 0.000 description 1
- LMQOEUTZXKKSBC-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)propoxy]aniline Chemical compound NC1=CC=CC(OCCCOC=2C=C(N)C=CC=2)=C1 LMQOEUTZXKKSBC-UHFFFAOYSA-N 0.000 description 1
- CKTOHFTWIAKLPM-UHFFFAOYSA-N 3-[3-(3-aminophenyl)propyl]aniline Chemical compound NC1=CC=CC(CCCC=2C=C(N)C=CC=2)=C1 CKTOHFTWIAKLPM-UHFFFAOYSA-N 0.000 description 1
- RKVYQWSCHYCGPT-UHFFFAOYSA-N 3-[4-(3-aminophenoxy)butoxy]aniline Chemical compound NC1=CC=CC(OCCCCOC=2C=C(N)C=CC=2)=C1 RKVYQWSCHYCGPT-UHFFFAOYSA-N 0.000 description 1
- XKBRJCSVQIUYGX-UHFFFAOYSA-N 3-[5-(3-aminophenoxy)pentoxy]aniline Chemical compound NC1=CC=CC(OCCCCCOC=2C=C(N)C=CC=2)=C1 XKBRJCSVQIUYGX-UHFFFAOYSA-N 0.000 description 1
- WWUPPHQXELKSQR-UHFFFAOYSA-N 3-[9-(3-aminophenoxy)decoxy]aniline Chemical compound NC=1C=C(OCCCCCCCCC(C)OC2=CC(=CC=C2)N)C=CC=1 WWUPPHQXELKSQR-UHFFFAOYSA-N 0.000 description 1
- LVYXPOCADCXMLP-UHFFFAOYSA-N 3-butoxy-n,n-dimethylpropanamide Chemical compound CCCCOCCC(=O)N(C)C LVYXPOCADCXMLP-UHFFFAOYSA-N 0.000 description 1
- PVKDNXFNSSLPRN-UHFFFAOYSA-N 3-ethoxy-n,n-dimethylpropanamide Chemical compound CCOCCC(=O)N(C)C PVKDNXFNSSLPRN-UHFFFAOYSA-N 0.000 description 1
- VSFAKKBYARHVMZ-UHFFFAOYSA-N 3-heptoxyaniline Chemical compound CCCCCCCOC1=CC=CC(N)=C1 VSFAKKBYARHVMZ-UHFFFAOYSA-N 0.000 description 1
- LBVMWHCOFMFPEG-UHFFFAOYSA-N 3-methoxy-n,n-dimethylpropanamide Chemical compound COCCC(=O)N(C)C LBVMWHCOFMFPEG-UHFFFAOYSA-N 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- CWNPOQFCIIFQDM-UHFFFAOYSA-N 3-nitrobenzyl alcohol Chemical compound OCC1=CC=CC([N+]([O-])=O)=C1 CWNPOQFCIIFQDM-UHFFFAOYSA-N 0.000 description 1
- RTZZCYNQPHTPPL-UHFFFAOYSA-N 3-nitrophenol Chemical compound OC1=CC=CC([N+]([O-])=O)=C1 RTZZCYNQPHTPPL-UHFFFAOYSA-N 0.000 description 1
- RHQMMOXFKUENGL-UHFFFAOYSA-N 3-phenylcyclohexa-1,5-diene-1,3-dicarboxylic acid Chemical compound C1(CC=CC(=C1)C(=O)O)(C1=CC=CC=C1)C(=O)O RHQMMOXFKUENGL-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- OPQVOOASZKDKBH-UHFFFAOYSA-N 4,8-dioxoadamantane-1,3-dicarboxylic acid Chemical compound C1C(C2=O)CC3CC2(C(O)=O)CC1(C(=O)O)C3=O OPQVOOASZKDKBH-UHFFFAOYSA-N 0.000 description 1
- FFKSVVOWOROQIU-UHFFFAOYSA-N 4-(2,5-dioxooxolan-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid Chemical compound C12=CC=CC=C2C(C(O)=O)C(C(=O)O)CC1C1CC(=O)OC1=O FFKSVVOWOROQIU-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- UITKHKNFVCYWNG-UHFFFAOYSA-N 4-(3,4-dicarboxybenzoyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 UITKHKNFVCYWNG-UHFFFAOYSA-N 0.000 description 1
- LVNPGQZSPDFZNC-UHFFFAOYSA-N 4-(4-amino-3-fluorophenyl)-2-fluoroaniline Chemical group C1=C(F)C(N)=CC=C1C1=CC=C(N)C(F)=C1 LVNPGQZSPDFZNC-UHFFFAOYSA-N 0.000 description 1
- LFEWXDOYPCWFHR-UHFFFAOYSA-N 4-(4-carboxybenzoyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C=C1 LFEWXDOYPCWFHR-UHFFFAOYSA-N 0.000 description 1
- WVDRSXGPQWNUBN-UHFFFAOYSA-N 4-(4-carboxyphenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C=C1 WVDRSXGPQWNUBN-UHFFFAOYSA-N 0.000 description 1
- SQJQLYOMPSJVQS-UHFFFAOYSA-N 4-(4-carboxyphenyl)sulfonylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1S(=O)(=O)C1=CC=C(C(O)=O)C=C1 SQJQLYOMPSJVQS-UHFFFAOYSA-N 0.000 description 1
- BFWYZZPDZZGSLJ-UHFFFAOYSA-N 4-(aminomethyl)aniline Chemical compound NCC1=CC=C(N)C=C1 BFWYZZPDZZGSLJ-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- GNPSQUCXOBDIDY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane Chemical compound C(CCCCCCC)C(C(OC)(OC)OC)CCC GNPSQUCXOBDIDY-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- IWXCYYWDGDDPAC-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)methyl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1CC1=CC=C(C(O)=O)C(C(O)=O)=C1 IWXCYYWDGDDPAC-UHFFFAOYSA-N 0.000 description 1
- NWIVYGKSHSJHEF-UHFFFAOYSA-N 4-[(4-amino-3,5-diethylphenyl)methyl]-2,6-diethylaniline Chemical compound CCC1=C(N)C(CC)=CC(CC=2C=C(CC)C(N)=C(CC)C=2)=C1 NWIVYGKSHSJHEF-UHFFFAOYSA-N 0.000 description 1
- IGSBHTZEJMPDSZ-UHFFFAOYSA-N 4-[(4-amino-3-methylcyclohexyl)methyl]-2-methylcyclohexan-1-amine Chemical compound C1CC(N)C(C)CC1CC1CC(C)C(N)CC1 IGSBHTZEJMPDSZ-UHFFFAOYSA-N 0.000 description 1
- GAMSSMZJKUMFEY-UHFFFAOYSA-N 4-[(4-carboxyphenyl)disulfanyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1SSC1=CC=C(C(O)=O)C=C1 GAMSSMZJKUMFEY-UHFFFAOYSA-N 0.000 description 1
- SBBQDUFLZGOASY-OWOJBTEDSA-N 4-[(e)-2-(4-carboxyphenyl)ethenyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1\C=C\C1=CC=C(C(O)=O)C=C1 SBBQDUFLZGOASY-OWOJBTEDSA-N 0.000 description 1
- DODZITHJXOKQAB-UHFFFAOYSA-N 4-[1-(4-aminophenyl)decyl]aniline Chemical compound C=1C=C(N)C=CC=1C(CCCCCCCCC)C1=CC=C(N)C=C1 DODZITHJXOKQAB-UHFFFAOYSA-N 0.000 description 1
- ASNOFHCTUSIHOM-UHFFFAOYSA-N 4-[10-(4-aminophenyl)anthracen-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=C(N)C=C1 ASNOFHCTUSIHOM-UHFFFAOYSA-N 0.000 description 1
- APXJLYIVOFARRM-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(C(O)=O)C(C(O)=O)=C1 APXJLYIVOFARRM-UHFFFAOYSA-N 0.000 description 1
- GEYAGBVEAJGCFB-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)propan-2-yl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1C(C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GEYAGBVEAJGCFB-UHFFFAOYSA-N 0.000 description 1
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 1
- HCUNREWMFYCWAQ-UHFFFAOYSA-N 4-[2-(4-carboxyphenyl)ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCC1=CC=C(C(O)=O)C=C1 HCUNREWMFYCWAQ-UHFFFAOYSA-N 0.000 description 1
- KWFFEQXPFFDJER-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)propoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCOC1=CC=C(N)C=C1 KWFFEQXPFFDJER-UHFFFAOYSA-N 0.000 description 1
- BOVVHULZWVFIOX-UHFFFAOYSA-N 4-[3-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC(C=2C=CC(N)=CC=2)=C1 BOVVHULZWVFIOX-UHFFFAOYSA-N 0.000 description 1
- BMIUMBLWVWZIHD-UHFFFAOYSA-N 4-[3-(4-aminophenyl)propyl]aniline Chemical compound C1=CC(N)=CC=C1CCCC1=CC=C(N)C=C1 BMIUMBLWVWZIHD-UHFFFAOYSA-N 0.000 description 1
- LAFZPVANKKJENB-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)butoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCOC1=CC=C(N)C=C1 LAFZPVANKKJENB-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- PZBWQICCJHUJGP-UHFFFAOYSA-N 4-[4-(4-aminophenyl)butyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCC1=CC=C(N)C=C1 PZBWQICCJHUJGP-UHFFFAOYSA-N 0.000 description 1
- QBSMHWVGUPQNJJ-UHFFFAOYSA-N 4-[4-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=C(C=2C=CC(N)=CC=2)C=C1 QBSMHWVGUPQNJJ-UHFFFAOYSA-N 0.000 description 1
- OUPZSDSIDCDXRS-UHFFFAOYSA-N 4-[4-[2-[4-(3-carboxypropoxy)phenyl]propan-2-yl]phenoxy]butanoic acid Chemical compound C=1C=C(OCCCC(O)=O)C=CC=1C(C)(C)C1=CC=C(OCCCC(O)=O)C=C1 OUPZSDSIDCDXRS-UHFFFAOYSA-N 0.000 description 1
- OBWFOWLCVBNCRD-UHFFFAOYSA-N 4-[4-ethyl-5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide Chemical compound CCC=1C(C(F)(F)F)=NN(C=2C=CC(=CC=2)S(N)(=O)=O)C=1C1=CC=C(C)C=C1 OBWFOWLCVBNCRD-UHFFFAOYSA-N 0.000 description 1
- SLHXQWDUYXSTPA-UHFFFAOYSA-N 4-[5-(4-aminophenoxy)pentoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCOC1=CC=C(N)C=C1 SLHXQWDUYXSTPA-UHFFFAOYSA-N 0.000 description 1
- UURATDYSEHCBAO-UHFFFAOYSA-N 4-[6-(3,4-dicarboxyphenyl)pyridin-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC(C=2C=C(C(C(O)=O)=CC=2)C(O)=O)=N1 UURATDYSEHCBAO-UHFFFAOYSA-N 0.000 description 1
- GRFCDFDVGOXFPY-UHFFFAOYSA-N 4-[6-(4-aminophenoxy)hexoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCOC1=CC=C(N)C=C1 GRFCDFDVGOXFPY-UHFFFAOYSA-N 0.000 description 1
- JBXBSFFXAMVASC-UHFFFAOYSA-N 4-[7-(4-aminophenoxy)heptoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCOC1=CC=C(N)C=C1 JBXBSFFXAMVASC-UHFFFAOYSA-N 0.000 description 1
- SURHEQARWKWZMT-UHFFFAOYSA-N 4-[8-(4-aminophenoxy)octoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCCOC1=CC=C(N)C=C1 SURHEQARWKWZMT-UHFFFAOYSA-N 0.000 description 1
- PBPYNPXJEIOCEL-UHFFFAOYSA-N 4-[[4-[(4-aminophenyl)methyl]phenyl]methyl]aniline Chemical compound C1=CC(N)=CC=C1CC(C=C1)=CC=C1CC1=CC=C(N)C=C1 PBPYNPXJEIOCEL-UHFFFAOYSA-N 0.000 description 1
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 description 1
- 229940086681 4-aminobenzoate Drugs 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HAEJSGLKJYIYTB-ZZXKWVIFSA-N 4-carboxycinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(C(O)=O)C=C1 HAEJSGLKJYIYTB-ZZXKWVIFSA-N 0.000 description 1
- VSHBABSXFHFTJN-UHFFFAOYSA-N 4-methoxymorpholine Chemical compound CON1CCOCC1 VSHBABSXFHFTJN-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- OAPDPORYXWQVJE-UHFFFAOYSA-N 4-propylaniline Chemical compound CCCC1=CC=C(N)C=C1 OAPDPORYXWQVJE-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- DMGSKALBYZFRAE-UHFFFAOYSA-N 5-methoxy-5-methylhexanoic acid Chemical compound COC(C)(C)CCCC(O)=O DMGSKALBYZFRAE-UHFFFAOYSA-N 0.000 description 1
- PMZBHPUNQNKBOA-UHFFFAOYSA-N 5-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=CC(C(O)=O)=CC(C(O)=O)=C1 PMZBHPUNQNKBOA-UHFFFAOYSA-N 0.000 description 1
- BJLUCDZIWWSFIB-UHFFFAOYSA-N 5-tert-butylbenzene-1,3-dicarboxylic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(O)=O)=C1 BJLUCDZIWWSFIB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- UHUQWLXEMNGTPP-UHFFFAOYSA-N C(=O)(O)C1=CC=C(C=C1)C1(OCCC(C1)(C)C)C1=CC=C(C=C1)C(=O)O Chemical compound C(=O)(O)C1=CC=C(C=C1)C1(OCCC(C1)(C)C)C1=CC=C(C=C1)C(=O)O UHUQWLXEMNGTPP-UHFFFAOYSA-N 0.000 description 1
- UERBMMDUKDUMHR-UHFFFAOYSA-N C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C)(C)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC Chemical compound C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C)(C)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC UERBMMDUKDUMHR-UHFFFAOYSA-N 0.000 description 1
- MSMWHDLMOOPUDG-UHFFFAOYSA-N C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC Chemical compound C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC MSMWHDLMOOPUDG-UHFFFAOYSA-N 0.000 description 1
- BDYWHGZDQJPOHF-UHFFFAOYSA-N C(=O)(O)C=1C=C(C=CC1C(=O)O)C(CCCCCCCCC)C1=CC(=C(C=C1)C(=O)O)C(=O)O Chemical compound C(=O)(O)C=1C=C(C=CC1C(=O)O)C(CCCCCCCCC)C1=CC(=C(C=C1)C(=O)O)C(=O)O BDYWHGZDQJPOHF-UHFFFAOYSA-N 0.000 description 1
- OSDWENQREZOTHL-UHFFFAOYSA-N C(=O)O.NC=1C=C(C=C(C(=O)O)C1)C(=O)O Chemical compound C(=O)O.NC=1C=C(C=C(C(=O)O)C1)C(=O)O OSDWENQREZOTHL-UHFFFAOYSA-N 0.000 description 1
- XTKINVYTSYKFFI-UHFFFAOYSA-N C(C(CCC(C(CCC)C(=O)O)C(=O)O)C(=O)O)C(=O)O Chemical compound C(C(CCC(C(CCC)C(=O)O)C(=O)O)C(=O)O)C(=O)O XTKINVYTSYKFFI-UHFFFAOYSA-N 0.000 description 1
- OTXFGEHSBKFEAB-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC OTXFGEHSBKFEAB-UHFFFAOYSA-N 0.000 description 1
- SWUMRQQSIBCUPC-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SWUMRQQSIBCUPC-UHFFFAOYSA-N 0.000 description 1
- ICWNIKLKVHTFOW-UHFFFAOYSA-N C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC Chemical compound C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC ICWNIKLKVHTFOW-UHFFFAOYSA-N 0.000 description 1
- SNPIERCLNKIBEM-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SNPIERCLNKIBEM-UHFFFAOYSA-N 0.000 description 1
- YDEAAJZYBOCXIO-UHFFFAOYSA-N C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC YDEAAJZYBOCXIO-UHFFFAOYSA-N 0.000 description 1
- KRBLAKCVBGXFPA-UHFFFAOYSA-N C1(=CC=CC=C1)O.NC1=C(C=C(C(=O)O)C(=C1)N)C(=O)O Chemical compound C1(=CC=CC=C1)O.NC1=C(C=C(C(=O)O)C(=C1)N)C(=O)O KRBLAKCVBGXFPA-UHFFFAOYSA-N 0.000 description 1
- MLRHPCHVFJSGQL-UHFFFAOYSA-N C12C(C(C(CC1)CC2)C(=O)O)C(=O)O.C21(CCC(CC2)(CC1)C(=O)O)C(=O)O Chemical compound C12C(C(C(CC1)CC2)C(=O)O)C(=O)O.C21(CCC(CC2)(CC1)C(=O)O)C(=O)O MLRHPCHVFJSGQL-UHFFFAOYSA-N 0.000 description 1
- XVBDXPUCPBDYAJ-UHFFFAOYSA-N CC(C(C1=CC(=CC=C1)N)(C1=CC(=CC=C1)N)C)CCCCCCCC Chemical compound CC(C(C1=CC(=CC=C1)N)(C1=CC(=CC=C1)N)C)CCCCCCCC XVBDXPUCPBDYAJ-UHFFFAOYSA-N 0.000 description 1
- AVYMJHXJQLLKPB-UHFFFAOYSA-N CC(C(C1=CC=C(C=C1)N)(C1=CC=C(C=C1)N)C)CCCCCCCC Chemical compound CC(C(C1=CC=C(C=C1)N)(C1=CC=C(C=C1)N)C)CCCCCCCC AVYMJHXJQLLKPB-UHFFFAOYSA-N 0.000 description 1
- GUGLGYAIYJRFSA-UHFFFAOYSA-N COC(CCCCCCCCCCCCNCCNCCN)(OC)OC Chemical compound COC(CCCCCCCCCCCCNCCNCCN)(OC)OC GUGLGYAIYJRFSA-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101150000715 DA18 gene Proteins 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N Dipicolinic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 244000126211 Hericium coralloides Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- UNVWJAYEKZVDDL-UHFFFAOYSA-N N(C(=O)N)CCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound N(C(=O)N)CCCC(C(OC)(OC)OC)CCCCCCCC UNVWJAYEKZVDDL-UHFFFAOYSA-N 0.000 description 1
- XEEHRQPQNJOFIQ-UHFFFAOYSA-N N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC XEEHRQPQNJOFIQ-UHFFFAOYSA-N 0.000 description 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methylthiourea Natural products CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 1
- HDJGANPLOWXKTM-UHFFFAOYSA-N NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC HDJGANPLOWXKTM-UHFFFAOYSA-N 0.000 description 1
- HNJYHRSYMUUVEX-UHFFFAOYSA-N NC(CC(C(OC)(OC)OC)CCCCCCCC)C Chemical compound NC(CC(C(OC)(OC)OC)CCCCCCCC)C HNJYHRSYMUUVEX-UHFFFAOYSA-N 0.000 description 1
- AJOYCSBPBSZRHI-UHFFFAOYSA-N NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C Chemical compound NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C AJOYCSBPBSZRHI-UHFFFAOYSA-N 0.000 description 1
- KCZYRUHGNZSIEY-UHFFFAOYSA-N NC=1C=C(C=CC1)C(CCCCCCCCC)C1=CC(=CC=C1)N Chemical compound NC=1C=C(C=CC1)C(CCCCCCCCC)C1=CC(=CC=C1)N KCZYRUHGNZSIEY-UHFFFAOYSA-N 0.000 description 1
- VVQRHMZIPYZPDL-UHFFFAOYSA-N NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 VVQRHMZIPYZPDL-UHFFFAOYSA-N 0.000 description 1
- REVLAIHBLDVITK-UHFFFAOYSA-N NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 REVLAIHBLDVITK-UHFFFAOYSA-N 0.000 description 1
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 1
- KTGXWDZUZLWXOF-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)C)CCCCCCCC KTGXWDZUZLWXOF-UHFFFAOYSA-N 0.000 description 1
- PEXBBTCNDBSFHT-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)OC)CCCCCCCC PEXBBTCNDBSFHT-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 239000004954 Polyphthalamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- GWNRJFTZPSCRAY-UHFFFAOYSA-N [3-(3-aminobenzoyl)oxyphenyl] 3-aminobenzoate Chemical compound NC1=CC=CC(C(=O)OC=2C=C(OC(=O)C=3C=C(N)C=CC=3)C=CC=2)=C1 GWNRJFTZPSCRAY-UHFFFAOYSA-N 0.000 description 1
- IVGBGCPUDUTSHT-UHFFFAOYSA-N [3-(3-aminobenzoyl)phenyl]-(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(C=CC=2)C(=O)C=2C=C(N)C=CC=2)=C1 IVGBGCPUDUTSHT-UHFFFAOYSA-N 0.000 description 1
- VRJPMYDKXNTGFV-UHFFFAOYSA-N [3-(4-aminobenzoyl)oxyphenyl] 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)OC1=CC=CC(OC(=O)C=2C=CC(N)=CC=2)=C1 VRJPMYDKXNTGFV-UHFFFAOYSA-N 0.000 description 1
- UVXIFYUJZWURAR-UHFFFAOYSA-N [3-(4-aminobenzoyl)phenyl]-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC(C(=O)C=2C=CC(N)=CC=2)=C1 UVXIFYUJZWURAR-UHFFFAOYSA-N 0.000 description 1
- SLROFZGOINZDQM-UHFFFAOYSA-N [4-(3-aminobenzoyl)oxyphenyl] 3-aminobenzoate Chemical compound NC1=CC=CC(C(=O)OC=2C=CC(OC(=O)C=3C=C(N)C=CC=3)=CC=2)=C1 SLROFZGOINZDQM-UHFFFAOYSA-N 0.000 description 1
- DBCMPVCYHLRHND-UHFFFAOYSA-N [4-(4-aminobenzoyl)phenyl]-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(C(=O)C=2C=CC(N)=CC=2)C=C1 DBCMPVCYHLRHND-UHFFFAOYSA-N 0.000 description 1
- PNVBTTRFUJULII-UHFFFAOYSA-N [C].[Pt]=S Chemical compound [C].[Pt]=S PNVBTTRFUJULII-UHFFFAOYSA-N 0.000 description 1
- JYMLXNHXFPCRGW-UHFFFAOYSA-N acetic acid;methyl hydrogen sulfate Chemical compound CC(O)=O.COS(O)(=O)=O JYMLXNHXFPCRGW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- FLNKWZNWHZDGRT-UHFFFAOYSA-N azane;dihydrochloride Chemical compound [NH4+].[NH4+].[Cl-].[Cl-] FLNKWZNWHZDGRT-UHFFFAOYSA-N 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- DVWBKCSKPCZFDE-UHFFFAOYSA-N bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylic acid Chemical compound C1CC2C(C(=O)O)=C(C(O)=O)C1C2 DVWBKCSKPCZFDE-UHFFFAOYSA-N 0.000 description 1
- JRXXLCKWQFKACW-UHFFFAOYSA-N biphenylacetylene Chemical compound C1=CC=CC=C1C#CC1=CC=CC=C1 JRXXLCKWQFKACW-UHFFFAOYSA-N 0.000 description 1
- GSEZYWGNEACOIW-UHFFFAOYSA-N bis(2-aminophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1N GSEZYWGNEACOIW-UHFFFAOYSA-N 0.000 description 1
- MKFFVFISLKXOSB-UHFFFAOYSA-N bis(3-aminophenyl) benzene-1,3-dicarboxylate Chemical compound NC1=CC=CC(OC(=O)C=2C=C(C=CC=2)C(=O)OC=2C=C(N)C=CC=2)=C1 MKFFVFISLKXOSB-UHFFFAOYSA-N 0.000 description 1
- TUQQUUXMCKXGDI-UHFFFAOYSA-N bis(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(N)C=CC=2)=C1 TUQQUUXMCKXGDI-UHFFFAOYSA-N 0.000 description 1
- FRCGXWDENTYRDC-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,3-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=CC(C(=O)OC=2C=CC(N)=CC=2)=C1 FRCGXWDENTYRDC-UHFFFAOYSA-N 0.000 description 1
- CFTXGNJIXHFHTH-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,4-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=C(C(=O)OC=2C=CC(N)=CC=2)C=C1 CFTXGNJIXHFHTH-UHFFFAOYSA-N 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- GGAUUQHSCNMCAU-UHFFFAOYSA-N butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)CC(C(O)=O)C(C(O)=O)CC(O)=O GGAUUQHSCNMCAU-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- XJFOWLSPGTXOAR-UHFFFAOYSA-N butanedioic acid;naphthalene Chemical compound OC(=O)CCC(O)=O.C1=CC=CC2=CC=CC=C21 XJFOWLSPGTXOAR-UHFFFAOYSA-N 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- MUYSADWCWFFZKR-UHFFFAOYSA-N cinchomeronic acid Chemical compound OC(=O)C1=CC=NC=C1C(O)=O MUYSADWCWFFZKR-UHFFFAOYSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- YHAJXZJGWSOHHZ-UHFFFAOYSA-N cyclobut-3-ene-1,2-dicarboxylic acid Chemical compound OC(=O)C1C=CC1C(O)=O YHAJXZJGWSOHHZ-UHFFFAOYSA-N 0.000 description 1
- CCQPAEQGAVNNIA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-N 0.000 description 1
- WYHYNUWZLKTEEY-UHFFFAOYSA-N cyclobutane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C1 WYHYNUWZLKTEEY-UHFFFAOYSA-N 0.000 description 1
- UMOGLHXZZGEOAW-UHFFFAOYSA-N cyclobutene-1,2-dicarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)CC1 UMOGLHXZZGEOAW-UHFFFAOYSA-N 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- XBZSBBLNHFMTEB-UHFFFAOYSA-N cyclohexane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCCC(C(O)=O)C1 XBZSBBLNHFMTEB-UHFFFAOYSA-N 0.000 description 1
- YZFOGXKZTWZVFN-UHFFFAOYSA-N cyclopentane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1 YZFOGXKZTWZVFN-UHFFFAOYSA-N 0.000 description 1
- LNGJOYPCXLOTKL-UHFFFAOYSA-N cyclopentane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)C1 LNGJOYPCXLOTKL-UHFFFAOYSA-N 0.000 description 1
- FDKLLWKMYAMLIF-UHFFFAOYSA-N cyclopropane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CC1 FDKLLWKMYAMLIF-UHFFFAOYSA-N 0.000 description 1
- RLWFMZKPPHHHCB-UHFFFAOYSA-N cyclopropane-1,2-dicarboxylate;hydron Chemical compound OC(=O)C1CC1C(O)=O RLWFMZKPPHHHCB-UHFFFAOYSA-N 0.000 description 1
- DHDZMONMPFKUJO-UHFFFAOYSA-N decane-1,9-diamine Chemical compound CC(N)CCCCCCCCN DHDZMONMPFKUJO-UHFFFAOYSA-N 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- OREAFAJWWJHCOT-UHFFFAOYSA-N dimethylmalonic acid Chemical compound OC(=O)C(C)(C)C(O)=O OREAFAJWWJHCOT-UHFFFAOYSA-N 0.000 description 1
- MPFLRYZEEAQMLQ-UHFFFAOYSA-N dinicotinic acid Chemical compound OC(=O)C1=CN=CC(C(O)=O)=C1 MPFLRYZEEAQMLQ-UHFFFAOYSA-N 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical group CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- SYLAFCZSYRXBJF-UHFFFAOYSA-N furan-3,4-dicarboxylic acid Chemical compound OC(=O)C1=COC=C1C(O)=O SYLAFCZSYRXBJF-UHFFFAOYSA-N 0.000 description 1
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- GLFIUJOSKPPXAZ-UHFFFAOYSA-N hexacyclo[8.4.1.13,8.02,9.04,7.011,14]hexadecane-5,6,12,13-tetracarboxylic acid Chemical compound C1C2C3C(C4C5C(C4C(O)=O)C(O)=O)CC5C3C1C1C2C(C(=O)O)C1C(O)=O GLFIUJOSKPPXAZ-UHFFFAOYSA-N 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- MJIVRKPEXXHNJT-UHFFFAOYSA-N lutidinic acid Chemical compound OC(=O)C1=CC=NC(C(O)=O)=C1 MJIVRKPEXXHNJT-UHFFFAOYSA-N 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- XGEGHDBEHXKFPX-NJFSPNSNSA-N methylurea Chemical compound [14CH3]NC(N)=O XGEGHDBEHXKFPX-NJFSPNSNSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- LSCYTCMNCWMCQE-UHFFFAOYSA-N n-methylpyridin-4-amine Chemical compound CNC1=CC=NC=C1 LSCYTCMNCWMCQE-UHFFFAOYSA-N 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- OKBVMLGZPNDWJK-UHFFFAOYSA-N naphthalene-1,4-diamine Chemical compound C1=CC=C2C(N)=CC=C(N)C2=C1 OKBVMLGZPNDWJK-UHFFFAOYSA-N 0.000 description 1
- ABMFBCRYHDZLRD-UHFFFAOYSA-N naphthalene-1,4-dicarboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1 ABMFBCRYHDZLRD-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- VAWFFNJAPKXVPH-UHFFFAOYSA-N naphthalene-1,6-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC2=CC(C(=O)O)=CC=C21 VAWFFNJAPKXVPH-UHFFFAOYSA-N 0.000 description 1
- GOGZBMRXLADNEV-UHFFFAOYSA-N naphthalene-2,6-diamine Chemical compound C1=C(N)C=CC2=CC(N)=CC=C21 GOGZBMRXLADNEV-UHFFFAOYSA-N 0.000 description 1
- HBJPJUGOYJOSLR-UHFFFAOYSA-N naphthalene-2,7-diamine Chemical compound C1=CC(N)=CC2=CC(N)=CC=C21 HBJPJUGOYJOSLR-UHFFFAOYSA-N 0.000 description 1
- WPUMVKJOWWJPRK-UHFFFAOYSA-N naphthalene-2,7-dicarboxylic acid Chemical compound C1=CC(C(O)=O)=CC2=CC(C(=O)O)=CC=C21 WPUMVKJOWWJPRK-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- UFOIOXZLTXNHQH-UHFFFAOYSA-N oxolane-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1OC(C(O)=O)C(C(O)=O)C1C(O)=O UFOIOXZLTXNHQH-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 238000011907 photodimerization Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006375 polyphtalamide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- ILVGAIQLOCKNQA-UHFFFAOYSA-N propyl 2-hydroxypropanoate Chemical compound CCCOC(=O)C(C)O ILVGAIQLOCKNQA-UHFFFAOYSA-N 0.000 description 1
- 229940032159 propylene carbonate Drugs 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- JREWFSHZWRKNBM-UHFFFAOYSA-N pyridine-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1=CN=C(C(O)=O)C(C(O)=O)=C1C(O)=O JREWFSHZWRKNBM-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- JQZAKMJZYGPUFD-UHFFFAOYSA-N spiro[3.3]heptane-2,6-dicarboxylic acid Chemical compound C1C(C(=O)O)CC21CC(C(O)=O)C2 JQZAKMJZYGPUFD-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- QWFRRFLKWRIKSZ-UHFFFAOYSA-N truxillic acid Chemical compound OC(=O)C1C(C=2C=CC=CC=2)C(C(O)=O)C1C1=CC=CC=C1 QWFRRFLKWRIKSZ-UHFFFAOYSA-N 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/13378—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
- G02F1/133788—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mathematical Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Description
本發明係表示有關液晶配向膜之製造方法、藉由該製造方法所得之液晶配向膜及使用該液晶配向膜的液晶顯示元件。 The present invention relates to a method for producing a liquid crystal alignment film, a liquid crystal alignment film obtained by the production method, and a liquid crystal display element using the liquid crystal alignment film.
液晶顯示元件係以質輕、薄型且低耗電的顯示裝置為人所知,近年則用於大型電視用途等,達到令人矚目的發展。液晶顯示元件係表示例如藉由具備電極之透明的一對基板,挾持液晶層所構成。又,液晶顯示元件中,為了使液晶在基板間成為所要的配向狀態時,有機材料所構成的有機膜作為液晶配向膜使用。 Liquid crystal display elements are known as light, thin, and low-power display devices, and have been used in large-scale television applications in recent years, and have achieved remarkable development. The liquid crystal display element is formed by, for example, holding a liquid crystal layer by a pair of substrates having transparent electrodes. Further, in the liquid crystal display device, an organic film made of an organic material is used as a liquid crystal alignment film in order to bring the liquid crystal into a desired alignment state between the substrates.
換言之,液晶配向膜係表示液晶顯示元件的構成構件,形成於與挾持液晶之基板的液晶接觸的面,擔任在該基板間使液晶配向於一定方向的功用。液晶配向膜除了使液晶配向於例如對於基板為平行的方向等之一定的方向的功用,且具有控制液晶之預傾角(Pretiltangle)的功用。此液晶配向膜中控制液晶配向的能力(以下稱為配向控制能)係表示藉由對構成液晶配向膜之有機膜進行配向處理而被賦予。 In other words, the liquid crystal alignment film indicates a constituent member of the liquid crystal display element, and is formed on a surface that is in contact with the liquid crystal of the substrate on which the liquid crystal is held, and serves to align the liquid crystal in a predetermined direction between the substrates. The liquid crystal alignment film has a function of controlling the pretilt angle of the liquid crystal in addition to aligning the liquid crystal to a certain direction such as a direction in which the substrates are parallel. The ability to control the alignment of the liquid crystal in the liquid crystal alignment film (hereinafter referred to as the alignment control energy) is indicated by the alignment treatment of the organic film constituting the liquid crystal alignment film.
現在,用於工業上之主要的液晶配向膜係將聚醯亞胺前驅物(聚醯胺酸(Polyamic acid)、聚醯胺酸酯)、聚醯亞胺等溶液所構成之聚醯亞胺系的液晶配向處理劑塗佈 於基板,進行成膜而製作的。 Nowadays, the main liquid crystal alignment film used in the industry is a polyimine composed of a solution of a polyimide precursor (polyamic acid, polyphthalate) or polyimine. Liquid crystal alignment treatment coating It is produced by film formation on a substrate.
又,對於基板面,使液晶水平配向、平行配向或傾斜配向等時,進行成膜後,藉由摩擦(rubbing)進行表面延伸處理。此外也提案利用藉由偏光紫外線照射等之各向異性光學反應的方法,近年則是檢討朝向工業化的方法。 Further, when the liquid crystal is horizontally aligned, parallel-aligned, or obliquely aligned, etc., the surface of the substrate is subjected to surface stretching treatment by rubbing. In addition, a method of anisotropic optical reaction by polarized ultraviolet light irradiation or the like has been proposed, and in recent years, a method toward industrialization has been reviewed.
摩擦處理係對於基板上之聚乙烯醇或聚醯胺或聚醯亞胺等的有機膜,其表面以綿、耐倫(nylon)、聚酯等的布,一定方向擦拭(摩擦),使液晶配向於擦拭後之方向(摩擦方向)的方法。此摩擦法係較簡便,可實現比較安定之液晶的配向狀態,因此被用於以往液晶顯示元件的製程。 The rubbing treatment is an organic film such as polyvinyl alcohol or polyamide or polyimide on a substrate, and the surface thereof is wiped (frictionally) in a certain direction with a cloth such as cotton, nylon or polyester to make a liquid crystal. A method of aligning the direction (friction direction) after wiping. This rubbing method is simple and can realize the alignment state of the relatively stable liquid crystal, and thus is used in the process of the conventional liquid crystal display element.
但是擦拭由聚醯亞胺等所構成之液晶配向膜之表面的摩擦法,有產生灰塵或靜電的問題。又,因近年之液晶表元件的高精細化、對應之基板上的電極或液晶驅動用之切換主動元件所造成的凹凸,因此液晶配向膜的表面無法使用布均勻擦拭,有時無法實現均勻的液晶配向。 However, the rubbing method of wiping the surface of the liquid crystal alignment film composed of polyimide or the like has a problem of generating dust or static electricity. In addition, due to the high definition of the liquid crystal display element in recent years, the unevenness caused by the switching of the active element on the substrate or the liquid crystal driving, the surface of the liquid crystal alignment film cannot be uniformly wiped with a cloth, and uniformity may not be achieved. LCD alignment.
取代摩擦處理之液晶配向膜的配向處理方法,正積極檢討光配向法。提案例如利用藉由偏光紫外線照射等之各向異性光化學反應的光配向方法,近年則是檢討朝向工業化的方法。 The alignment method of the liquid crystal alignment film which replaces the rubbing treatment is actively reviewing the photoalignment method. For example, a photo-alignment method using an anisotropic photochemical reaction such as polarized ultraviolet ray irradiation has been proposed, and in recent years, a method toward industrialization has been reviewed.
光配向法有幾種方法,一般而言,藉由直線偏光或平行化(collimate)的光於構成液晶配向膜之有機膜的表面形成各向異性,依據該各向異性使液晶配向者。 There are several methods for the photo-alignment method. Generally, anisotropy is formed on the surface of the organic film constituting the liquid crystal alignment film by linearly polarized or collimated light, and the liquid crystal is aligned according to the anisotropy.
主要之具體的光配向法例如有分解型的光配向法為人 所知。分解型的光配向法係指例如將偏光紫外線照射於聚醯亞胺膜,利用分子結構之紫外線吸收的偏光方向依存性,產生各向異性的分解,藉由未分解殘留的聚醯亞胺,使液晶配向的方法(參照例如專利文獻1)。 The main specific optical alignment method, for example, has a decomposed photo-alignment method for human beings. Known. The decomposition-type photo-alignment method is, for example, that a polarized ultraviolet ray is irradiated onto a polyimide film, and an anisotropic decomposition occurs by utilizing a polarization dependence of ultraviolet absorption of a molecular structure, and the polyimine is not decomposed. A method of aligning liquid crystals (see, for example, Patent Document 1).
又,二聚化型的光配向法也為人知。二聚化型的光配向法係指使用例如聚乙烯基肉桂酸酯,照射偏光紫外線,在與偏光平行之2個側鏈之雙鍵部分,產生二聚化反應,使液晶配向於與偏光方向直交之方向的方法(參照例如非專利文獻1)。 Further, a dimerization type photoalignment method is also known. The dimerization type photo-alignment method refers to the use of, for example, polyvinyl cinnamate to irradiate polarized ultraviolet rays, and a dimerization reaction occurs in the double bond portions of two side chains parallel to the polarized light to align the liquid crystal with the polarization direction. A method of the direction of the orthogonality (see, for example, Non-Patent Document 1).
如上述,藉由光配向法之液晶配向膜的配向處理方法係不用摩擦,無發生灰塵或靜電的疑慮。又,藉由光配向法之液晶配向膜的配向處理方法,即使表面有凹凸之液晶顯示元件的基板,也可實施配向處理,也可適用於工業上的生產製程。 As described above, the alignment treatment method of the liquid crystal alignment film by the photo-alignment method does not require rubbing, and there is no doubt that dust or static electricity is generated. Moreover, the alignment treatment method of the liquid crystal alignment film by the photo-alignment method can be applied to an industrial production process even if the substrate of the liquid crystal display element having the uneven surface is subjected to the alignment treatment.
又,液晶顯示元件之顯示特性之提昇係使用改變聚醯胺酸、聚醯胺酸酯、聚醯亞胺等之結構的方法、摻合特性不同之聚醯胺酸、聚醯胺酸酯、聚醯亞胺等的方法、添加添加劑的方法等,改善液晶配向性及電特性等、控制預傾角等。例如提案使用以具有特定結構之基團作為側鏈的聚合物(參照專利文獻2)。 Further, the display characteristics of the liquid crystal display element are improved by using a method of changing the structure of polyacrylic acid, polyamidomate, polythenimine or the like, polyglycolic acid, polyglycolate having different blending characteristics, A method such as polyimide or a method of adding an additive, etc., improves liquid crystal alignment property, electrical characteristics, etc., and controls a pretilt angle. For example, it is proposed to use a polymer having a specific structure as a side chain (see Patent Document 2).
但是隨著液晶顯示元件之高性能化、大面積化、顯示裝置之省電化等,液晶配向膜所要求的特性也變得嚴格。專利文獻2等使用以往液晶配向處理劑時,有燒焦特性不足,因AC(交流)驅動使液晶配向性能變化產生殘像的問 題。 However, as the performance of the liquid crystal display element is increased, the area is increased, and the power consumption of the display device is reduced, the characteristics required for the liquid crystal alignment film are also severe. When the conventional liquid crystal alignment treatment agent is used in Patent Document 2 or the like, the scorch characteristics are insufficient, and the residual image of the liquid crystal alignment performance is changed by AC (alternating current) driving. question.
[專利文獻1]日本專利第3893659號公報 [Patent Document 1] Japanese Patent No. 3893659
[專利文獻2]日本特表2001-517719號公報 [Patent Document 2] Japanese Patent Publication No. 2001-517719
[非專利文獻1]M.Shadt et al., Jpn. J. Appl. Phys. 31, 2155 (1992) [Non-Patent Document 1] M. Shadt et al., Jpn. J. Appl. Phys. 31, 2155 (1992)
光配向法係以液晶顯示元件之配向處理方法而言,相較於以往已用於工業上的摩擦處理時,不需要摩擦步驟,具有較大的優點。 In the photo-alignment method, the alignment treatment method of the liquid crystal display element has a large advantage in that it does not require a rubbing step as compared with the conventional rubbing treatment used in the industry.
但是上述專利文獻1所記載之分解型的光配向法係對於聚醯亞胺膜,由輸出500W之高壓水銀燈的紫外光照射60分鐘等,需要長時間且大量的紫外線照射。 However, in the decomposition type photo-alignment method described in Patent Document 1, the polyimide film is irradiated with ultraviolet light of a high-pressure mercury lamp of 500 W for 60 minutes or the like, and it takes a long time and a large amount of ultraviolet rays to be irradiated.
又,二聚化型之光配向法,有時需要數~數十焦耳(J)程度之大量的紫外線照射。又,對於液晶配向膜之紫外線的照射量,即使僅為數十~數百微焦耳(mJ)程度時,為了得到均勻之液晶配向時,必須大量導入光反應基 的導入量。因此,即使紫外線照射後,有時也有殘留未反應基,使用這種液晶配向膜的液晶顯示元件係藉由背光或外光,使未反應基反應,而有液晶之配向狀態產生變化等不良的問題。如此,必須大量的紫外線照射,或未反應的光反應基殘存係因液晶配向膜所用之有機膜的光反應效率較低而造成的。 Further, in the dimerization type photoalignment method, a large amount of ultraviolet irradiation of several to several tens of joules (J) is sometimes required. Further, when the amount of ultraviolet rays irradiated to the liquid crystal alignment film is only about several tens to several hundreds of microjoules (mJ), in order to obtain uniform liquid crystal alignment, it is necessary to introduce a large amount of photoreactive groups. The amount of imports. Therefore, even after ultraviolet irradiation, unreacted groups may remain, and the liquid crystal display element using such a liquid crystal alignment film may react with an unreacted group by a backlight or external light, and may have a change in the alignment state of the liquid crystal. problem. Thus, a large amount of ultraviolet ray irradiation or an unreacted photoreactive group remains due to a low photoreaction efficiency of the organic film used for the liquid crystal alignment film.
換言之,需要開發一種光反應效率高之液晶配向膜用的有機膜材料及開發一種可提高光反應效率之液晶配向膜的製造方法。 In other words, it is necessary to develop an organic film material for a liquid crystal alignment film having high photoreaction efficiency and to develop a method for producing a liquid crystal alignment film which can improve photoreaction efficiency.
本發明的目的係提供一種實現高的光反應效率,可進行高效率之配向處理之液晶配向膜的製造方法、具備所得之液晶配向膜的液晶顯示元件。 An object of the present invention is to provide a method for producing a liquid crystal alignment film which can realize high-efficiency photoreaction efficiency, which can perform high-efficiency alignment treatment, and a liquid crystal display element including the obtained liquid crystal alignment film.
又,本發明之目的係提供利用使用新穎二胺所得之聚醯亞胺前驅物之液晶配向膜的製造方法、使用所得之液晶配向膜,可降低因AC驅動所造成之液晶配向性能之變化之殘像特性良好的液晶顯示元件。 Moreover, the object of the present invention is to provide a method for producing a liquid crystal alignment film using a polyimide precursor obtained by using a novel diamine, and using the obtained liquid crystal alignment film, which can reduce variations in liquid crystal alignment properties caused by AC driving. A liquid crystal display element having excellent afterimage characteristics.
本發明人經過精心研究的結果,遂完成以下(1)~(12)之技術要件的本發明。 As a result of intensive research, the inventors have completed the present invention of the technical requirements of the following (1) to (12).
(1)一種液晶配向膜之製造方法,其特徵係於基板上形成含有具有光反應基之聚醯亞胺或聚醯亞胺前驅物的薄膜,將前薄膜面邊加熱,邊照射經偏光後的紫外線,於前述基板上製造由含有聚醯亞胺前驅物之高分子所構成的 液晶配向膜。 (1) A method for producing a liquid crystal alignment film, characterized in that a film containing a photoreactive group of a polyimide or a polyimide precursor is formed on a substrate, and the front film side is heated while being irradiated with a polarized light. Ultraviolet light, which is made of a polymer containing a polyimide precursor on the substrate. Liquid crystal alignment film.
(2)如前述(1)項之液晶配向膜之製造方法,其中前述具有光反應基的聚醯亞胺前驅物係含有以下述式[1]表示之重複單位及以下述式[2]表示之重複單位,
(3)如前述(1)項之液晶配向膜之製造方法,前述具有光反應基的聚醯亞胺前驅物係含有以上述式[1]表示之重複單位及以下述式[3]表示之重複單位,
(4)如前述(1)項之液晶配向膜之製造方法,其中前述具有光反應基的聚醯亞胺前驅物為使含有以下述式[4]表示之二胺的二胺成分與四羧酸二酐進行聚縮合反應(polycondensation)而得者,
(5)如前述(1)~(4)項中任一項之液晶配向膜之製造方法,其中前述薄膜的厚度為5~300nm。 (5) The method for producing a liquid crystal alignment film according to any one of the above items, wherein the film has a thickness of 5 to 300 nm.
(6)如前述(1)~(5)項中任一項之液晶配向膜之製造方法,其中前述具有光反應基之聚醯亞胺前驅物的含量為0.1~30質量%,使用含有溶劑的液晶配向處理劑形成 前述薄膜。 (6) The method for producing a liquid crystal alignment film according to any one of the above aspects, wherein the content of the photoreactive group-containing polyimine precursor is 0.1 to 30% by mass, and the solvent is used. Liquid crystal alignment treatment agent formation The aforementioned film.
(7)如前述(1)~(6)項中任一項之液晶配向膜之製造方法,其中前述加熱之溫度係選自前述具有光反應基的聚醯亞胺前驅物不會變成聚醯亞胺之溫度範圍的溫度。 (7) The method for producing a liquid crystal alignment film according to any one of the above aspects, wherein the temperature of the heating is selected from the group consisting of the above-mentioned photoreactive group-containing polyimide precursor does not become polyfluorene. The temperature in the temperature range of the imine.
(8)如前述(1)~(7)項中任一項之液晶配向膜之製造方法,其中前述加熱之溫度係50℃~300℃的範圍內。 (8) The method for producing a liquid crystal alignment film according to any one of the preceding claims, wherein the heating temperature is in a range of from 50 ° C to 300 ° C.
(9)如前述(1)~(8)項中任一項之液晶配向膜之製造方法,其中前述加熱之溫度為80℃~250℃的範圍內。 (9) The method for producing a liquid crystal alignment film according to any one of the above (1), wherein the heating temperature is in a range of from 80 °C to 250 °C.
(10)如前述(1)~(9)項中任一項之液晶配向膜之製造方法,其中紫外線的照射量為100~1000mJ。 (10) The method for producing a liquid crystal alignment film according to any one of the items (1) to (9), wherein the ultraviolet ray irradiation amount is 100 to 1000 mJ.
(11)一種液晶配向膜,其特徵係藉由如前述(1)~(10)項中任一項之液晶配向膜之製造方法所製造。 (11) A liquid crystal alignment film produced by the method for producing a liquid crystal alignment film according to any one of the items (1) to (10) above.
(12)一種液晶顯示元件,其特徵係具有如前述(11)項的液晶配向膜。 (12) A liquid crystal display element characterized by having the liquid crystal alignment film of the above (11).
依據本發明時,可提供實現高的光反應效率,可進行高效率之配向處理的液晶配向膜之製造方法。使用所得之液晶配向膜的液晶顯示元件係高的製造效率,且液晶配向膜內之光反應殘基少,即使長期間使用也不易發生液晶之配向狀態產生變化等的不良。 According to the present invention, it is possible to provide a method for producing a liquid crystal alignment film which can realize high photoreaction efficiency and can perform high-efficiency alignment treatment. The liquid crystal display element using the obtained liquid crystal alignment film has high manufacturing efficiency, and has few photoreactive residues in the liquid crystal alignment film, and it is less likely to cause a change in the alignment state of the liquid crystal even when used for a long period of time.
本發明不需要對液晶配向膜再進行摩擦。又,實現含有聚醯亞胺前驅物之高分子膜之高反應效率的光反應,可 製造高效率的液晶配向膜。 The present invention does not require friction on the liquid crystal alignment film. Moreover, a photoreaction with high reaction efficiency of a polymer film containing a polyimide precursor is realized. A highly efficient liquid crystal alignment film is produced.
又,本發明中,使用由新穎二胺所得之聚醯亞胺前驅物,具有液晶配向膜的液晶顯示元件,可減低因AC驅動所造成之液晶配向性能變化,且液晶配向性能不易變化,不易產生殘像。 Further, in the present invention, a polyimine precursor obtained from a novel diamine, a liquid crystal display element having a liquid crystal alignment film, can reduce a change in liquid crystal alignment property caused by AC driving, and the liquid crystal alignment property is not easily changed, and is difficult to be used. Generate afterimages.
本發明之液晶配向膜之製造方法係利用使用含有聚醯亞胺前驅物的高分子膜,藉由偏光照射進行配向處理的方法。例如於基板上形成具有光反應基之聚醯胺酸酯衍生物的膜,接著進行加熱,維持加熱狀態同時對膜面照射經偏光後的紫外線,於基板上形成由聚醯胺酸酯衍生物所構成的液晶配向膜。 The method for producing a liquid crystal alignment film of the present invention is a method of performing an alignment treatment by polarized light irradiation using a polymer film containing a polyimide precursor. For example, a film of a polyphthalate derivative having a photoreactive group is formed on a substrate, followed by heating to maintain a heated state while irradiating the film surface with polarized ultraviolet rays to form a polyphthalate derivative on the substrate. A liquid crystal alignment film formed.
本發明之液晶配向膜之製造方法中所使用的聚醯亞胺前驅物係含有以下述式[1]表示之重複單位及選自由以下述式[2]表示之重複單位及下述式[3]表示之重複單位之至少一種。以下述式[2]及式[3]表示之重複單位具有光反應基。 The polyimine precursor used in the method for producing a liquid crystal alignment film of the present invention contains a repeating unit represented by the following formula [1] and a repeating unit represented by the following formula [2] and the following formula [3] ] indicates at least one of the repeating units. The repeating unit represented by the following formula [2] and formula [3] has a photoreactive group.
上述式[1]中,R1係2價有機基。R2係表示4價有機基。R3係表示氫原子或碳數1~6之有機基。R4係表示氫原子或 碳數1~6之有機基。n1係表示正的整數。 In the above formula [1], R 1 is a divalent organic group. R 2 represents a tetravalent organic group. R 3 represents a hydrogen atom or an organic group having 1 to 6 carbon atoms. R 4 represents a hydrogen atom or an organic group having 1 to 6 carbon atoms. The n 1 system represents a positive integer.
以上述式[1]表示之重複單位可使用以下述式[1-A]表示之二胺成分及以下述式[1-B]表示之四羧酸之酸酐的四羧酸二酐成分得到。 The repeating unit represented by the above formula [1] can be obtained by using a diamine component represented by the following formula [1-A] and a tetracarboxylic dianhydride component of an acid anhydride of a tetracarboxylic acid represented by the following formula [1-B].
上述式[1-A]與式[1-B]中,R1及R2係與上述式[1]中之R1及R2相同。 In the above formula [1-A] and formula [1-B], R 1 and R 2 are the same as R 1 and R 2 in the above formula [1].
以上述式[1-A]表示之二胺成分的具體例有對-苯二胺、2,3,5,6-四甲基-對-苯二胺、2,5-二甲基-對-苯二胺、間-苯二胺、2,4-二甲基-間-苯二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄醇、2,4-二胺基苄醇、4,6-二胺基間苯二酚、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、 雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二苯胺、3,3’-硫二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、4,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,3-伸苯基雙(亞甲基)]二苯胺、1,4-伸苯基雙[(4-胺基苯基)甲酮]、1,4-伸苯基雙[(3-胺基苯基)甲 酮]、1,3-伸苯基雙[(4-胺基苯基)甲酮]、1,3-伸苯基雙[(3-胺基苯基)甲酮]、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯醯胺)、N,N’-雙(1,3-伸苯基)雙(3-胺基苯醯胺)、N,N’-雙(4-胺基苯基)對苯二甲醯胺、N,N’-雙(3-胺基苯基)對苯二甲醯胺、N,N’-雙(4-胺基苯基)間苯二甲醯胺、N,N’-雙(3-胺基苯基)間苯二甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-雙(3- 胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷、4-(胺基甲基)苯胺、3-(胺基甲基)苯胺、3-((胺基甲基)甲基)苯胺、4-(2-胺基乙基)苯胺、3-(2-胺基乙基苯胺)等之芳香族二胺、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷等之脂環式二胺、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、1,11-二胺基十一烷、1,12-二胺基十二烷等之脂肪族二胺等。 Specific examples of the diamine component represented by the above formula [1-A] include p-phenylenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, and 2,5-dimethyl-pair. -phenylenediamine, m-phenylenediamine, 2,4-dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diamino Phenol, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoisophthalic acid Phenol, 4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diamine Biphenyl, 3,3'-dihydroxy-4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro- 4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-di Aminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-di Aminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4' -diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodi Phenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, Bis(3-aminophenyl)decane, dimethyl-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2, 2'-Diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N-methyl (3, 3'-Diaminodiphenyl)amine, N-methyl(3,4'-diaminodiphenyl)amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'- Diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diamino Naphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7 -diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane, 1,3 - bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4- (3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-aminophenoxy)benzene, 1,3- Bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4- Aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylenebis(methylene)]diphenylamine, 4,4' -[1,3-phenylenebis(methylene)]diphenylamine, 3,4'-[1,4-phenylenebis(methylene)]diphenylamine, 3,4'-[1, 3-phenylphenylbis(methylene)]diphenylamine, 3,3'-[1,4-phenylenebis(methylene)]diphenylamine, 3,3'-[1,3-phenylene Bis(methylene)]diphenylamine, 1,4-phenylene bis[(4-aminophenyl)methanone], 1,4-phenylene bis[(3-aminophenyl)methyl Ketone], 1,3-phenylene bis[(4-aminophenyl)methanone], 1,3-phenylene bis[(3-aminophenyl)methanone], 1,4-stretch Phenyl bis(4-aminobenzoate), 1,4-phenylene bis(3-aminobenzoate), 1,3-phenylene bis(4-aminobenzoate) ), 1,3-phenylene bis(3-aminobenzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalic acid Acid ester, bis(4-aminophenyl)isophthalate, bis(3-aminophenyl)isophthalate, N,N'-(1,4-phenylene) double (4-Aminobenzoguanamine), N,N'-(1,3-phenylene)bis(4-aminophenylguanamine), N,N'-(1,4-phenylene) double (3-aminophenylguanamine), N,N'-bis(1,3-phenylene)bis(3-aminophenylguanamine), N,N'-bis(4-aminophenyl) Paraxylamine, N,N'-bis(3-aminophenyl)terephthalamide, N,N'-bis(4-aminophenyl)m-xylyleneamine, N , N'-bis(3-aminophenyl)m-xylyleneamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy) Diphenylanthracene, 2,2'-bis[4-(4-aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl]hexa Fluoropropane, 2,2'-bis(4-aminophenyl) Fluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2'-double (4-Aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane, 1,3 - bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,4- Bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,5-bis(3-aminophenoxy)pentane, 1,6 - bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1, 7-double (3- Aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis (4) -aminophenoxy)decane, 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminophenoxy)decane, 1,10-(3- Aminophenoxy)decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-aminophenoxy)undecane, 1,12-(4- Aminophenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane, 4-(aminomethyl)aniline, 3-(aminomethyl)aniline, 3-( Aromatic diamines such as (aminomethyl)methyl)aniline, 4-(2-aminoethyl)aniline, 3-(2-aminoethylaniline), bis(4-aminocyclohexyl) An alicyclic diamine such as methane or bis(4-amino-3-methylcyclohexyl)methane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diamine Pentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-diamine An aliphatic diamine such as decane, 1,11-diaminoundecane or 1,12-diaminododecane.
另外,以上述式[1-A]表示之二胺成分的其他例,例如有在二胺側鏈具有烷基、含氟烷基、芳香環、脂肪族環或雜環者、或具有此等所構成之大環狀取代物者等。具體而言,例如有下述式[DA1]~式[DA30]表示之二胺化合物。 Further, other examples of the diamine component represented by the above formula [1-A] include, for example, an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring or a heterocyclic ring in the side chain of the diamine, or have such a A large ring-shaped substitute composed of the like. Specifically, for example, there is a diamine compound represented by the following formula [DA1] to formula [DA30].
上述式[DA1]~式[DA6]中,A2係表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A3表示碳數1~22之直鏈狀或分支狀烷基、或碳數1~22之直鏈狀或分支狀含氟烷基。 In the above formula [DA1]~form [DA6], A 2 represents -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, A 3 represents a linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.
式[DA7]中,p為1~10之整數。 In the formula [DA7], p is an integer of 1 to 10.
式[DA8]~[DA12]中,A4係表示碳數2~24之烷基或含氟烷基。 In the formula [DA8] to [DA12], A 4 represents an alkyl group having 2 to 24 carbon atoms or a fluorine-containing alkyl group.
式[DA13]及式[DA15]中,A5係表示-O-、-OCH2-、-CH2O-、-COOCH2-、或-CH2OCO-,A6係表示碳數1~22之烷基、烷氧基、含氟烷氧或含氟烷氧氧。 In the formula [DA13] and the formula [DA15], A 5 represents -O-, -OCH 2 -, -CH 2 O-, -COOCH 2 -, or -CH 2 OCO-, and the A 6 system represents a carbon number of 1~. 22 alkyl, alkoxy, fluoroalkoxy or fluoroalkoxy.
式[DA16]~[DA18]中,A7係表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、或-CH2-,A8係表示碳數1~22之烷基、烷氧基、含氟烷氧或含氟烷氧氧。 In the formula [DA16]~[DA18], A 7 represents -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 - or -CH 2 -, A 8 represents an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkoxy group or a fluorine-containing alkoxy group.
式[DA19]及式[DA20]中,A9係表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、-CH2-、-O-、或-NH-,A10係表示氟基、氰基、三氟甲烷基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧 基、或羥基。 In the formula [DA19] and the formula [DA20], A 9 represents -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 -, -CH 2 -, -O-, or -NH-, A 10 represents a fluorine group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a methyl group, an ethyl group, an ethylene group Base, or hydroxyl group.
式[DA21]及式[DA22]中,A11係表示碳數3~12之烷基,1,4-環己烯之順式-反式異構係分別為反式異構物。 In the formula [DA21] and the formula [DA22], A 11 represents an alkyl group having 3 to 12 carbon atoms, and the cis-trans isomers of 1,4-cyclohexene are each a trans isomer.
式[DA23]及式[DA24]中,A12係表示碳數3~12之烷基,1,4-環己烯之順式-反式異構係分別為反式異構物。 In the formula [DA23] and the formula [DA24], A 12 represents an alkyl group having 3 to 12 carbon atoms, and the cis-trans isomers of 1,4-cyclohexene are each a trans isomer.
以上述式[1-B]表示之四羧酸的具體例有1,2,3,4-環丁烷四羧酸、1,2,3,4-環戊烷四羧酸、2,3,4,5-四氫呋喃四羧 酸、1,2,4,5-環己烷四羧酸、3,4-二羧基-1-環己基琥珀酸、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸等之脂環式四羧酸。 Specific examples of the tetracarboxylic acid represented by the above formula [1-B] include 1,2,3,4-cyclobutanetetracarboxylic acid, 1,2,3,4-cyclopentanetetracarboxylic acid, 2,3. ,4,5-tetrahydrofuran tetracarboxylate Acid, 1,2,4,5-cyclohexanetetracarboxylic acid, 3,4-dicarboxy-1-cyclohexyl succinic acid, 3,4-dicarboxy-1,2,3,4-tetrahydro-1 An alicyclic tetracarboxylic acid such as naphthylsuccinic acid.
其他例之四羧酸,例如有均苯四酸、2,3,6,7-萘四羧酸、1,2,5,6-萘四羧酸、1,4,5,8-萘四羧酸、2,3,6,7-蒽四羧酸、1,2,5,6-蒽四羧酸、3,3’,4,4’-聯苯四羧酸、2,3,3’,4-聯苯四羧酸、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸、3,4,9,10-苝(perylene)四羧酸、1,3-二苯基-1,2,3,4-環丁烷四羧酸等之二酸酐。 Other examples of tetracarboxylic acids, such as pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, 1,2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalene tetra Carboxylic acid, 2,3,6,7-nonanetetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3',4,4'-biphenyltetracarboxylic acid, 2,3,3 ',4-biphenyltetracarboxylic acid, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic acid, bis(3,4-dicarboxybenzene Base, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro-2 , 2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethyl decane, bis(3,4-dicarboxyphenyl)diphenyl decane, 2, 3,4,5-pyridinetetracarboxylic acid, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4,4'-diphenylphosphonium tetracarboxylic acid, 3,4, 9,10-perylene dianhydride such as tetracarboxylic acid or 1,3-diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid.
本發明之液晶配向膜之製造方法中所使用的聚醯亞胺前驅物係含有以上述式[1]表示之重複單位及選自以下述式[2]表示之重複單位及下述式[3]表示之重複單位之至少任一種。以下述式[2]及式[3]表示之重複單位具有光反應基。因此,本發明之液晶配向膜之製造方法中使用的聚醯亞胺前驅物變成具有光反應基。光反應基較佳為藉由光照射產生交聯反應的基團。 The polyimine precursor used in the method for producing a liquid crystal alignment film of the present invention contains a repeating unit represented by the above formula [1] and a repeating unit selected from the following formula [2] and the following formula [3] ] indicates at least one of the repeating units. The repeating unit represented by the following formula [2] and formula [3] has a photoreactive group. Therefore, the polyimide precursor used in the method for producing a liquid crystal alignment film of the present invention becomes a photoreactive group. The photoreactive group is preferably a group which generates a crosslinking reaction by light irradiation.
本發明之液晶配向膜之製造方法中使用的聚醯亞胺前驅物係如上述,含有選自以下述式[2]及式[3]表示之重複單位之至少一種。 The polyimine precursor used in the method for producing a liquid crystal alignment film of the present invention contains at least one selected from the group consisting of the following formulas [2] and [3].
上述式[2]中,R5係表示構成光反應基的2價有機基。R6係表示4價有機基。R7係表示氫原子或碳數1~6之有機基。R8係表示氫原子或碳數1~6之有機基。n2係表示正的整數。 In the above formula [2], R 5 represents a divalent organic group constituting a photoreactive group. R 6 represents a tetravalent organic group. R 7 represents a hydrogen atom or an organic group having 1 to 6 carbon atoms. R 8 represents a hydrogen atom or an organic group having 1 to 6 carbon atoms. The n 2 system represents a positive integer.
上述式[3]中,R9係表示2價有機基。R10係表示構成光反應性基的2價有機基。n3係表示正的整數。 In the above formula [3], R 9 represents a divalent organic group. R 10 represents a divalent organic group constituting a photoreactive group. The n 3 system represents a positive integer.
以上述式[2]表示之重複單位可使用以下述式[2-A]表示之二胺成分及以下述式[2-B]表示之四羧酸之酸酐的四羧酸二酐成分而得。 The repeating unit represented by the above formula [2] can be obtained by using a diamine component represented by the following formula [2-A] and a tetracarboxylic dianhydride component of an acid anhydride of a tetracarboxylic acid represented by the following formula [2-B]. .
上述式[2-A]與式[2-B]中,R5及R6係與上述式[2]中之R5及R6相同。 In the above formula [2-A] and formula [2-B], R 5 and R 6 are the same as R 5 and R 6 in the above formula [2].
以上述式[2-A]表示之二胺成分可使用光交聯性的二胺。其具體例有以下所示的化合物。 A photocrosslinkable diamine can be used for the diamine component represented by the above formula [2-A]. Specific examples thereof include the compounds shown below.
上述式[2-B]表示之四羧酸,例如有與上述式[1-B]表示之四羧酸所列舉者同樣的四羧酸。 The tetracarboxylic acid represented by the above formula [2-B] has, for example, the same tetracarboxylic acid as those exemplified for the tetracarboxylic acid represented by the above formula [1-B].
上述式[3]表示之重複單位可使用以下述式[3-A]表示之二胺成分及下述式[3-B]表示之二羧酸成分而得到。 The repeating unit represented by the above formula [3] can be obtained by using a diamine component represented by the following formula [3-A] and a dicarboxylic acid component represented by the following formula [3-B].
上述式[3-A]及式[3-B]中,R9及R10係與上述式[3]中之R9及R10相同。 In the above formula [3-A] and formula [3-B], R 9 and R 10 are the same as R 9 and R 10 in the above formula [3].
以上述式[3-A]表示之二胺成分,例如有與上述式[1- A]表示之二胺成分所列舉者同樣的二胺成分。 The diamine component represented by the above formula [3-A] has, for example, the above formula [1- A] represents the same diamine component as the diamine component.
上述式[3-B]表示之二羧酸成分的具體例有以下所示的化合物。 Specific examples of the dicarboxylic acid component represented by the above formula [3-B] include the compounds shown below.
本發明之液晶配向膜之製造方法所使用的聚醯亞胺前 驅物中,相對於以上述式[1]表示之重複單位,以上述式[2]表示之重複單位及/或以上述式[3]表示之重複單位的含有比率係如下述。 The pre-polyimine used in the method for producing a liquid crystal alignment film of the present invention The content ratio of the repeating unit represented by the above formula [2] and/or the repeating unit represented by the above formula [3] with respect to the repeating unit represented by the above formula [1] is as follows.
僅含有以上述式[2]表示之重複單位時,以莫耳比換算,(式[1]表示之重複單位)/(式[2]表示之重複單位)較佳為1/99~99/1的範圍,更佳為5/95~95/5的範圍。 When only the repeating unit represented by the above formula [2] is contained, the molar ratio (the repeating unit represented by the formula [1]) / (the repeating unit represented by the formula [2]) is preferably 1/99 to 99/ The range of 1 is more preferably in the range of 5/95 to 95/5.
同樣地,僅含有以上述式[3]表示的重複單位時,以莫耳比換算,(式[1]表示之重複單位)/(式[3]表示之重複單位)較佳為1/99~99/1的範圍,更佳為5/95~95/5的範圍。 Similarly, when only the repeating unit represented by the above formula [3] is contained, the molar ratio (the repeating unit represented by the formula [1]) / (the repeating unit represented by the formula [3]) is preferably 1/99. The range of ~99/1 is more preferably in the range of 5/95 to 95/5.
又,含有以上述式[2]表示之重複單位及上述式[3]表示之重複單位兩者時,以莫耳比換算,(式[1]表示之重複單位)/{(式[2]表示之重複單位)+(式[3]表示之重複單位)}較佳為1/99~99/1的範圍,更佳為5/95~95/5的範圍。 In addition, when both the repeating unit represented by the above formula [2] and the repeating unit represented by the above formula [3] are included, the molar ratio is expressed in (the repeating unit represented by the formula [1]) / {(form [2] The repeating unit expressed by + (the repeating unit represented by the formula [3])} is preferably in the range of 1/99 to 99/1, more preferably in the range of 5/95 to 95/5.
本發明中,具有前述光反應基的聚醯亞胺前驅物,可為使含有以下述式(4)表示之新穎二胺的二胺成分與四羧酸二酐進行聚縮合反應而得的聚醯亞胺前驅物。 In the present invention, the polyimine precursor having the photoreactive group may be a polycondensation reaction obtained by subjecting a diamine component containing a novel diamine represented by the following formula (4) to a tetracarboxylic dianhydride. A quinone imine precursor.
式(4)中之X1、X2、X3、X4、X5係如上述定義。式(4)中具有1個以上的肉桂醯基(cinnamoyl)。又,式(4)中,肉桂醯基係以下述式表示,以式(4)表示之二胺係具有至少1個,較佳為2~4個的肉桂醯基。 X 1 , X 2 , X 3 , X 4 and X 5 in the formula (4) are as defined above. In the formula (4), one or more cinnamoyl groups are contained. Further, in the formula (4), the cinnamyl group is represented by the following formula, and the diamine represented by the formula (4) has at least one, preferably 2 to 4, cinnamyl groups.
又,式(4)中,苯環所具有之胺基(-NH2)的位置無特別限定,但是從液晶配向性能或合成之容易度的觀點,例如各自相對於-X1-X2-X3-X4-X5-,存在於對位或間位較佳。 Further, in the formula (4), the position of the amine group (-NH 2 ) which the benzene ring has is not particularly limited, but from the viewpoint of liquid crystal alignment performance or ease of synthesis, for example, each is relative to -X 1 -X 2 - X 3 -X 4 -X 5 -, preferably present in the para or meta position.
以式(4)表示之較佳的二胺,例如有下述二胺。 Preferred diamines represented by the formula (4) include, for example, the following diamines.
以式(4)表示之二胺的具體例有下述二胺。 Specific examples of the diamine represented by the formula (4) include the following diamines.
使用含有以上述式(4)表示之本發明的二胺為原料的聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等的液晶配向處理劑形成的液晶配向膜係降低因AC(交流)驅動所造成之液晶配向性能的變化,例如液晶之配向方位的變化者。因此,具有此液晶配向膜的液晶顯示元件係因以AC驅動之液晶配向膜的液晶配向性能安 定,因此藉由AC驅動不易產生殘像,具有藉由AC驅動之殘像特性非常良好的效果。又,使用以上述式(4)表示之二胺形成的液晶配向膜,可形成液晶配向性能優異,且實質上無配向缺陷者。 Liquid crystal alignment treatment using a polyamidiamine precursor such as polyacrylamide or polyglycolate containing a diamine of the present invention represented by the above formula (4), polyimine, polyamine or the like The liquid crystal alignment film formed by the agent reduces a change in the alignment property of the liquid crystal caused by AC (alternating current) driving, for example, a change in the alignment direction of the liquid crystal. Therefore, the liquid crystal display element having the liquid crystal alignment film is based on the liquid crystal alignment property of the liquid crystal alignment film driven by AC. Therefore, it is difficult to generate an afterimage by AC driving, and the afterimage characteristic by AC driving is very good. Further, by using the liquid crystal alignment film formed of the diamine represented by the above formula (4), it is possible to form an excellent liquid crystal alignment property and substantially no alignment defect.
如此,使用以上述式(4)表示之二胺而得之液晶配向膜、及具有該液晶配向膜的液晶顯示元件,可降低AC驅動所造成之液晶配向性能的變化,不易產生因AC驅動所造成之殘像的理由雖不明確,可推測為如下述。例如在聚醯亞胺前驅物、聚醯亞胺、聚醯亞胺等之主鏈,藉由導入可將配向性賦予液晶,來自以式(4)表示之二胺的特定光反應性基(即-HN-C6H4-X1-X2-X3-X4-X5-C6H4-NH-),即使因AC驅動造成液晶移動,來自以式(4)表示之二胺的特定光反應性基不易移動,因此配向方位不易偏離的緣故。 Thus, the liquid crystal alignment film obtained by using the diamine represented by the above formula (4) and the liquid crystal display element having the liquid crystal alignment film can reduce variations in liquid crystal alignment performance caused by AC driving, and are less likely to be generated by the AC driving device. Although the reason for the residual image is not clear, it can be presumed as follows. For example, in the main chain of a polyimine precursor, a polyimine, a polyimine, or the like, a specific photoreactive group derived from a diamine represented by the formula (4) can be imparted to the liquid crystal by introduction ( That is, -HN-C 6 H 4 -X 1 -X 2 -X 3 -X 4 -X 5 -C 6 H 4 -NH-), even if the liquid crystal moves due to AC driving, it is derived from the formula (4) The specific photoreactive group of the amine is not easily moved, so the alignment orientation is not easily deviated.
又,將來自以本發明之式(4)表示之二胺的構造(特定的光反應性基)導入於側鏈,而非聚醯亞胺前驅物、聚醯亞胺、聚醯亞胺等的主鏈時,擠壓藉由AC驅動而移動的液晶,使側鏈移動,配合此側鏈移動,來自配向性賦予液晶之以式(4)表示之二胺的結構移動,因此配向方位大幅偏移,容易產生殘像。 Further, a structure (specific photoreactive group) derived from the diamine represented by the formula (4) of the present invention is introduced into a side chain instead of a polyimine imide, a polyimine, a polyimine, or the like. In the main chain, the liquid crystal moved by the AC drive is squeezed to move the side chain, and the movement of the side chain is shifted, and the structure of the diamine represented by the formula (4) from the alignment imparting liquid crystal is moved, so that the alignment direction is large. Offset, easy to produce afterimages.
以式(4)表示之二胺的合成方法無特別限定,例如可依據後述的合成例來製造。以上述式(a)表示之二胺時,可藉由以下所示的方法來合成。 The method for synthesizing the diamine represented by the formula (4) is not particularly limited, and can be produced, for example, according to a synthesis example described later. When the diamine represented by the above formula (a) is used, it can be synthesized by the method shown below.
以式(a)表示之二胺係將對應之以下述式(a’)表 示之二硝基化合物進行合成,接著使硝基在溶劑中還原,轉換成胺基而得。使二硝基化合物還原的方法,無特別限定,通常為以鈀-碳、氧化鉑、阮尼鎳、鐵、氯化錫、鉑黑、銠-氧化鋁、硫化鉑碳等作為觸媒使用。又,從烯烴不進行環元而殘留的狀態,僅將硝基以高收率選擇性還原的觀點,可利用使用鐵或氯化錫的化學還原法。還原係使用作為溶劑之乙酸乙酯、甲苯、四氫呋喃、二噁烷、醇系等溶劑,使用作為還原劑之氫氣、聯胺、氯化氫、氯化銨等的反應來進行還原。 The diamine represented by the formula (a) will correspond to the following formula (a') The dinitro compound is synthesized, and then the nitro group is reduced in a solvent to be converted into an amine group. The method for reducing the dinitro compound is not particularly limited, and is usually carried out using palladium-carbon, platinum oxide, Raney nickel, iron, tin chloride, platinum black, ruthenium-alumina, platinum sulfide carbon or the like as a catalyst. Further, from the viewpoint that the olefin does not carry out the ring element, the chemical reduction method using iron or tin chloride can be used from the viewpoint of selectively reducing the nitro group in a high yield. The reduction is carried out by using a solvent such as ethyl acetate, toluene, tetrahydrofuran, dioxane or an alcohol as a solvent, and reduction using hydrogen, a hydrazine, hydrogen chloride, ammonium chloride or the like as a reducing agent.
以式(a’)表示之二硝基化合物的合成方法無特別限定,可藉由任意的方法進行合成。其具體例,例如有藉由以下反應式所示的方法進行合成。 The method for synthesizing the dinitro compound represented by the formula (a') is not particularly limited, and the synthesis can be carried out by any method. Specific examples thereof include synthesis by a method represented by the following reaction formula.
上述反應中,使硝基苯化合物A與具有羧酸的化合物B進行反應的方法,例如在有機溶劑中,例如使用DMAP/DCC、或DMAP/EDC的直接縮合法、將羧酸使用亞硫醯氯、乙二醯氯(oxalyl chloride)、氯化磷醯(phosphoryl chloride)、二氯化硫醯(sulfuryl chloride)、三氯化磷等作為酸氯化物,進行反應的方法。又,DMAP係指4-N,N-二甲基胺基吡啶,DCC係指二環己基碳二亞胺(CARBODIIMIDE),EDC係指1-(3-二甲基胺基丙基)-3-乙基碳二亞胺鹽酸鹽。 In the above reaction, a method of reacting a nitrobenzene compound A with a compound B having a carboxylic acid, for example, in an organic solvent, for example, a direct condensation method using DMAP/DCC or DMAP/EDC, and a thiocyanate using a carboxylic acid A method in which chlorine, oxalyl chloride, phosphoryl chloride, sulfuryl chloride, phosphorus trichloride or the like is used as an acid chloride to carry out a reaction. Further, DMAP means 4-N,N-dimethylaminopyridine, DCC means dicyclohexylcarbodiimide (CARBODIIMIDE), and EDC means 1-(3-dimethylaminopropyl)-3. - Ethyl carbodiimide hydrochloride.
上述硝基苯化合物A中,X及Y係分別與式(a)中之X及Y同義,具體例有4-硝基酚、3-硝基酚、2-硝基酚、4-硝基苄醇、3-硝基苄醇、2-硝基苄醇、4-硝基苯乙醇、3-硝基苯乙、2-硝基苯乙等。必要時,在苯環與羥基之間可插入連結基Y。又,苯環上可鍵結其他的取代基,苯環上之硝基的取代位置可適當選擇可得到目的之二胺的取代位置者。又,此處所示的化合物係一例,無特別限定。 In the above nitrobenzene compound A, X and Y are respectively synonymous with X and Y in the formula (a), and specific examples thereof include 4-nitrophenol, 3-nitrophenol, 2-nitrophenol, and 4-nitro group. Benzyl alcohol, 3-nitrobenzyl alcohol, 2-nitrobenzyl alcohol, 4-nitrophenylethanol, 3-nitrophenylethyl, 2-nitrophenylethyl and the like. If necessary, a linking group Y can be inserted between the benzene ring and the hydroxyl group. Further, another substituent may be bonded to the benzene ring, and the substitution position of the nitro group on the benzene ring may be appropriately selected to obtain the substitution position of the desired diamine. Moreover, the compound shown here is an example, and is not specifically limited.
有機溶劑係不影響反應的溶劑,具體而言,例如有甲苯、二甲苯等之芳香族系溶劑;己烷、庚烷等之脂肪族烴系溶劑;二氯甲烷、1,2-二氯乙烷等之鹵系溶劑;四氫呋喃、1,4-二噁烷等之醚系溶劑;N,N-二甲基甲醯胺;N,N-二甲基乙醯胺;N-甲基吡咯烷酮;二甲基亞碸等之非質子性極性溶劑可單獨或複數混合使用。此等之使用量為任意。 The organic solvent is a solvent which does not affect the reaction, and specifically, for example, an aromatic solvent such as toluene or xylene; an aliphatic hydrocarbon solvent such as hexane or heptane; dichloromethane or 1,2-dichloroethane; a halogen solvent such as an alkane; an ether solvent such as tetrahydrofuran or 1,4-dioxane; N,N-dimethylformamide; N,N-dimethylacetamide; N-methylpyrrolidone; The aprotic polar solvent such as dimethyl hydrazine may be used singly or in combination. The usage amount of these is arbitrary.
其他之二胺也使用與上述式(a)表示之二胺同樣的 手法進行合成。 The other diamine is also the same as the diamine represented by the above formula (a). Synthesize by synthesis.
本發明之聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物係藉由使含有以上述式(4)表示之二胺的二胺成分與四羧酸成分進行反應而得者。又,聚醯胺酸酯也可使聚醯胺酸之羧基轉變成酯的方法而得到。又,此等聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物進行醯亞胺化,可得到本發明之聚醯亞胺。 The polyimine precursor such as polyglycolic acid or polyglycolate of the present invention is obtained by reacting a diamine component containing a diamine represented by the above formula (4) with a tetracarboxylic acid component. . Further, the polyglycolate can also be obtained by a method in which a carboxyl group of polyproline is converted into an ester. Further, the polyamidene precursors such as polylysine and polylysine are subjected to ruthenium imidization to obtain the polyimine of the present invention.
本發明之聚醯胺係使含有以上述式(4)表示之二胺的二胺成分與二羧酸之鹵化物在鹼存在下進行反應,或將含有以上述式(1)表示之二胺的二胺成分與二羧酸在適當的縮合劑、鹼的存在下進行反應而得。 The polyamine of the present invention is a reaction of a diamine component containing a diamine represented by the above formula (4) with a halide of a dicarboxylic acid in the presence of a base, or a diamine represented by the above formula (1) The diamine component is obtained by reacting a dicarboxylic acid in the presence of a suitable condensing agent or a base.
聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺及聚醯胺中任一均可作為得到液晶配向膜用的聚合物使用。又,二胺成分所含有之以式(4)表示之二胺可為1種類或2種類以上,此外,二胺成分也可含有1種類或2種類以上之以式(4)表示之二胺以外之其他的二胺。 Any of a polyimine precursor such as polyamine or a polyamidite, a polyimine, and a polyamine can be used as a polymer for obtaining a liquid crystal alignment film. In addition, the diamine component represented by the formula (4) may be one type or two or more types, and the diamine component may contain one type or two or more types of diamine represented by the formula (4). Other diamines than others.
以式(4)表示之二胺的含量係相對於二胺成分全量為10莫耳%以上,較佳為30~100莫耳%,更佳為50~100莫耳%。 The content of the diamine represented by the formula (4) is 10 mol% or more, preferably 30 to 100 mol%, more preferably 50 to 100 mol%, based on the total amount of the diamine component.
本說明書中,無特別記載時,比例係以莫耳數為基準。 In the present specification, the ratio is based on the number of moles unless otherwise specified.
二胺成分可含有之以上述式(4)表示之二胺以外之其他的二胺,可使用例如上述式[1-A]表示之二胺成分之具體例所列舉的二胺。 The diamine component may contain a diamine other than the diamine represented by the above formula (4), and a diamine exemplified as a specific example of the diamine component represented by the above formula [1-A] may be used.
上述其他的二胺係配合作為液晶配向膜時之液晶配向性、電壓保持率、蓄積電荷等的特性,可使用1種類或2種類以上混合使用。 The above-mentioned other diamines may be used in combination of one type or two types or more in combination with the liquid crystal alignment property, the voltage holding ratio, and the charge accumulated in the liquid crystal alignment film.
四羧酸成分係指選自四羧酸及四羧酸衍生物之至少一種。四羧酸衍生物例如有四羧酸二鹵化物、四羧酸二酐、四羧酸二酯二氯化物、四羧酸二酯等。 The tetracarboxylic acid component means at least one selected from the group consisting of a tetracarboxylic acid and a tetracarboxylic acid derivative. Examples of the tetracarboxylic acid derivative include a tetracarboxylic acid dihalide, a tetracarboxylic dianhydride, a tetracarboxylic acid diester dichloride, and a tetracarboxylic acid diester.
例如使四羧酸二鹵化物、四羧酸二酐等與二胺成分進行反應,可得到聚醯胺酸。又,四羧酸二酯二氯化物與二胺成分之反應或四羧酸二酯與二胺成分在適當的縮合劑或鹼之存在下進行反應,可得到聚醯胺酸酯。使用的四羧酸成分可為1種類或2種類以上。 For example, a polycarboxylic acid can be obtained by reacting a tetracarboxylic acid dihalide or a tetracarboxylic dianhydride with a diamine component. Further, a reaction of a tetracarboxylic acid diester dichloride with a diamine component or a reaction of a tetracarboxylic acid diester with a diamine component in the presence of a suitable condensing agent or a base can provide a polyphthalate. The tetracarboxylic acid component to be used may be one type or two or more types.
四羧酸成分例如有以下述式(5)表示之四羧酸二酐。 The tetracarboxylic acid component is, for example, a tetracarboxylic dianhydride represented by the following formula (5).
式(5)中,Z1之具體例,例如有以下述式(5a)~(5j)表示之4價有機基。 In the formula (5), specific examples of Z 1 include, for example, a tetravalent organic group represented by the following formulas (5a) to (5j).
Z1之特佳的結構,從聚合反應性或合成之容易性,較佳為式(5a)、式(5c)、式(5d)、式(5e)、式(5f)或式(5g)。其中,較佳為式(5a)、式(5e)、式(5f)或式(5g)。 A particularly preferable structure of Z 1 , from the viewpoint of polymerization reactivity or ease of synthesis, is preferably a formula (5a), a formula (5c), a formula (5d), a formula (5e), a formula (5f) or a formula (5g). . Among them, the formula (5a), the formula (5e), the formula (5f) or the formula (5g) is preferred.
又,以式(5)表示之四羧酸二酐對四羧酸成分全量的比例,無特別限定,例如四羧酸成分可僅為以上述式(5)表示的四羧酸二酐。當然,四羧酸成分在不影響本發明之效果的範圍內,可含有以式(5)表示之四羧酸二酐以外的四羧酸或四羧酸衍生物。此時,四羧酸成分全量之1莫耳%以上為上述式(5)表示之四羧酸二酐較佳,更佳為5莫耳%以上,更佳為10莫耳%以上。 In addition, the ratio of the tetracarboxylic dianhydride to the total amount of the tetracarboxylic acid component represented by the formula (5) is not particularly limited, and for example, the tetracarboxylic acid component may be only the tetracarboxylic dianhydride represented by the above formula (5). Of course, the tetracarboxylic acid component may contain a tetracarboxylic acid or a tetracarboxylic acid derivative other than the tetracarboxylic dianhydride represented by the formula (5) within a range that does not impair the effects of the present invention. In this case, the tetracarboxylic acid dianhydride represented by the above formula (5) is more preferably 1 mol% or more of the total amount of the tetracarboxylic acid component, more preferably 5 mol% or more, and still more preferably 10 mol% or more.
上述式(5)表示之四羧酸二酐以外之其他的四羧酸二酐,例如以上述式[1-B]表示之四羧酸之其他例所列舉之四羧酸二酐同樣可使用。 The tetracarboxylic dianhydride other than the tetracarboxylic dianhydride represented by the above formula (5), for example, the tetracarboxylic dianhydride exemplified as another example of the tetracarboxylic acid represented by the above formula [1-B] can be used. .
四羧酸二酯也無特別限定。其具體例如下述。 The tetracarboxylic acid diester is also not particularly limited. Specifically, it is as follows.
脂肪族四羧酸二酯之具體例有1,2,3,4-環丁烷四羧酸二烷酯、1,2-二甲基-1,2,3,4-環丁烷四羧酸二烷酯、1,3-二甲基-1,2,3,4-環丁烷四羧酸二烷酯、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二烷酯、1,2,3,4-環戊烷四羧酸二烷酯、2,3,4,5-四氫呋喃四羧酸二烷酯、1,2,4,5-環己烷四羧酸二烷酯、3,4-二羧基-1-環己基琥珀酸二烷酯、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二烷酯、1,2,3,4-丁烷四羧酸二烷酯、雙環[3,3,0]辛烷-2,4,6,8-四羧酸二烷酯、3,3’,4,4’-二環己基四羧酸二烷酯、2,3,5-三羧基環戊基乙酸二烷酯、順-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二烷酯、三環[4.2.1.02,5]壬烷-3,4,7,8-四羧酸-3,4:7,8-二烷酯、六環[6.6.0.12,7.03,6.19,14.010,13]十六烷-4,5,11,12-四羧酸-4,5:11,12-二烷酯、4-(2,5-二氧代四氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸二烷酯等。 Specific examples of the aliphatic tetracarboxylic acid diester are 1,2,3,4-cyclobutanetetracarboxylic acid dialkyl ester, 1,2-dimethyl-1,2,3,4-cyclobutane tetracarboxylic acid. Dialkyl acid ester, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic acid dialkyl ester, 1,2,3,4-tetramethyl-1,2,3,4 - cyclobutane tetracarboxylic acid dialkyl ester, 1,2,3,4-cyclopentane tetracarboxylic acid dialkyl ester, 2,3,4,5-tetrahydrofuran tetracarboxylic acid dialkyl ester, 1,2,4 , 5-cyclohexanetetracarboxylic acid dialkyl ester, 3,4-dicarboxy-1-cyclohexyl succinic acid dialkyl ester, 3,4-dicarboxy-1,2,3,4-tetrahydro-1- Dialkyl naphthalene succinate, dialkyl 1,2,3,4-butane tetracarboxylate, dicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic acid dialkyl ester, 3,3',4,4'-dicyclohexyltetracarboxylic acid dialkyl ester, 2,3,5-tricarboxycyclopentyl acetic acid dialkyl ester, cis-3,7-dibutylcyclooctane-1, 5-diene-1,2,5,6-tetracarboxylic acid dialkyl ester, tricyclo[4.2.1.0 2,5 ]decane-3,4,7,8-tetracarboxylic acid-3,4:7 , 8-dialkyl ester, hexacyclo[6.6.0.1 2,7 .0 3,6 .1 9,14 .0 10,13 ]hexadecane-4,5,11,12-tetracarboxylic acid-4, 5:11,12-dialkyl ester, 4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid dialkyl ester, etc. .
芳香族四羧酸二烷酯例如有均苯四甲酸二烷酯、3,3’,4,4’-聯苯四羧酸二烷酯、2,2’,3,3’-聯苯四羧酸二烷酯、2,3,3’,4-聯苯四羧酸二烷酯、3,3’,4,4’-二苯甲酮四羧酸二烷酯、2,3,3’,4-二苯甲酮四羧酸二烷酯、雙(3,4-二羧基苯基)醚二烷酯、雙(3,4-二羧基苯基)碸二烷酯、1,2,5,6-萘四羧酸二烷酯、2,3,6,7-萘四羧酸二烷酯等。 The aromatic tetracarboxylic acid dialkyl esters are, for example, dialkyl pyromellitate, dialkyl 3,3',4,4'-biphenyltetracarboxylate, 2,2',3,3'-biphenyl tetra Dialkyl carboxylate, dialkyl 2,3,3',4-biphenyltetracarboxylate, dialkyl 3,3',4,4'-benzophenone tetracarboxylate, 2,3,3 ',4-Dibenzophenone tetracarboxylic acid dialkyl ester, bis(3,4-dicarboxyphenyl)ether dialkyl ester, bis(3,4-dicarboxyphenyl)decane dialkyl ester, 1,2 , 5,6-naphthalenetetracarboxylic acid dialkyl ester, 2,3,6,7-naphthalenetetracarboxylic acid dialkyl ester, and the like.
為了得到本發明之聚醯胺時,使與二胺成分反應的二羧酸等,無特別限定。為了得到聚醯胺時,與二胺成分反應的二羧酸或其衍生物之脂肪族二羧酸的具體例有丙二 酸、草酸、二甲基丙二酸、丁二酸、富馬酸、戊二酸、己二酸、黏康酸、2-甲基己二酸、三甲基己二酸、庚二酸、2,2-二甲基戊二酸、3,3-二乙基丁二酸、壬二酸、癸二酸、辛二酸等。 In order to obtain the polyamine of the present invention, the dicarboxylic acid or the like which reacts with the diamine component is not particularly limited. In order to obtain polyamine, a specific example of an aliphatic dicarboxylic acid of a dicarboxylic acid or a derivative thereof which reacts with a diamine component is propylene. Acid, oxalic acid, dimethylmalonic acid, succinic acid, fumaric acid, glutaric acid, adipic acid, muconic acid, 2-methyladipate, trimethyl adipate, pimelic acid, 2,2-dimethylglutaric acid, 3,3-diethyl succinic acid, sebacic acid, sebacic acid, suberic acid and the like.
脂環式系之二羧酸,例如有1,1-環丙烷二羧酸、1,2-環丙烷二羧酸、1,1-環丁烷二羧酸、1,2-環丁烷二羧酸、1,3-環丁烷二羧酸、3,4-二苯基-1,2-環丁烷二羧酸、2,4-二苯基-1,3-環丁烷二羧酸、1-環丁烯-1,2-二羧酸、1-環丁烯-3,4-二羧酸、1,1-環戊烷二羧酸、1,2-環戊烷二羧酸、1,3-環戊烷二羧酸、1,1-環己烷二羧酸、1,2-環己烷二羧酸、1,3-環己烷二羧酸、1,4-環己烷二羧酸、1,4-(2-降莰烯)二羧酸、降莰烯-2,3-二羧酸、雙環[2.2.2]辛烷-1,4-二羧酸、雙環[2.2.2]辛烷-2,3-二羧酸、2,5-二氧代-1,4-雙環[2.2.2]辛烷二羧酸、1,3-金剛烷二羧酸、4,8-二氧代-1,3-金剛烷二羧酸、2,6-螺[3.3]庚烷二羧酸、1,3-金剛烷二酢酸、樟腦酸等。 An alicyclic dicarboxylic acid such as 1,1-cyclopropanedicarboxylic acid, 1,2-cyclopropanedicarboxylic acid, 1,1-cyclobutanedicarboxylic acid, 1,2-cyclobutane II Carboxylic acid, 1,3-cyclobutanedicarboxylic acid, 3,4-diphenyl-1,2-cyclobutanedicarboxylic acid, 2,4-diphenyl-1,3-cyclobutanedicarboxylate Acid, 1-cyclobutene-1,2-dicarboxylic acid, 1-cyclobutene-3,4-dicarboxylic acid, 1,1-cyclopentanedicarboxylic acid, 1,2-cyclopentanedicarboxylate Acid, 1,3-cyclopentanedicarboxylic acid, 1,1-cyclohexanedicarboxylic acid, 1,2-cyclohexanedicarboxylic acid, 1,3-cyclohexanedicarboxylic acid, 1,4- Cyclohexanedicarboxylic acid, 1,4-(2-northene)dicarboxylic acid, norbornene-2,3-dicarboxylic acid, bicyclo[2.2.2]octane-1,4-dicarboxylic acid Bicyclo[2.2.2]octane-2,3-dicarboxylic acid, 2,5-dioxo-1,4-bicyclo[2.2.2]octanedicarboxylic acid, 1,3-adamantane dicarboxylate Acid, 4,8-dioxo-1,3-adamantane dicarboxylic acid, 2,6-spiro[3.3]heptane dicarboxylic acid, 1,3-adamantane dicarboxylic acid, camphoric acid, and the like.
芳香族二羧酸例如有o-苯二甲酸、間苯二甲酸、對苯二甲酸、5-甲基間苯二甲酸、5-tert-丁基間苯二甲酸、5-胺基間苯二甲酸、5-羥基間苯二甲酸、2,5-二甲基對苯二甲酸、四甲基對苯二甲酸、1,4-萘二羧酸、2,5-萘二羧酸、2,6-萘二羧酸、2,7-萘二羧酸、1,4-蒽二羧酸、1,4-蒽醌二羧酸、2,5-聯苯二羧酸、4,4’-聯苯二羧酸、1,5-聯苯撐二羧酸、4,4”-聯三苯二羧酸、4,4’-二苯基甲烷二羧酸、4,4’-二苯基乙烷二羧酸、4,4’-二苯基丙烷二羧酸、4,4’- 二苯基六氟丙烷二羧酸、4,4’-二苯基醚二羧酸、4,4’-聯苄二羧酸、4,4’-茋(stilbene)二羧酸、4,4’-二苯乙炔(tolan)二羧酸、4,4’-羰基二苯甲酸、4,4’-磺醯基二苯甲酸、4,4’-二硫二苯甲酸、p-苯撐二乙酸、3,3’-p-苯撐二丙酸、4-羧基桂皮酸、p-苯二丙烯酸、3,3’-[4,4’-(亞甲基二-p-苯撐)]二丙酸、4,4’-[4,4’-(氧二-p-苯撐)]二丙酸、4,4’-[4,4’-(氧二-p-苯撐)]二丁酸、(異丙叉二-p-苯撐二氧基)二丁酸、雙(p-羧基苯基)二甲基矽烷等之二羧酸等。 The aromatic dicarboxylic acid is, for example, o-phthalic acid, isophthalic acid, terephthalic acid, 5-methylisophthalic acid, 5-tert-butylisophthalic acid, 5-aminoisophthalic acid Formic acid, 5-hydroxyisophthalic acid, 2,5-dimethylterephthalic acid, tetramethylterephthalic acid, 1,4-naphthalene dicarboxylic acid, 2,5-naphthalene dicarboxylic acid, 2, 6-naphthalene dicarboxylic acid, 2,7-naphthalene dicarboxylic acid, 1,4-anthraquinone dicarboxylic acid, 1,4-nonanedicarboxylic acid, 2,5-biphenyldicarboxylic acid, 4,4'- Biphenyldicarboxylic acid, 1,5-biphenyldicarboxylic acid, 4,4"-biphenyldicarboxylic acid, 4,4'-diphenylmethanedicarboxylic acid, 4,4'-diphenyl Ethane dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'- Diphenylhexafluoropropanedicarboxylic acid, 4,4'-diphenyl ether dicarboxylic acid, 4,4'-bibenzyldicarboxylic acid, 4,4'-stilbene dicarboxylic acid, 4,4 '-Diphenylacetylene (tolan) dicarboxylic acid, 4,4'-carbonyldibenzoic acid, 4,4'-sulfonyldibenzoic acid, 4,4'-dithiodibenzoic acid, p-phenylene Acetic acid, 3,3'-p-phenyl dipropionic acid, 4-carboxycinnamic acid, p-benzene diacrylic acid, 3,3'-[4,4'-(methylenebis-p-phenylene)] Dipropionic acid, 4,4'-[4,4'-(oxadi-p-phenylene)]dipropionic acid, 4,4'-[4,4'-(oxydi-p-phenylene)] Dicarboxylic acid such as dibutyric acid, (isopropylidene di-p-phenylenedioxy)dibutyric acid or bis(p-carboxyphenyl)dimethyloxane.
含有雜環的二羧酸,例如有1,5-(9-氧代茀)二羧酸、3,4-呋喃二羧酸、4,5-噻唑二羧酸、2-苯基-4,5-噻唑二羧酸、1,2,5-噻唑-3,4-二羧酸、1,2,5-噁二唑-3,4-二羧酸、2,3-吡啶二羧酸、2,4-吡啶二羧酸、2,5-吡啶二羧酸、2,6-吡啶二羧酸、3,4-吡啶二羧酸、3,5-吡啶二羧酸等。 The dicarboxylic acid containing a heterocyclic ring, for example, 1,5-(9-oxoindole)dicarboxylic acid, 3,4-furandicarboxylic acid, 4,5-thiazoledicarboxylic acid, 2-phenyl-4, 5-thiazoledicarboxylic acid, 1,2,5-thiazole-3,4-dicarboxylic acid, 1,2,5-oxadiazole-3,4-dicarboxylic acid, 2,3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 2,5-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid, 3,4-pyridinedicarboxylic acid, 3,5-pyridinedicarboxylic acid, and the like.
上述各種二羧酸可為酸二鹵化物或酸酐的結構者。此等之二羧酸類,特別是可提供直線結構之聚醯胺的二羧酸類,在保持液晶分子之配向性的觀點較佳。此等中,較佳為使用對苯二甲酸、異對苯二甲酸、1,4-環己烷二羧酸、4,4’-聯苯二羧酸、4,4’-二苯基甲烷二羧酸、4,4’-二苯基乙烷二羧酸、4,4’-二苯基丙烷二羧酸、4,4’-二苯基六氟丙烷二羧酸、2,2-雙(苯基)丙烷二羧酸、4,4”-聯三苯(terphenyl)二羧酸、2,6-萘二羧酸、2,5-吡啶二羧酸、此等之酸二鹵化物等。上述化合物也有異構物,但是也可為含有彼等的混合物。也可併用2種以上的化合物。本發 明使用的二羧酸類不限於上述例示化合物者。 The above various dicarboxylic acids may be those having an acid dihalide or an acid anhydride. These dicarboxylic acids, particularly dicarboxylic acids which provide a linear polyamine, are preferred from the viewpoint of maintaining the alignment of liquid crystal molecules. Among these, it is preferred to use terephthalic acid, isoterephthalic acid, 1,4-cyclohexanedicarboxylic acid, 4,4'-biphenyldicarboxylic acid, 4,4'-diphenylmethane. Dicarboxylic acid, 4,4'-diphenylethane dicarboxylic acid, 4,4'-diphenylpropane dicarboxylic acid, 4,4'-diphenylhexafluoropropane dicarboxylic acid, 2,2- Bis(phenyl)propane dicarboxylic acid, 4,4"-terphenyl (terphenyl) dicarboxylic acid, 2,6-naphthalenedicarboxylic acid, 2,5-pyridinedicarboxylic acid, such acid dihalides The above compounds may also have an isomer, but may be a mixture containing them. It is also possible to use two or more kinds of compounds in combination. The dicarboxylic acid to be used is not limited to the above-exemplified compounds.
上述式(5)表示之四羧酸二酐、其他四羧酸及其四羧酸衍生物、二羧酸等係配合作為液晶配向膜時之液晶配向性、電壓保持率、蓄積電荷等之所要的特性,可使用1種類或混合2種類以上使用。 The tetracarboxylic dianhydride, the other tetracarboxylic acid, the tetracarboxylic acid derivative, the dicarboxylic acid, etc., which are represented by the above formula (5), are required to blend liquid crystal alignment, voltage holding ratio, charge charge, etc. when used as a liquid crystal alignment film. The characteristics can be used in one type or in a mixture of two or more types.
二胺成分與四羧酸成分之反應,通常係在有機溶劑中進行。此時所用的有機溶劑只要是可溶解生成後之聚醯胺酸等的聚醯亞胺前驅物者時,即無特別限定。具體例有N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-甲基已內醯胺、二甲基亞碸、四甲基脲、吡啶、二甲基碸、六甲基亞碸、γ-丁內酯、異丙醇、甲氧基甲基戊醇、二戊烯、乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、甲基賽路蘇(cellosolve)、乙基賽路蘇、甲基賽路蘇乙酸酯、乙基賽路蘇乙酸酯、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙酸酯、乙二醇單異丙醚、乙二醇單丁醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲醚、丙二醇第三丁醚、二丙二醇單甲醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲醚、二丙二醇單乙酸酯單甲醚、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇單乙酸酯單乙醚、二丙二醇單丙醚、二丙二醇單乙酸酯單丙醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲醚、3-甲基-3-甲氧基丁醇、二異丙醚、乙基異丁醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁醚、二異丁基酮、甲基環己烯、丙醚、二己醚、二噁烷、正己烷、 正戊烷、正辛烷、二乙醚、環己酮、碳酸乙烯酯、碳酸丙烯酯、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、二甘醇二甲醚(Diglyme)、4-羥基-4-甲基-2-戊酮等。此等可單獨使用,亦可混合使用。再者,即使為不溶解聚醯亞胺前驅物的溶劑,只要是不會使生成後之聚醯胺酸析出的範圍內,可與上述溶劑混合使用。又,有機溶劑中之水分係妨礙聚合反應,成為使生成後之聚醯亞胺前驅物水解的原因,故有機溶劑較佳為使用經脫水乾燥者。 The reaction of the diamine component with the tetracarboxylic acid component is usually carried out in an organic solvent. The organic solvent to be used in this case is not particularly limited as long as it is a polyimine precursor which can dissolve the produced polyamic acid or the like. Specific examples are N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, dimethyl alum, and four Methyl urea, pyridine, dimethyl hydrazine, hexamethyl hydrazine, γ-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl decyl ketone , methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cellosolve, ethyl celecoxib, methyl sarbuta acetate, ethyl 赛路苏Acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate , propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, Dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetic acid Ester, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol , diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, dibutyl ether, diisobutyl ketone, methyl cyclohexene, propyl ether, dihexyl ether, dioxane, Hexane, N-Pentane, n-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, acetone Methyl ester, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3 -methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, diglyme, 4-hydroxy-4-methyl-2-pentanone Wait. These may be used alone or in combination. Further, even a solvent which does not dissolve the polyimide precursor can be used in combination with the above solvent as long as it does not precipitate the polyamic acid after the formation. Further, since the water in the organic solvent hinders the polymerization reaction and causes hydrolysis of the produced polyimide precursor, the organic solvent is preferably dried by dehydration.
二胺成分與四羧酸成分在有機溶劑中反應時,可使用下列方法:使二胺成分分散或溶解於有機溶劑之溶液進行攪拌,將四羧酸成分直接添加,或分散或溶解於有機溶劑中後進行添加的方法,相反地,例如將二胺成分添加於使四羧酸成分分散或溶解於有機溶劑之溶液中的方法、交互添加四羧酸成分與二胺成分的方法等,本發明中,可使用此等之任一種方法。二胺成分或四羧酸成分使用複數種化合物時,可預先混合後的狀態進行反應,或可各別依序反應,或將各別反應後之低分子量體進行混合反應。此時聚合溫度可選擇在-20℃~150℃之任意的溫度,較佳為-5℃~100℃的範圍。又,反應可以任意濃度進行。但濃度過低時難以獲得高分子量的聚醯亞胺前驅物(特別是聚醯亞 胺),而濃度過高時,反應液之黏性過高而難以均勻攪拌。故二胺成分及四羧酸成分之總量的濃度係在反應液中,較佳為1~50質量%,更佳為5~30質量%。反應初期係在高濃度下進行,其後可追加有機溶劑。 When the diamine component and the tetracarboxylic acid component are reacted in an organic solvent, the following method may be employed: a solution in which the diamine component is dispersed or dissolved in an organic solvent is stirred, and the tetracarboxylic acid component is directly added or dispersed or dissolved in an organic solvent. In the middle, the method of adding, for example, a method in which a diamine component is added to a solution in which a tetracarboxylic acid component is dispersed or dissolved in an organic solvent, a method in which a tetracarboxylic acid component and a diamine component are alternately added, and the like, and the like Any of these methods can be used. When a plurality of kinds of compounds are used as the diamine component or the tetracarboxylic acid component, the reaction may be carried out in a state of being mixed beforehand, or may be sequentially reacted, or a low molecular weight body after each reaction may be subjected to a mixing reaction. The polymerization temperature at this time may be selected from any temperature of from -20 ° C to 150 ° C, preferably from -5 ° C to 100 ° C. Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it is difficult to obtain a high molecular weight polyimine precursor (especially poly Amine), and when the concentration is too high, the viscosity of the reaction liquid is too high to be uniformly stirred. Therefore, the concentration of the total amount of the diamine component and the tetracarboxylic acid component is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass, based on the reaction liquid. The initial stage of the reaction is carried out at a high concentration, and thereafter an organic solvent can be added.
聚醯胺酸等之聚醯亞胺前驅物之聚縮合反應時,二胺成分之合成莫耳數與四羧酸成分之合計莫耳數之比,較佳為0.8~1.2。與通常之聚縮合反應相同,此莫耳比愈接近1.0,則生成之聚醯亞胺前驅物之分子量愈大。 In the polycondensation reaction of the polyimine precursor such as polyamine, the ratio of the molar number of the synthetic mole of the diamine component to the total number of moles of the tetracarboxylic acid component is preferably 0.8 to 1.2. As with the usual polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the resulting polyimine precursor.
又,聚醯胺酸酯係如上述,可藉由四羧酸二酯二氯化物與二胺成分的反應或使四羧酸二酯與二胺成分在適當的縮合劑、鹼之存在下進行反應而得到。又,以上述的方法預先合成聚醯胺酸,利用高分子反應使聚醯胺酸之羧基進行酯化也可得到。 Further, the polyglycolate may be subjected to a reaction of a tetracarboxylic acid diester dichloride and a diamine component or a tetracarboxylic acid diester and a diamine component in the presence of a suitable condensing agent or a base as described above. Obtained by reaction. Further, polylysine is synthesized in advance by the above method, and a carboxyl group of polylysine is esterified by a polymer reaction.
具體而言,例如四羧酸二酯二氯化物與二胺成分在鹼與有機溶劑之存在下,以-20~150℃,較佳為0~50℃,反應30分鐘~24小時,較佳為1~4小時,可合成聚醯胺酸酯。 Specifically, for example, the tetracarboxylic acid diester dichloride and the diamine component are reacted in the presence of a base and an organic solvent at -20 to 150 ° C, preferably 0 to 50 ° C, for 30 minutes to 24 hours, preferably. For 1 to 4 hours, a polyphthalate can be synthesized.
鹼可使用吡啶、三乙胺、4-甲基胺基吡啶等,為了反應穩定進行,較佳為吡啶。鹼的添加量從容易除去的量,且容易得到高分子量體的觀點,相對於四羧酸二酯二氯化物,較佳為2~4倍莫耳。 As the base, pyridine, triethylamine, 4-methylaminopyridine or the like can be used, and for the reaction to proceed stably, pyridine is preferred. The amount of the base to be added is preferably from 2 to 4 moles per mole of the tetracarboxylic acid diester dichloride from the viewpoint of easy removal amount and easy availability of a high molecular weight body.
又,使四羧酸二酯與二胺成分在縮合劑存在下,進行聚縮合時,縮合劑可使用三苯基亞磷酸酯、二環己基碳二亞胺(carhodiimide)、1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽、N,N’-羰基二咪唑、二甲氧基-1,3,5-三 吖嗪基(azinyl)甲基嗎啉、O-(苯並三唑-1-基)-N,N,N’,N’-四甲基脲四氟硼酸鹽(Tetramethyluronium‧tetrafluoroborate:)、O-(苯並三唑-1-基)-N,N,N’,N’-四甲基脲六氟磷酸鹽、(2,3-二氫-2-硫氧(thioxo)-3-苯並噁唑基)磺酸二苯酯、4-(4,6-二甲氧基-1,3,5-三嗪-2-基)4-甲氧基嗎啉氯化物n-水合物等。 Further, when the tetracarboxylic acid diester and the diamine component are subjected to polycondensation in the presence of a condensing agent, triphenyl phosphite, dicyclohexylcarbodiimide or 1-ethyl- can be used as the condensing agent. 3-(3-dimethylaminopropyl)carbodiimide hydrochloride, N,N'-carbonyldiimidazole, dimethoxy-1,3,5-three Azinyl methylmorpholine, O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (Tetramethyluronium‧tetrafluoroborate:), O -(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, (2,3-dihydro-2-thioxo-3-benzene And dizozolyl)sulfonic acid diphenyl ester, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)4-methoxymorpholine chloride n-hydrate, etc. .
又,使用上述縮合劑的方法中,添加路易斯酸作為添加劑,可有效進行反應。路易斯酸較佳為氯化鋰、溴化鋰等之鹵化鋰。路易斯酸之添加量係相對於反應之二胺或四羧酸二酯,較佳為0.1~1.0倍莫耳量。 Further, in the method using the above condensing agent, a Lewis acid is added as an additive, and the reaction can be carried out efficiently. The Lewis acid is preferably a lithium halide such as lithium chloride or lithium bromide. The amount of the Lewis acid added is preferably 0.1 to 1.0 times the molar amount relative to the diamine or tetracarboxylic acid diester of the reaction.
上述反應用的溶劑可使用與合成聚醯胺酸時所用之溶劑同樣的溶劑,但是從單體及聚合物的溶解性而言,較佳為N-甲基-2-吡咯烷酮、γ-丁內酯,此等可使用1種或混合2種以上使用。合成時之濃度係從聚合物不易析出,且容易得到高分子量體的觀點,四羧酸二酯二氯化物、四羧酸二酯等之四羧酸衍生物與二胺成分之反應溶液中的合計濃度較佳為1~30質量%,更佳為5~20質量%。又,為了防止四羧酸二酯二氯化物之水解,聚醯胺酸酯之合成用的溶劑,盡可能進行脫水為佳,在氮氣氛中反應等、防止外氣混入較佳。 The solvent for the above reaction may be the same solvent as the solvent used in the synthesis of the polyamic acid, but from the viewpoint of the solubility of the monomer and the polymer, N-methyl-2-pyrrolidone and γ-butane are preferred. The ester may be used alone or in combination of two or more. The concentration at the time of the synthesis is not easily precipitated from the polymer, and a high molecular weight body is easily obtained, and a reaction solution of a tetracarboxylic acid derivative such as a tetracarboxylic acid diester dichloride or a tetracarboxylic acid diester and a diamine component is contained. The total concentration is preferably from 1 to 30% by mass, more preferably from 5 to 20% by mass. Further, in order to prevent hydrolysis of the tetracarboxylic acid diester dichloride, it is preferred to carry out dehydration as much as possible for the synthesis of the polyphthalate, and it is preferred to prevent the external air from being mixed by reaction in a nitrogen atmosphere.
如此聚合後的聚醯亞胺前驅物,例如具有下述式[h]表示之重複單位的聚合物。 The polyimine precursor thus polymerized is, for example, a polymer having a repeating unit represented by the following formula [h].
式[h]中,R11及R12分別可為1種類,且具有相同重複單位的聚合物,或R11或R12分別可為複數種,且具有不同結構之重複單位的聚合物。 In the formula [h], R 11 and R 12 each may be a single type, and have the same repeating unit of the polymer, or R 11 or R 12 may be a plurality of polymers each having a repeating unit of a different structure.
式[h]中,R11係來自原料之以下述式[k]等表示之四羧酸成分的基團。又,R12係來自原料之以下述式[s]等表示之二胺成分的基團,例如R12為來自以上述式(4)表示之二胺的基團時,為-C6H4-X1-X2-X3-X4-X5-C6H4-。又,上述式[h]係以上述式(4)表示之二胺作為原料,在主鏈被導入-HN-C6H4-X1-X2-X3-X4-X5-C6H4-NH-的聚醯亞胺前驅物。 In the formula [h], R 11 is a group derived from a tetracarboxylic acid component represented by the following formula [k] or the like from a raw material. Further, R 12 is a group derived from a diamine component represented by the following formula [s] or the like from a raw material. For example, when R 12 is a group derived from the diamine represented by the above formula (4), it is -C 6 H 4 . -X 1 -X 2 -X 3 -X 4 -X 5 -C 6 H 4 -. Further, the above formula [h] is a diamine represented by the above formula (4) as a raw material, and is introduced into -HN-C 6 H 4 -X 1 -X 2 -X 3 -X 4 -X 5 -C in the main chain. 6 H 4 -NH-polyimine precursor.
藉由將如式[h]之聚醯亞胺前驅物進行脫水閉環可得到聚醯亞胺。 The polyimine is obtained by subjecting the polyimine precursor of the formula [h] to dehydration ring closure.
使聚醯亞胺前驅物進行醯亞胺化的方法,例如有將聚醯亞胺前驅物溶液直接加熱之熱醯亞胺化,或將觸媒添加於聚醯亞胺前驅物溶液中的觸媒醯亞胺化等。 A method for subjecting a polyimine precursor to ruthenium imidization, for example, a hydrazine imidization by directly heating a solution of a polyimide precursor solution, or a contact of a catalyst in a solution of a polyimide precursor solution Media imidization and the like.
使聚醯亞胺前驅物在溶液中進行熱醯亞胺化時的溫度為100℃~400℃,較佳為120℃~250℃,將醯亞胺化反應所生成的水一邊排除反應體系外一邊進行醯亞胺化反應較佳。 The temperature at which the polyimine precursor is thermally imidated in the solution is from 100 ° C to 400 ° C, preferably from 120 ° C to 250 ° C, and the water formed by the imidization reaction is excluded from the reaction system. It is preferred to carry out the oxime imidization reaction.
聚醯亞胺前驅物之觸媒醯亞胺化係將鹼性觸媒與酸酐添加於聚醯亞胺前驅物溶液中,以-20~250℃,較佳為0~180℃攪拌進行觸媒醯亞胺化。鹼性觸媒的量係醯胺酸基之0.5~30倍莫耳,較佳為2~20倍莫耳,酸酐的量為醯胺酸基之1~50倍莫耳,較佳為3~30倍莫耳。 The catalyst oxime imidization of the polyimide precursor is added to the polyimide precursor solution by adding a basic catalyst and an acid anhydride, and stirring at -20 to 250 ° C, preferably 0 to 180 ° C.醯imination. The amount of the alkaline catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the prolyl group, and the amount of the acid anhydride is 1 to 50 moles of the amidate group, preferably 3 to 3 30 times Mo.
鹼性觸媒例如有吡啶、三乙胺、三甲胺、三丁胺、三辛胺等。其中吡啶由於具有進行反應所需之適度的鹼性,故較佳。 The basic catalyst is, for example, pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine or the like. Among them, pyridine is preferred because it has a moderate basicity required for carrying out the reaction.
酸酐例如有乙酸酐、偏苯三酸酐、均苯四酸酐等。其中使用乙酸酐時,反應結束後之純化容易,故較佳。藉由觸媒醯亞胺化之醯亞胺化率,可藉由調節觸媒量與反應溫度、反應時間來控制。 Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic anhydride. When acetic anhydride is used, purification after the completion of the reaction is easy, which is preferable. The imidization ratio of the imidization by the catalyst oxime can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time.
自聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺等之反應溶液回收生成之聚醯亞胺前驅物或聚醯亞胺時,只要將反應溶液注入溶劑中使之沉澱即可。沉澱所用 的溶劑,例如有甲醇、丙酮、己烷、丁基賽路蘇、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、甲苯、苯、水等。投入於溶劑中,使之沉澱的聚醯亞胺前驅物或聚醯亞胺係經過濾回收後,可在常壓或減壓下,於常溫或加熱乾燥。又,將沉澱回收之聚醯亞胺前驅物或聚醯亞胺再溶解於有機溶劑中,再沉澱回收之操作重複2~10次時,可減少聚醯亞胺前驅物或聚醯亞胺中的雜質。此時之溶劑例如有醇類、酮類、或烴等,使用由此等中選出之三種以上的溶劑時,可更進一步提高純化效率,故較佳。 When the polyimine precursor or the polyimine is recovered from a reaction solution of a polyamidiamine precursor such as polyglycolic acid or a polyphthalamide, or a polyimine, the reaction solution is injected into the solvent. It can be precipitated in the middle. Used for precipitation The solvent may, for example, be methanol, acetone, hexane, butyl sarbuta, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water or the like. The polyimine precursor or the polyimine which is deposited in a solvent and precipitated is collected by filtration, and then dried at normal temperature or under heat at normal pressure or reduced pressure. Further, the precipitated polyimine precursor or polyimine is redissolved in an organic solvent, and the reprecipitation recovery operation is repeated 2 to 10 times to reduce the polyimine precursor or polyimine. Impurities. In this case, the solvent is, for example, an alcohol, a ketone or a hydrocarbon. When three or more solvents selected from the above are used, the purification efficiency can be further improved, which is preferable.
聚醯亞胺之醯胺酸基之脫水閉環率(醯亞胺化率)不一定需要100%,可在0~100%的範圍內配合用途及目的任意選擇,較佳為50~100%。 The dehydration ring closure ratio (the imidization ratio) of the amidino group of the polyimine is not necessarily required to be 100%, and may be arbitrarily selected in the range of 0 to 100%, preferably 50 to 100%.
聚醯胺也可與聚醯胺酸酯同樣合成。 Polyamide can also be synthesized in the same manner as polyglycolate.
本發明之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等之分子量,若考慮使用此等所得之聚合物被膜(液晶配向膜)的強度、聚合物被膜形成時之作業性及聚合物被膜之均勻性時,以GPC(凝膠滲透層析:(Gel Permeation Chromatography))法測定之重量平均分子量較佳為5,000~1,000,000,更佳為10,000~150,000。 The molecular weight of the polymer film (liquid crystal alignment film) obtained by using the above-mentioned polymer film (liquid crystal alignment film), the workability and polymerization at the time of formation of a polymer film, and the molecular weight of the polymerized polyimide precursor, the polyimine, and the polyamine. When the uniformity of the coating film is used, the weight average molecular weight measured by GPC (Gel Permeation Chromatography) is preferably 5,000 to 1,000,000, more preferably 10,000 to 150,000.
本發明之液晶配向膜之製造方法係於基板上形成含有上述聚醯亞胺前驅物的薄膜,接著加熱,且邊維持加熱狀態邊對於膜面照射經偏光的紫外線。藉由該偏光的紫外線照射,引發更高反應效率的光交聯反應,在含有聚醯亞胺前驅物的薄膜中倒入各向異性,在基板上形成含有聚醯亞 胺前驅物的液晶配向膜。 In the method for producing a liquid crystal alignment film of the present invention, a film containing the polyimide precursor is formed on a substrate, followed by heating, and the polarized ultraviolet light is irradiated to the film surface while maintaining the heating state. By the polarized ultraviolet irradiation, a photocrosslinking reaction of higher reaction efficiency is initiated, an anisotropy is poured into a film containing a polyimide precursor, and a polyfluorene is formed on the substrate. A liquid crystal alignment film of an amine precursor.
本發明係於含有聚醯亞胺前驅物的薄膜之中不含聚醯亞胺較佳。假如無法避免在含有聚醯亞胺前驅物之薄膜之中含有聚醯亞胺時,其含量係相對於聚醯亞胺前驅物,較佳為30莫耳%以下,更佳為20莫耳%以下,更佳為10莫耳%以下。 The present invention is preferably one which does not contain a polyimine in a film containing a polyimide precursor. If it is unavoidable to contain polyimine in the film containing the polyimide precursor, the content thereof is preferably 30 mol% or less, more preferably 20 mol%, relative to the polyimide precursor. Hereinafter, it is more preferably 10 mol% or less.
聚醯亞胺係比較剛直的高分子材料,薄膜中含有較多時,會影響含有聚醯亞胺前驅物之膜的柔軟性。又,偏光照射時會影響併用加熱處理的效果,有可能妨礙含有聚醯亞胺前驅物之膜中之光反應進行。結果因光反應有妨礙各向異性導入於含有聚醯亞胺前驅物之膜的疑慮。 When the polyimine is a relatively rigid polymer material and contains a large amount of the film, the flexibility of the film containing the polyimide precursor is affected. Further, when polarized light is irradiated, the effect of heat treatment is affected, and the light reaction in the film containing the polyimide precursor may be hindered. As a result, the photoreaction has a concern that the anisotropy is prevented from being introduced into the film containing the polyimide precursor.
因此,形成於基板上之含有聚醯亞胺前驅物之薄膜的加熱溫度係實現薄膜之高光反應效率之範圍的溫度,較佳為不產生聚醯亞胺前驅物之化學反應的範圍溫度。換言之,加熱溫度的上限係因使用之聚醯亞胺前驅物的種類,選擇產生熱反應,不會變成聚醯亞胺之範圍的溫度較佳。下限係因使用之聚醯亞胺前驅物的種類,選擇具有可提高後述光反應性效果的溫度較佳。 Therefore, the heating temperature of the film containing the polyimide precursor formed on the substrate is a temperature at which the high light reaction efficiency of the film is achieved, and is preferably a temperature range in which the chemical reaction of the polyimide precursor is not generated. In other words, the upper limit of the heating temperature is selected to cause a thermal reaction depending on the type of the polyimide precursor to be used, and the temperature which does not become a range of the polyimine is preferable. The lower limit is preferably a temperature at which the effect of improving the photoreactivity described later is selected depending on the type of the polyimide precursor to be used.
具體而言,形成於基板上之含有聚醯亞胺前驅物之薄膜的加熱溫度為50~300℃,較佳為80~250℃的範圍,更佳為150~200℃。 Specifically, the film containing the polyimide precursor formed on the substrate has a heating temperature of 50 to 300 ° C, preferably 80 to 250 ° C, more preferably 150 to 200 ° C.
基板上之含有聚醯亞胺前驅物之薄膜的加熱與其加熱狀態之維持,可使用例如加熱板、熱循環型烘箱或IR(紅外線)型烘箱等來維持。其中,選擇使用可容易進行紫外 線照射之加熱板較佳。 The heating of the film containing the polyimide precursor on the substrate and the maintenance of the heating state thereof can be maintained using, for example, a hot plate, a heat cycle type oven, or an IR (infrared) type oven. Among them, the choice to use can be easily carried out UV The heating plate for wire irradiation is preferred.
對含有聚醯亞胺前驅物之薄膜的膜面照射偏光的紫外線時,對於基板,由固定方向照射介於偏光板偏光後的紫外線。使用之紫外線的波長,例如可使用100~400nm之範圍的紫外線。較佳為因使用之聚醯亞胺前驅物的種類,介於濾光片等選擇最佳的波長。例如選擇使用300~400nm之範圍的紫外線,可選擇性引發光交聯反應。紫外線可使用例如由高壓水銀燈放射的光。 When the film surface of the film containing the polyimide precursor is irradiated with polarized ultraviolet rays, the substrate is irradiated with ultraviolet rays polarized by the polarizing plate in a fixed direction. For the wavelength of the ultraviolet light to be used, for example, ultraviolet rays in the range of 100 to 400 nm can be used. It is preferred to select the optimum wavelength depending on the type of the polyimide precursor to be used, such as a filter. For example, the use of ultraviolet light in the range of 300 to 400 nm can selectively initiate photocrosslinking reaction. Ultraviolet rays can use, for example, light emitted by a high pressure mercury lamp.
本發明之液晶配向膜之製造方法可以非常高的效率進行使用之含有聚醯亞胺前驅物之薄膜的光反應。具體而言,相較於以往光配向法,以約1/10程度的紫外線照射量,即可進行含有構成液晶配向膜之聚醯亞胺前驅物之薄膜中的光反應,可提高約10倍的光反應的效率。 The method for producing a liquid crystal alignment film of the present invention can carry out a photoreaction of a film containing a polyimide precursor using a very high efficiency. Specifically, compared with the conventional photo-alignment method, the photoreaction in the film containing the polyimine precursor constituting the liquid crystal alignment film can be increased by about 10 times with an ultraviolet irradiation amount of about 1/10. The efficiency of the light reaction.
結果本發明在照射光進行的配向處理時,紫外線的照射量可遠少於以往光配向法的量。換言之,本發明係相較於以往光配向法所必要之數J~數十J時,以更少之紫外線的照射量,可製造具備液晶之配向控制能的液晶配向膜。具體而言為10~1000mJ,較佳為20~800mJ之範圍的紫外線照射量,可製造液晶配向膜。此時,10~20mW之強度的紫外線照射數秒~數十秒,可製造液晶配向膜,也可提高液晶配向膜之製造產能(處理能力)。 As a result, in the alignment treatment by the irradiation light of the present invention, the amount of ultraviolet rays irradiated can be much smaller than that of the conventional photoalignment method. In other words, in the present invention, a liquid crystal alignment film having alignment control energy of liquid crystal can be produced with a smaller amount of ultraviolet rays than the number of J to tens of J necessary for the conventional photoalignment method. Specifically, it is a liquid crystal alignment film which is an ultraviolet irradiation amount in the range of 10 to 1000 mJ, preferably 20 to 800 mJ. At this time, ultraviolet light having a strength of 10 to 20 mW is irradiated for several seconds to several tens of seconds, and a liquid crystal alignment film can be produced, and the production capacity (processing ability) of the liquid crystal alignment film can be improved.
如上述,本發明之液晶配向膜的製造方法係將含有聚醯亞胺前驅物之薄膜進行加熱,邊維持加熱狀態,邊照射偏光的紫外線,藉由較少的紫外線照射量,可以高效率製 造液晶配向膜。換言之,本發明可以高效率製造液晶配向膜。 As described above, in the method for producing a liquid crystal alignment film of the present invention, the film containing the polyimide precursor is heated, and while maintaining the heated state, the polarized ultraviolet rays are irradiated, and the amount of ultraviolet irradiation is small, so that the film can be efficiently produced. Create a liquid crystal alignment film. In other words, the present invention can produce a liquid crystal alignment film with high efficiency.
又,利用本發明之液晶配向膜的製造方法,使用所得之液晶配向膜,製造液晶顯示元件。 Moreover, the liquid crystal display element is manufactured using the obtained liquid crystal alignment film by the manufacturing method of the liquid crystal alignment film of this invention.
其次說明使用本發明之液晶配向膜的液晶顯示元件。 Next, a liquid crystal display element using the liquid crystal alignment film of the present invention will be described.
本發明之液晶配向處理劑係含有上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等者。液晶配向處理劑係指形成液晶配向膜用的溶液,將形成液晶配向膜用的聚合物成分分散或溶解於有機溶劑的溶液。其中,液晶配向膜係指使液晶配向於所定方向用的膜。 The liquid crystal alignment treatment agent of the present invention contains the above-mentioned polyimine precursor such as polylysine or polylysine, polyimine or polyamine. The liquid crystal alignment treatment agent refers to a solution for forming a liquid crystal alignment film, and a solution in which a polymer component for forming a liquid crystal alignment film is dispersed or dissolved in an organic solvent. Here, the liquid crystal alignment film refers to a film for aligning the liquid crystal in a predetermined direction.
本發明係含有選自本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺及聚醯胺之至少一種作為上述聚合物成分。 The present invention contains at least one selected from the group consisting of a polyimine precursor such as polylysine or polylysine of the present invention, a polyimine, and a polyamine as the polymer component.
又,本發明之聚醯亞胺前驅物係溶解於溶劑中,構成液狀的液晶配向處理劑,也可使用於形成含有聚醯亞胺前驅物的薄膜,此外,也可用於液晶配向膜之製造。此時,液晶配向處理劑中之聚醯亞胺前驅物的含量,較佳為0.1~30質量%,更佳為0.5~30質量%,特佳為1~25質量%。 Further, the polyimine precursor of the present invention is dissolved in a solvent to form a liquid liquid crystal alignment treatment agent, and can also be used for forming a film containing a polyimide precursor, and can also be used for a liquid crystal alignment film. Manufacturing. In this case, the content of the polyimide precursor in the liquid crystal alignment agent is preferably from 0.1 to 30% by mass, more preferably from 0.5 to 30% by mass, particularly preferably from 1 to 25% by mass.
本發明之液晶配向處理劑中,含有的聚合物成分可全部為本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等,或可於本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等之聚合物成分中混合其他的聚合物。聚合物成分為含有其他的聚合物時,聚合物成分全量中之其他聚合物的含量 為0.5~50質量%,較佳為1~30質量%。 In the liquid crystal alignment treatment agent of the present invention, all of the polymer components contained in the present invention may be the polyimine imine precursors such as polylysine or polylysine of the present invention, polyimine, polyamine, and the like. Alternatively, another polymer may be blended in the polymer component of the polyimine precursor such as polylysine or polyperurate of the present invention, polyimine or polyamine. When the polymer component is other polymer, the content of other polymers in the total amount of the polymer component It is 0.5 to 50% by mass, preferably 1 to 30% by mass.
其他的聚合物例如有與例如四羧酸二酐成分、二羧酸等反應的二胺成分為僅使用本發明之上述式(4)表示之二胺以外的二胺所得的聚醯亞胺前驅物、聚醯亞胺、聚醯胺等。又,聚醯亞胺前驅物、聚醯亞胺及聚醯胺以外的聚合物,具體而言,例如有丙烯酸聚合物、甲基丙烯酸聚合物、聚苯乙烯等。 The other polymer, for example, a diamine component which is reacted with, for example, a tetracarboxylic dianhydride component, a dicarboxylic acid or the like, is a polyimine precursor obtained by using only a diamine other than the diamine represented by the above formula (4) of the present invention. , polyimine, polyamine, and the like. Further, examples of the polymer other than the polyimine precursor, the polyimine, and the polyamine include, for example, an acrylic polymer, a methacrylic polymer, and polystyrene.
本發明之液晶配向處理劑中,選自本發明之上述聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物、聚醯亞胺及聚醯胺之至少一種與必要時混合之其他的聚合物合計的含有比例係於聚合物成分全量中,為0.1~30質量%,較佳為1~25質量%,更佳為3~15質量%,特佳為3~10質量%。 In the liquid crystal alignment treatment agent of the present invention, at least one selected from the group consisting of a polyamidamine precursor such as polylysine or polylysine of the present invention, a polyimine, and a polyamine is mixed as necessary. The total content of the other polymers is 0.1 to 30% by mass, preferably 1 to 25% by mass, more preferably 3 to 15% by mass, particularly preferably 3 to 10% by mass, based on the total amount of the polymer component.
本發明之液晶配向處理劑中所用的有機溶劑,只要是溶解本發明之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等之聚合物成分的有機溶劑時,即無特別限定。其具體例有N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-甲基已內醯胺、2-吡咯烷酮、N-乙基吡咯烷酮、N-乙烯基吡咯烷酮、二甲基亞碸、四甲基脲、吡啶、二甲基碸、六甲基亞碸、γ-丁內酯、3-甲氧基-N,N-二甲基丙醯胺、3-乙氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、1,3-二甲基-咪唑啉酮、乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、環己酮、碳酸乙烯酯、碳酸丙烯酯、二甘醇二甲醚(Diglyme)、4-羥基-4-甲基-2-戊酮等。此等可單獨使用 或混合使用。 The organic solvent used in the liquid crystal alignment treatment agent of the present invention is not particularly limited as long as it is an organic solvent which dissolves the polymer component of the polyimine precursor of the present invention, polyimine or polyamine. Specific examples thereof are N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone, N- Ethylpyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethylurea, pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, 3-methoxy-N,N- Dimethylpropanamide, 3-ethoxy-N,N-dimethylpropanamide, 3-butoxy-N,N-dimethylpropanamide, 1,3-dimethyl-imidazole Linone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate, diethylene glycol Diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These can be used separately Or mixed use.
本發明之液晶配向處理劑在不影響本發明效果的範圍內,可含有提高塗佈液晶配向處理劑時之聚合物被膜之膜厚均勻性或表面平滑性的有機溶劑(也稱為弱溶劑)或化合物。也可含有提高液晶配向膜與基板之密著性的化合物等。 The liquid crystal alignment agent of the present invention may contain an organic solvent (also referred to as a weak solvent) which improves the film thickness uniformity or surface smoothness of the polymer film when the liquid crystal alignment agent is applied, within a range that does not impair the effects of the present invention. Or a compound. A compound or the like which improves the adhesion between the liquid crystal alignment film and the substrate may be contained.
提高膜厚均勻性或表面平滑性的弱溶劑的具體例如下述者,例如有異丙醇、甲氧基甲基戊醇、甲基賽路蘇、乙基賽路蘇、丁基賽路蘇、甲基賽路蘇乙酸酯、乙基賽路蘇乙酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯、乙二醇、乙二醇單乙酸酯、乙二醇單異丙醚、乙二醇單丁醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲醚、丙二醇第三丁醚、二丙二醇單甲醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲醚、二丙二醇單乙酸酯單甲醚、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇單乙酸酯單乙醚、二丙二醇單丙醚、二丙二醇單乙酸酯單丙醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲醚、3-甲基-3-甲氧基丁醇、二異丙醚、乙基異丁醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁醚、二異丁基酮、甲基環己烯、丙醚、二己醚、正己烷、正戊烷、正辛烷、二乙醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、1-甲 氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二醇-1-單甲醚-2-乙酸酯、丙二醇-1-單乙醚-2-乙酸酯、二丙二醇、2-(2-乙氧基丙氧基)丙醇、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、乳酸異戊酯等具有低表面張力的有機溶劑等。 Specific examples of the weak solvent for increasing the film thickness uniformity or the surface smoothness include, for example, isopropanol, methoxymethylpentanol, methyl stilbene, ethyl stilbene, and butyl 赛苏苏. , Methyl sulphate acetate, ethyl sirolimus acetate, butyl carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetic acid Ester, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol Alcohol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, Dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, B Isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, dibutyl ether, diisobutyl ketone, methylcyclohexene, propyl ether, dihexyl ether, n-hexane, n-pentane, n-octane, Two Ether, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, 3- Methyl ethyl ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, 3-methoxy Butyl propyl propionate, 1-methyl Oxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol diethyl Acid ester, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, lactate An organic solvent having a low surface tension such as an ester, ethyl lactate, n-propyl lactate, n-butyl lactate or isoamyl lactate.
此等弱溶劑可使用一種或混合複數種使用。使用如上述之弱溶劑時,較佳為液晶配向處理劑中所含之有機溶劑全部的5~80質量%,更佳20~60質量%。 These weak solvents can be used one kind or a mixture of plural kinds. When the weak solvent as described above is used, it is preferably from 5 to 80% by mass, more preferably from 20 to 60% by mass, based on the total of the organic solvent contained in the liquid crystal alignment agent.
提高膜厚之均勻性或表面平滑性的化合物,例如有氟系界面活性劑、矽氧系界面活性劑或非離子系界面活性劑等。更具體而言,例如有EF TOP EF301、EF303、EF352(TOHKEM PRODUCTS公司製)、MAGAFAC F171、F173、R-30(大日本油墨公司製),FLORARD FC430、FC431(住友3M公司製)、Asahigard AG710、SURFLON S-382、SC101、SC102、SC103、SC104、SC105、SC106(旭硝子公司製)等。此等界面活性劑之使用比例係相對於液晶配向處理劑中所含有之聚合物成分100質量份,較佳為0.01~2質量份,更佳為0.01~1質量份。 Examples of the compound which improves the uniformity of the film thickness or the surface smoothness include a fluorine-based surfactant, a rhodium-based surfactant, and a nonionic surfactant. More specifically, for example, EF TOP EF301, EF303, EF352 (manufactured by TOHKEM PRODUCTS), MAGAFAC F171, F173, R-30 (manufactured by Dainippon Ink Co., Ltd.), FLORARD FC430, FC431 (manufactured by Sumitomo 3M), Asahigard AG710 , SURFLON S-382, SC101, SC102, SC103, SC104, SC105, SC106 (made by Asahi Glass Co., Ltd.). The ratio of use of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment treatment agent.
提高液晶配向膜與基板之密著性之化合物,例如有含有官能性矽烷化合物、含有環氧基化合物等。例如有3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)- 3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三甲氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、N,N,N’,N’-四縮水甘油基-間-苯二甲胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲烷等。 The compound which improves the adhesiveness of a liquid crystal alignment film and a board|substrate, for example, has a functional decane compound, and an epoxy-containing compound. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N- (2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)- 3-aminopropylmethyldimethoxydecane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyl Trimethoxydecane, N-ethoxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyl Tri-extension ethyltriamine, 10-trimethoxydecyl-1,4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9- Trimethoxydecyl-3,6-diazaindolyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl-3-amino group Propyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyl Triethoxy decane, N-bis(oxyethyl)-3-aminopropyltrimethoxydecane, N-bis(oxyethyl)-3-aminopropyltriethoxydecane, Ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl Oleic ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2 , 4-hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane Alkane, N, N, N', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, and the like.
使用提高與基板之密著性的化合物時,其使用量係相對於液晶配向處理劑所含有之聚合物成分100質量份,較佳為0.1~30質量份,更佳為1~20質量份。使用量未達0.1質量份時,無法期待密著性改善的效果,多於30質量份時,有時液晶配向性變差的情況。 When the compound is used to improve the adhesion to the substrate, the amount thereof is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent. When the amount used is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected, and when it is more than 30 parts by mass, the liquid crystal alignment may be deteriorated.
本發明之液晶配向處理劑除上述以外,只要在不損及本發明效果的範圍內,為了改變液晶配向膜之介電率或導電性等電特性,可添加介電體或導電物質、提高作為液晶配向膜時之膜的硬度或緊密度為目的之交聯性化合物。 In addition to the above, the liquid crystal alignment agent of the present invention may be added with a dielectric or a conductive material in order to change the dielectric properties such as the dielectric constant or the conductivity of the liquid crystal alignment film, without departing from the effects of the present invention. The hardness or tightness of the film in the case of the liquid crystal alignment film is a crosslinkable compound for the purpose.
本發明之液晶配向處理劑係塗佈於基板上,經焙燒後,必要時以摩擦(rubbing)處理或光照射(輻射線照射)進行配向處理,可作為液晶配向膜使用。這種本發明之液晶配向膜係以上述式(4)表示之二胺作為原料之聚醯亞胺前驅物、聚醯亞胺、聚醯胺等所形成,因此不易因AC驅動造成液晶配向性能變化。 The liquid crystal alignment treatment agent of the present invention is applied onto a substrate, and after firing, if necessary, it is subjected to alignment treatment by rubbing treatment or light irradiation (radiation irradiation), and can be used as a liquid crystal alignment film. The liquid crystal alignment film of the present invention is formed by using a diamine represented by the above formula (4) as a raw material of a polyimide precursor, a polyimine, a polyamide, or the like, and thus is not easily caused by AC driving. Variety.
基板只要是透明性高的基板,即無特別限定,除玻璃基板外,可使用丙烯酸基板或聚碳酸酯基板等塑膠基板。從製程簡化的觀點而言,較佳為使用形成有液晶驅動用之ITO(Indium Tin Oxide)電極等的基板。又,反射型的液晶顯示元件若僅為單側之基板時,也可使用矽晶圓等不透明的基板,此時之電極亦可使用鋁等反射光的材料。又,如TFT型之液晶顯示元件的高功能元件,可使用在液晶驅動用之電極與基板之間形成有如電晶體的元件者。 The substrate is not particularly limited as long as it is a substrate having high transparency, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used in addition to the glass substrate. From the viewpoint of process simplification, it is preferred to use a substrate on which an ITO (Indium Tin Oxide) electrode or the like for liquid crystal driving is formed. Further, when the reflective liquid crystal display element is only a single-sided substrate, an opaque substrate such as a germanium wafer may be used. In this case, a material that reflects light such as aluminum may be used as the electrode. Further, as a high-function element of a TFT-type liquid crystal display element, an element such as a transistor formed between an electrode for driving a liquid crystal and a substrate can be used.
液晶配向處理劑之塗佈方法並無特別限制,但工業上一般係以網版印刷、平板印刷、軟板印刷、噴墨印刷等之方法進行塗佈。其他塗佈方法例如有浸漬法、輥塗法、狹縫塗佈法、旋轉塗佈法、噴霧法等,可依據目的需要使用此等塗佈方法。 The coating method of the liquid crystal alignment agent is not particularly limited, but industrially, it is generally applied by a method such as screen printing, lithography, soft printing, or inkjet printing. Other coating methods include, for example, a dipping method, a roll coating method, a slit coating method, a spin coating method, a spray method, and the like, and such coating methods may be used depending on the purpose.
於基板上塗佈液晶配向處理劑後,藉由加熱板、熱循 環型烘箱、IR(紅外線)型烘箱等的加熱手段,以50~300℃,較佳為80~250℃使溶劑蒸發可形成液晶配向膜(聚合物之薄膜)。焙燒後之液晶配向膜之厚度太厚時,對於液晶顯示元件之消耗電力方面不利,太薄時,有時液晶顯示元件有信賴性降低的情況,故較佳為5~300nm,更佳為10~100nm。使液晶水平配向或傾斜配向時,以摩擦或偏光紫外線照射等處理焙燒後的液晶配向膜,可使液晶配向。例如藉由偏光紫外線等之光照射,使來自以式(4)表示之二胺等的光反應基進行二聚化反應,可藉由該反應所產生之各向異性使液晶配向。 After coating the liquid crystal alignment treatment agent on the substrate, the heating plate and the heat are used A heating means such as a ring type oven or an IR (infrared) type oven may evaporate the solvent at 50 to 300 ° C, preferably 80 to 250 ° C to form a liquid crystal alignment film (film of a polymer). When the thickness of the liquid crystal alignment film after baking is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element. When the thickness is too thin, the reliability of the liquid crystal display element may be lowered. Therefore, it is preferably 5 to 300 nm, more preferably 10 ~100nm. When the liquid crystal is aligned horizontally or obliquely, the liquid crystal alignment film after baking is treated by rubbing or polarized ultraviolet light irradiation to align the liquid crystal. For example, by diffracting a photoreactive group derived from a diamine represented by the formula (4) by light irradiation such as polarized ultraviolet rays, the liquid crystal can be aligned by the anisotropy generated by the reaction.
偏光紫外線之照射可使液晶配向膜邊加熱邊照射。 The irradiation of the polarized ultraviolet rays allows the liquid crystal alignment film to be irradiated while being heated.
形成於基板上之含有聚醯亞胺前驅物的薄膜係使用例如加熱板等,進行80~250℃之加熱。此時,加熱溫度的上限係因使用之聚醯亞胺前驅物的種類,選擇產生熱反應,不會變成聚醯亞胺之範圍的溫度。下限係因使用之聚醯亞胺前驅物的種類,選擇具有可提高光反應性效果的溫度。 The film containing the polyimide precursor formed on the substrate is heated at 80 to 250 ° C using, for example, a hot plate. At this time, the upper limit of the heating temperature is selected to generate a thermal reaction depending on the type of the polyimide precursor to be used, and does not become a temperature in the range of the polyimide. The lower limit is a temperature at which the effect of improving the photoreactivity is selected depending on the type of the polyimide precursor to be used.
以上述範圍內之選擇溫度邊進行加熱,如上述選擇光照射的條件,對含有聚醯亞胺前驅物之薄膜的膜面,由一定的方向,介於偏光板照射偏光的紫外線。如此,可製造於基板上具備液晶配向控制能的液晶配向膜。 Heating is performed at a selected temperature within the above range, and the film surface of the film containing the polyimide precursor is irradiated with polarized ultraviolet rays in a predetermined direction in a predetermined direction as described above. In this way, a liquid crystal alignment film having liquid crystal alignment control energy on the substrate can be manufactured.
本發明之液晶顯示元件係藉上述方法,自本發明之液晶配向處理劑獲得附液晶配向膜的基板後,以習知方法製作液晶胞(cell),作成液晶顯示元件者。例如具備液晶胞的液晶顯示元件,其中液晶胞具有對向配置之2片基 板、設置於基板間的液晶層、設置於基板與液晶層之間藉由本發明之液晶配向處理劑所形成的上述液晶配向膜。這種本發明之液晶顯示元件例如有水平配向(IPS:In-Plane Switching)方式、扭轉向列(TN:Twisted Nematic)方式、OCB配向(OCB:Optically Compensated Bend)或垂直配向(VA:Vertical Alignment)方式等。液晶配向膜係2片基板中,設置於至少一方即可。 In the liquid crystal display device of the present invention, a liquid crystal alignment cell is obtained by a conventional method from the liquid crystal alignment treatment agent of the present invention, and a liquid crystal cell is produced by a known method to form a liquid crystal display device. For example, a liquid crystal display element having a liquid crystal cell in which the liquid crystal cell has two substrates arranged in opposite directions A liquid crystal layer disposed between the substrate and the substrate, and the liquid crystal alignment film formed between the substrate and the liquid crystal layer by the liquid crystal alignment treatment agent of the present invention. Such a liquid crystal display element of the present invention has, for example, an IPS (In-Plane Switching) method, a TN (Twisted Nematic) method, an OCB (Optically Compensated Bend) or a vertical alignment (VA: Vertical Alignment). ) Ways, etc. The liquid crystal alignment film system may be provided in at least one of the two substrates.
本發明之液晶顯示元件所用的基板只要是透明性高的基板時,即無特別限定,通常係於基板上形成有驅動液晶用之透明電極的基板。具體例有與上述液晶配向膜所記載的基板同樣者。 The substrate used for the liquid crystal display device of the present invention is not particularly limited as long as it is a substrate having high transparency, and a substrate for driving a transparent electrode for liquid crystal is usually formed on the substrate. Specific examples are the same as those described for the liquid crystal alignment film.
又,液晶配向膜係將本發明之液晶配向處理劑塗佈於此基板上後,進行焙燒,必要時藉由摩擦處理或照射偏光紫外線等之輻射線而形成者,詳細如上述。 In the liquid crystal alignment film, the liquid crystal alignment treatment agent of the present invention is applied onto the substrate, and then fired, if necessary, by rubbing treatment or irradiation with radiation such as polarized ultraviolet rays, as described above.
構成本發明之液晶顯示元件之液晶層的液晶材料無特別限定,可使用具有正之介電各向異性之正型液晶、具有負之介電各向異性之負型液晶等。具體例可使用以往水平配向方式所使用的液晶材料,例如MercK公司製之MLC-2041等。 The liquid crystal material constituting the liquid crystal layer of the liquid crystal display element of the present invention is not particularly limited, and a positive type liquid crystal having positive dielectric anisotropy, a negative type liquid crystal having negative dielectric anisotropy, or the like can be used. As a specific example, a liquid crystal material used in the conventional horizontal alignment method, for example, MLC-2041 manufactured by MercK Co., Ltd., or the like can be used.
液晶胞之製作之一例,例如準備形成有液晶配向膜之一對基板,於其中一片基板之液晶配向膜上散佈如珠粒等之間隙物(Spacer),使液晶配向膜面成為內側,再貼合另一片基板,減壓注入液晶,進行封裝的方法,或將液晶滴下於散佈有間隙物之液晶配向膜面後,貼合基板並進行 封裝的方法等。間隙物之厚度較佳為1~30μm,更佳為2~10μm。水平配向方式之液晶顯示元件時,如上述封閉液晶後,偏光板配置於基板的外側。 For example, in the production of a liquid crystal cell, for example, a pair of substrates of a liquid crystal alignment film are prepared, and a spacer such as a bead is spread on a liquid crystal alignment film of one of the substrates, so that the liquid crystal alignment film surface becomes inside, and then Combining another substrate, injecting liquid crystal under reduced pressure, or encapsulating the liquid crystal, dropping the liquid crystal onto the liquid crystal alignment film surface on which the spacer is dispersed, bonding the substrate and performing the bonding The method of packaging, etc. The thickness of the spacer is preferably from 1 to 30 μm, more preferably from 2 to 10 μm. In the case of the liquid crystal display element of the horizontal alignment type, the polarizing plate is disposed outside the substrate after the liquid crystal is sealed as described above.
如上述,使用本發明之液晶配向處理劑所製作的液晶顯示元件係具有可抑制因AC驅動所造成之液晶配向性能變化的液晶配向膜,因此殘像特性非常優異,不易產生燒焦,不易產生顯示不良或對比降低。 As described above, the liquid crystal display element produced by using the liquid crystal alignment treatment agent of the present invention has a liquid crystal alignment film capable of suppressing a change in liquid crystal alignment performance due to AC driving, and therefore has excellent afterimage characteristics, is less likely to cause scorch, and is less likely to be generated. Poor display or contrast reduction.
以下舉本發明之實施例,具體說明本發明,但是本發明不限於此等實施例者。 The present invention will be specifically described below by way of examples of the invention, but the invention is not limited thereto.
單體(3)係依據反應式(i)進行合成。 Monomer (3) is synthesized according to reaction formula (i).
將單體(1)20g(0.09mol)添加於乾燥乙醇60ml中,進行攪拌迴流使固體全部溶解為止,然後再攪拌迴流2小時。反應終了後,減壓餾除乙醇直到固體稍微析出為止。將乾燥乙醇之約50%(volume))的反應溶液在室溫下冷却,過濾分開析出物後,以乙醇洗淨得到目的物之單 體(2)。在減壓餾除濾液的溶劑得到目的物異構物之混合物。此異構物的混合物以乙酸乙酯進行再結晶得到單體(2)。收量為10g,收率為35.2%。 20 g (0.09 mol) of the monomer (1) was added to 60 ml of dry ethanol, and the mixture was stirred and refluxed to dissolve all the solids, followed by stirring under reflux for 2 hours. After the completion of the reaction, ethanol was distilled off under reduced pressure until the solid was slightly precipitated. The reaction solution of about 50% of the dried ethanol is cooled at room temperature, and the precipitate is separated by filtration, and then washed with ethanol to obtain a single substance of interest. Body (2). The solvent of the filtrate was distilled off under reduced pressure to give a mixture of the desired substance isomer. The mixture of the isomers was recrystallized from ethyl acetate to give the monomer (2). The yield was 10 g and the yield was 35.2%.
所得之單體(2)之1H-NMR係以TMS(Si(CH3)4)為基準物質,在氘(deuterium)化二甲基亞碸(簡稱DMSO)之溶劑中,使用NMR測定裝置(JEOL公司製、500MHz)進行。單體(2)之1H-NMR測定結果如下所示,其他的化合物也同樣。 The 1 H-NMR of the obtained monomer (2) is based on TMS (Si(CH 3 ) 4 ), and an NMR measuring device is used in a solvent of deuterium dimethyl hydrazine (DMSO). (made by JEOL, 500MHz). The results of 1 H-NMR measurement of the monomer (2) are shown below, and the same applies to the other compounds.
1H-NMR(500MHz,DMSO,δppm)=1.27(t,J=7.09Hz,6H,-CH2-CH3-),4.28(q,J=7.04Hz,4H,-CH2-CH3),7.96(S,2H,Ph)。 1 H-NMR (500 MHz, DMSO, δ ppm) = 1.27 (t, J = 7.09 Hz, 6H, -CH 2 -CH 3 -), 4.28 (q, J = 7.04 Hz, 4H, -CH 2 -CH 3 ) , 7.96 (S, 2H, Ph).
在單體(2)4.77g(0.015mol)與乙酸乙酯35ml之混合液中添加少量的N,N’-二甲基甲醯胺。其次,添加亞硫醯氯(Thionyl Chloride)3ml,進行攪拌迴流。確認固體全部溶解後,再攪拌迴流1小時。反應終了後,減壓餾除溶劑與過剩的亞硫醯氯。生成物係以己烷再結晶進行純化,得到純化後的單體(3)。收量為4.3g,收率為80.5%。1H-NMR之溶劑係氘化氯仿(CDCl3)。 A small amount of N,N'-dimethylformamide was added to a mixture of 4.77 g (0.015 mol) of monomer (2) and 35 ml of ethyl acetate. Next, 3 ml of Thionyl Chloride was added, and the mixture was stirred and refluxed. After confirming that all the solids were dissolved, the mixture was further stirred under reflux for 1 hour. After the completion of the reaction, the solvent and excess sulphur sulfoxide were distilled off under reduced pressure. The resulting product was purified by recrystallization from hexane to give purified monomer (3). The yield was 4.3 g and the yield was 80.5%. The solvent of 1 H-NMR was deuterated chloroform (CDCl 3 ).
1H-NMR(500MHz,CDCl3,δppm)=1.43(t,J=7.12Hz,6H,-CH2-CH3-),4.46(q,J=7.1Hz,4H,-CH2-CH3),8.16(S,2H,Ph)。 1 H-NMR (500 MHz, CDCl 3 , δ ppm) = 1.43 (t,J = 7.12 Hz, 6H, -CH 2 -CH 3 -), 4.46 (q, J = 7.1 Hz, 4H, -CH 2 -CH 3 ), 8.16 (S, 2H, Ph).
單體(5)係依據反應式(ii)進行合成。 Monomer (5) is synthesized according to reaction formula (ii).
在單體(4)4.8g(0.022mol)與50ml之乙酸乙酯的混合液中添加少量的N,N’-二甲基甲醯胺。其次,添加亞硫醯氯(Thionyl Chloride)6ml,進行攪拌迴流。確認固體全部溶解後,再攪拌迴流1小時。反應終了後,減壓餾除溶劑與過剩的亞硫醯氯。生成物係以乙酸乙酯/己烷系再結晶進行純化,得到純化後的單體(5)。收量為3.5g,收率為62.4%。1H-NMR之溶劑係氘化氯仿(CDCl3)。 A small amount of N,N'-dimethylformamide was added to a mixture of 4.8 g (0.022 mol) of monomer (4) and 50 ml of ethyl acetate. Next, 6 ml of Thionyl Chloride was added, and the mixture was stirred and refluxed. After confirming that all the solids were dissolved, the mixture was further stirred under reflux for 1 hour. After the completion of the reaction, the solvent and excess sulphur sulfoxide were distilled off under reduced pressure. The product was purified by recrystallization from ethyl acetate/hexane to give purified monomer (5). The yield was 3.5 g and the yield was 62.4%. The solvent of 1 H-NMR was deuterated chloroform (CDCl 3 ).
1H-NMR(500MHz,CDCl3,δppm)=6.72(d,J=15.7Hz,2H,-CH=CH-),7.65(S,4H,Ph),7.82(d,J=15.7Hz,2H,-CH=CH-) 1 H-NMR (500 MHz, CDCl 3 , δ ppm) = 6.72 (d, J = 15.7 Hz, 2H, -CH=CH-), 7.65 (S, 4H, Ph), 7.82 (d, J = 15.7 Hz, 2H) , -CH=CH-)
聚醯胺酸酯衍生物之分子量之測定係與後述[實施例B]所記載之聚合物之分子量測定方法同樣進行。 The measurement of the molecular weight of the polyphthalate derivative is carried out in the same manner as the method for measuring the molecular weight of the polymer described in [Example B] to be described later.
將APHFP1.49g(4.5 mmol)與LiCl 1.5g添加於60ml之乾燥NMP中,在室溫下攪拌直到固體全部溶解為止。然後,添加氯三甲基矽烷0.12g。將單體(3)0.31g(0.9 mmol)、單體(5)0.91g(3.5 mmol)、及乾燥THF5ml之混合溶液在室溫下滴下於此溶液中,滴下漏斗以2ml的乾 燥THF清洗後,攪拌1小時。然後,徐徐提高反應溫度,於40℃下再攪拌3小時。反應終了後,將反應溶液注入800ml的水中,生成後的聚合物進行分離後,過濾分開,使用乙醇與丙酮洗淨。其次,使聚合物乾燥後,溶解於NMP中,藉由乙醇、及氯仿再沈澱,進行純化。然後,將沈澱物過濾分開,充分乾燥得到Mn為31,400,Mw為66,000的聚醯胺酸酯衍生物(6FPAE2-8)粉末(A)。 APHFP 1.49 g (4.5 mmol) and LiCl 1.5 g were added to 60 ml of dry NMP, and stirred at room temperature until the solids were all dissolved. Then, 0.12 g of chlorotrimethylnonane was added. A mixed solution of 0.31 g (0.9 mmol) of monomer (3), 0.91 g (3.5 mmol) of monomer (5), and 5 ml of dry THF was added dropwise to the solution at room temperature, and the funnel was dropped to 2 ml of dryness. After washing with dry THF, it was stirred for 1 hour. Then, the reaction temperature was gradually raised, and the mixture was further stirred at 40 ° C for 3 hours. After the completion of the reaction, the reaction solution was poured into 800 ml of water, and the resulting polymer was separated, filtered, and washed with ethanol and acetone. Next, the polymer was dried, dissolved in NMP, and reprecipitated by ethanol and chloroform to carry out purification. Then, the precipitate was separated by filtration and sufficiently dried to obtain a polyamine derivative (6FPAE2-8) powder (A) having a Mn of 31,400 and a Mw of 66,000.
將APHFP1.49g(4.5 mmol)與LiCl 1.5g添加於60ml之乾燥NMP中,在室溫下攪拌直到固體全部溶解為止。然後,添加氯三甲基矽烷0.12g。將單體(3)0.77g(2.2mmol)、單體(5)0.57g(2.2 mmol)、及乾燥THF5ml之混合溶液在室溫下滴下於此溶液中,滴下漏斗以2ml的乾燥THF清洗後,攪拌1小時。然後,徐徐提高反應溫度,於40℃下再攪拌3小時。反應終了後,將反應溶液注入800ml的水中,生成後的聚合物進行分離後,過濾分開,使用乙醇與丙酮洗淨。其次,使聚合物乾燥後,溶解於NMP中,藉由乙醇、及氯仿再沈澱,進行純化。然後,將沈澱物過濾分開,充分乾燥得到Mn為28,600,Mw為52,800之聚醯胺酸酯衍生物(6FPAE5-5)粉末(B)。 APHFP 1.49 g (4.5 mmol) and LiCl 1.5 g were added to 60 ml of dry NMP, and stirred at room temperature until the solids were all dissolved. Then, 0.12 g of chlorotrimethylnonane was added. A mixed solution of 0.77 g (2.2 mmol) of monomer (3), 0.57 g (2.2 mmol) of monomer (5), and 5 ml of dry THF was added dropwise to the solution at room temperature, and the funnel was washed with 2 ml of dry THF. Stir for 1 hour. Then, the reaction temperature was gradually raised, and the mixture was further stirred at 40 ° C for 3 hours. After the completion of the reaction, the reaction solution was poured into 800 ml of water, and the resulting polymer was separated, filtered, and washed with ethanol and acetone. Next, the polymer was dried, dissolved in NMP, and reprecipitated by ethanol and chloroform to carry out purification. Then, the precipitate was separated by filtration and sufficiently dried to obtain a polyamine derivative (6FPAE5-5) powder (B) having a Mn of 28,600 and a Mw of 52,800.
於合成例3所得之聚醯胺酸酯衍生物(6FPAE2-8)粉 末(A)中添加NMP及BCS,稀釋成4質量%,得到液晶配向處理劑(I)。此液晶配向處理劑未發現混濁或析出等之異常,確認樹脂成分為均勻溶解。 The polyphthalate derivative (6FPAE2-8) powder obtained in Synthesis Example 3 NMP and BCS were added to the final (A), and the mixture was diluted to 4% by mass to obtain a liquid crystal alignment treatment agent (I). No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
於合成例4所得之聚醯胺酸酯衍生物(6FPAE5-5)粉末(B)中添加NMP及BCS,稀釋成4質量%,得到液晶配向處理劑(II)。此液晶配向處理劑未發現混濁或析出等之異常,確認樹脂成分為均勻溶解。 NMP and BCS were added to the polyacetate derivative (6FPAE5-5) powder (B) obtained in Synthesis Example 4, and diluted to 4% by mass to obtain a liquid crystal alignment treatment agent (II). No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
使用含有實施例1所得之聚醯胺酸酯衍生物(6FPAE2-8)的液晶配向處理劑(I),旋轉塗佈於透明的玻璃基板(厚度1.1mm、寬30mm、長40mm)上,於80℃的加熱板上乾燥5分鐘後、形成膜厚40nm的塗膜,得到附配向處理前之液晶配向膜的基板。 The liquid crystal alignment treatment agent (I) containing the polyphthalate derivative (6FPAE2-8) obtained in Example 1 was spin-coated on a transparent glass substrate (thickness: 1.1 mm, width: 30 mm, length: 40 mm). After drying on a hot plate at 80 ° C for 5 minutes, a coating film having a film thickness of 40 nm was formed, and a substrate to which a liquid crystal alignment film before treatment was attached was obtained.
使用含有實施例2所得之聚醯胺酸酯衍生物(6FPAE5-5)的液晶配向處理劑(II),旋轉塗佈於透明的玻璃基板上,於80℃的加熱板上乾燥5分鐘後、形成膜厚40nm的塗膜,得到附配向處理前之液晶配向膜的基板。 The liquid crystal alignment treatment agent (II) containing the polyphthalate derivative (6FPAE5-5) obtained in Example 2 was spin-coated on a transparent glass substrate and dried on a hot plate at 80 ° C for 5 minutes. A coating film having a film thickness of 40 nm was formed, and a substrate to which a liquid crystal alignment film before treatment was attached was obtained.
使用實施例3所得之附配向處理前之液晶配向膜的基板,將此於加熱板上加熱至240℃,維持該加熱狀態下,對於基板上之液晶配向膜面,由一定的方向介於偏光板(Mejiro Precision公司製),照射偏光後之紫外線(牛尾電機公司製高壓水銀燈、Mejiro Precision公司製偏光照射裝置)。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為500mJ。如此得到附配向處理後之液晶配向膜的基板。 Using the substrate obtained in Example 3 and attached to the liquid crystal alignment film before the treatment, the substrate was heated to 240 ° C on the hot plate, and in the heated state, the liquid crystal alignment film surface on the substrate was polarized by a certain direction. A plate (manufactured by Mejiro Precision Co., Ltd.) was irradiated with ultraviolet light after polarized light (high-pressure mercury lamp manufactured by Oxtail Electric Co., Ltd., and polarized light irradiation device manufactured by Mejiro Precision Co., Ltd.). The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 500 mJ. Thus, a substrate to which the liquid crystal alignment film after the treatment was attached was obtained.
使用實施例3所得之附配向處理前之液晶配向膜的基板,將此維持於室溫狀態下,對於基板上之液晶配向膜面,由一定的方向介於偏光板,照射偏光後之紫外線。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為500mJ。如此得到形成有液晶配向膜之附液晶配向膜的基板。 Using the substrate obtained in the third embodiment and attached to the liquid crystal alignment film before the treatment, the liquid crystal alignment film surface on the substrate was irradiated with a polarized light in a predetermined direction with respect to the liquid crystal alignment film surface on the substrate, and the polarized ultraviolet light was irradiated. The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 500 mJ. Thus, a substrate on which a liquid crystal alignment film of a liquid crystal alignment film is formed is obtained.
使用實施例3所得之附配向處理前之液晶配向膜的基板,將此維持於室溫狀態下,對於基板上之液晶配向膜面,由一定的方向介於偏光板,照射偏光後之紫外線。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為4500mJ。如此得到形成有液晶配向膜之附液晶配向膜的基板。 Using the substrate obtained in the third embodiment and attached to the liquid crystal alignment film before the treatment, the liquid crystal alignment film surface on the substrate was irradiated with a polarized light in a predetermined direction with respect to the liquid crystal alignment film surface on the substrate, and the polarized ultraviolet light was irradiated. The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 4500 mJ. Thus, a substrate on which a liquid crystal alignment film of a liquid crystal alignment film is formed is obtained.
使用實施例4所得之附配向處理前之液晶配向膜的基板,將此於加熱板上加熱至160℃,維持該加熱狀態下,對於基板上之液晶配向膜面,由一定的方向介於偏光板,照射偏光後之紫外線。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為250mJ。如此得到附配向處理後之液晶配向膜的基板。 Using the substrate obtained in Example 4 and attached to the liquid crystal alignment film before the treatment, the substrate was heated to 160 ° C on the hot plate, and in the heated state, the liquid crystal alignment film surface on the substrate was polarized by a certain direction. The plate is irradiated with ultraviolet light after polarized light. The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 250 mJ. Thus, a substrate to which the liquid crystal alignment film after the treatment was attached was obtained.
除加熱板上之加熱溫度為200℃外,與實施例6同樣的方法得到附配向處理之液晶配向膜的基板。 A substrate to which a liquid crystal alignment film to be treated was attached was obtained in the same manner as in Example 6 except that the heating temperature on the hot plate was 200 °C.
除加熱板上之加熱溫度為240℃外,與實施例6同樣的方法得到附配向處理之液晶配向膜的基板。 A substrate to which a liquid crystal alignment film to be treated was attached was obtained in the same manner as in Example 6 except that the heating temperature on the hot plate was 240 °C.
實施例3~8、比較例1及比較例2所得之附液晶配向膜之基板的製作條件如表1所示。 The production conditions of the substrates with liquid crystal alignment films obtained in Examples 3 to 8, Comparative Example 1, and Comparative Example 2 are shown in Table 1.
將液晶配向處理劑A5(記載於後述之[實施例B])旋轉塗佈於石英基板(厚度1.1mm、寬40mm、長40mm)。接著,以90℃的加熱板乾燥60秒後,以200℃之熱風循環式烘箱焙燒30分鐘,形成膜厚100nm的液晶配向膜。其次,於加熱板上加熱至240℃,維持該加熱狀態下,對於基板上之液晶配向膜面,介於偏光板,照射313nm之紫外線1000 mJ/cm2,得到附液晶配向膜的基板。 The liquid crystal alignment agent A5 (described in [Example B] described later) was spin-coated on a quartz substrate (thickness: 1.1 mm, width: 40 mm, length: 40 mm). Subsequently, the film was dried on a hot plate at 90 ° C for 60 seconds, and then fired in a hot air circulating oven at 200 ° C for 30 minutes to form a liquid crystal alignment film having a film thickness of 100 nm. Next, the substrate was heated to 240 ° C on a hot plate, and in the heated state, the liquid crystal alignment film surface on the substrate was placed on a polarizing plate, and ultraviolet rays of 313 nm were irradiated at 1000 mJ/cm 2 to obtain a substrate with a liquid crystal alignment film.
與實施例9同樣形成液晶配向膜,室溫(23℃)下,對於基板之液晶配向膜面介於偏光板,照射313nm之紫外線1000 mJ/cm2,得到附液晶配向膜的基板。 A liquid crystal alignment film was formed in the same manner as in Example 9. At room temperature (23 ° C), the liquid crystal alignment film surface of the substrate was placed on a polarizing plate, and ultraviolet rays of 313 nm were irradiated at 1000 mJ/cm 2 to obtain a substrate with a liquid crystal alignment film.
與實施例9同樣形成液晶配向膜,得到未加熱及紫外 線照射之附液晶配向膜的基板。比較例4的紫外線吸收光譜係作為實施例9及比較例3之比較對象。 A liquid crystal alignment film was formed in the same manner as in Example 9 to obtain unheated and ultraviolet light. The substrate of the liquid crystal alignment film attached to the line. The ultraviolet absorption spectrum of Comparative Example 4 was used as a comparison object of Example 9 and Comparative Example 3.
實施例9、比較例3、4所得之附液晶配向膜之基板的製作條件如表2所示。 The production conditions of the substrate with the liquid crystal alignment film obtained in Example 9 and Comparative Examples 3 and 4 are shown in Table 2.
液晶配向膜之紫外線吸收光譜之測定係藉由UV-Vis吸光高度測定法進行。 The measurement of the ultraviolet absorption spectrum of the liquid crystal alignment film was carried out by UV-Vis absorption height measurement.
使用實施例5所得之附配向處理後之液晶配向膜的基板,測定液晶配向膜之紫外線吸收光譜。此外,使用實施例3所得之附配向處理前之液晶配向膜的基板,測定配向處理前之液晶配向膜的紫外線吸收光譜作為比較對象。 The ultraviolet absorption spectrum of the liquid crystal alignment film was measured using the substrate obtained in Example 5 and attached to the treated liquid crystal alignment film. Further, the ultraviolet absorption spectrum of the liquid crystal alignment film before the alignment treatment was measured using the substrate obtained in the third embodiment and attached to the liquid crystal alignment film before the treatment.
圖1係實施例3所得之配向處理前之液晶配向膜及實施例5所得之液晶配向膜的紫外線吸收光譜。 Fig. 1 is a view showing the ultraviolet absorption spectrum of the liquid crystal alignment film before the alignment treatment obtained in Example 3 and the liquid crystal alignment film obtained in Example 5.
圖1係表示實施例5所得之液晶配向膜的紫外線吸收光譜,比較對象為未加熱或未進行偏光紫外線照射之實施例3之液晶配向膜的紫外線吸收光譜。如圖1所示,將實施例5之液晶配向膜的紫外線吸收光譜(圖1中記載「實施例5」)與實施例3之液晶配向膜的紫外線吸收光譜(圖1中 記載「實施例3」)進行比較時,得知實施例5之液晶配向膜中,波長350nm附近之吸光度大幅降低。此吸光度之降低係因加熱板上之240℃之加熱與500mJ之偏光紫外線之照射處理所造成的。實施例3之液晶配向膜之波長300~350nm附近的吸收係來自構成液晶配向膜之聚醯胺酸酯衍生物所含有之光反應基的吸收,藉由在加熱板上之240℃之加熱與500mJ之偏光紫外線之照射處理,得知在聚醯胺酸酯衍生物之膜中,有效率地進行光交聯反應。 Fig. 1 is a view showing an ultraviolet absorption spectrum of a liquid crystal alignment film obtained in Example 5, and the object of comparison was an ultraviolet absorption spectrum of a liquid crystal alignment film of Example 3 which was not heated or irradiated with polarized ultraviolet rays. As shown in Fig. 1, the ultraviolet absorption spectrum ("Example 5" in Fig. 1) of the liquid crystal alignment film of Example 5 and the ultraviolet absorption spectrum of the liquid crystal alignment film of Example 3 (in Fig. 1) When "Comparative Example 3" was described, it was found that the liquid crystal alignment film of Example 5 had a large decrease in absorbance at a wavelength of around 350 nm. This decrease in absorbance is caused by the heating of 240 ° C on the hot plate and the irradiation of 500 mJ of polarized ultraviolet light. The absorption of the liquid crystal alignment film of Example 3 at a wavelength of about 300 to 350 nm is derived from the absorption of the photoreactive group contained in the polyphthalate derivative constituting the liquid crystal alignment film by heating at 240 ° C on a hot plate. The irradiation treatment of polarized ultraviolet rays of 500 mJ revealed that the photocrosslinking reaction was efficiently carried out in the film of the polyphthalate derivative.
其次,使用比較例1之形成有液晶配向膜之附液晶配向膜的基板與比較例2之形成有液晶配向膜之附液晶配向膜的基板,測定各自之液晶配向膜的紫外線吸收光譜。此外,使用實施例3所得之附配向處理前之液晶配向膜的基板,測定配向處理前之液晶配向膜的紫外線吸收光譜作為比較對象。 Next, the substrate on which the liquid crystal alignment film of the liquid crystal alignment film of Comparative Example 1 was formed and the substrate on which the liquid crystal alignment film of the liquid crystal alignment film of Comparative Example 2 were formed were used, and the ultraviolet absorption spectrum of each liquid crystal alignment film was measured. Further, the ultraviolet absorption spectrum of the liquid crystal alignment film before the alignment treatment was measured using the substrate obtained in the third embodiment and attached to the liquid crystal alignment film before the treatment.
圖2係實施例3所得之配向處理前之液晶配向膜及比較例1、2所得之液晶配向膜的紫外線吸收光譜。 2 is an ultraviolet absorption spectrum of the liquid crystal alignment film before the alignment treatment obtained in Example 3 and the liquid crystal alignment films obtained in Comparative Examples 1 and 2.
圖2係表示比較例1之液晶配向膜及比較例2之液晶配向膜的紫外線吸收光譜,比較對象為未加熱或未進行偏光紫外線照射之實施例3之液晶配向膜的紫外線吸收光譜。如圖2所示,將實施例3之液晶配向膜的紫外線吸收光譜(圖2中記載「實施例3」)與比較例1之液晶配向膜的紫外線吸收光譜(圖2中記載「比較例1」)進行比較時,得知比較例1之液晶配向膜中,波長300~350nm附近之吸光度降低。同樣地,將比較例2之液晶配向膜之紫外線吸收光 譜(圖2中記載「比較例2」)進行比較時,得知比較例2之液晶配向膜中,於波長300~350nm附近之吸光度再降低。由此得知隨著偏光紫外線之照射量增加,液晶配向膜在波長300~350nm附近之吸光度降低。波長300~350nm附近之吸收係來自構成液晶配向膜之聚醯胺酸酯衍生物所含有之光反應基的吸收,藉由偏光紫外線之照射處理,得知在聚醯胺酸酯衍生物之膜中,進行光交聯反應。 2 is an ultraviolet absorption spectrum of the liquid crystal alignment film of Comparative Example 1 and the liquid crystal alignment film of Comparative Example 2, and the comparison object is an ultraviolet absorption spectrum of the liquid crystal alignment film of Example 3 which is not heated or irradiated with polarized ultraviolet rays. As shown in Fig. 2, the ultraviolet absorption spectrum of the liquid crystal alignment film of Example 3 ("Example 3" shown in Fig. 2) and the ultraviolet absorption spectrum of the liquid crystal alignment film of Comparative Example 1 are shown in Fig. 2 (Comparative Example 1) When the comparison was made, it was found that the absorbance at a wavelength of 300 to 350 nm was lowered in the liquid crystal alignment film of Comparative Example 1. Similarly, the ultraviolet absorbing light of the liquid crystal alignment film of Comparative Example 2 was used. When the spectrum ("Comparative Example 2" described in Fig. 2) was compared, it was found that the absorbance at a wavelength of 300 to 350 nm was further lowered in the liquid crystal alignment film of Comparative Example 2. From this, it is understood that as the amount of irradiation of the polarized ultraviolet rays increases, the absorbance of the liquid crystal alignment film at a wavelength of around 300 to 350 nm decreases. The absorption near the wavelength of 300 to 350 nm is derived from the absorption of the photoreactive group contained in the polyphthalate derivative constituting the liquid crystal alignment film, and the film of the polyphthalate derivative is known by irradiation treatment with polarized ultraviolet rays. In the middle, a photocrosslinking reaction is carried out.
又,比較圖1與圖2時,得知圖2所示之比較例2之液晶配向膜在波長300~350nm附近之吸光度與圖1所示之實施例5所得之液晶配向膜在波長300~350nm附近之吸光度同等的值。實施例5中之偏光紫外線之照射量為500mJ,比較例2之液晶配向膜中之偏光紫外線照射量係4500mJ。由此可知,偏光之紫外線之照射時,併用240℃之加熱處理之實施例5的液晶配向膜係以非常高效率進行光反應。實施例5之液晶配向膜的情形,其光反應的效率相較於比較例1、2等於偏光照射時未併用加熱處理之液晶配向膜的情形,可提高10倍程度。 Further, when comparing FIG. 1 with FIG. 2, it is found that the liquid crystal alignment film of Comparative Example 2 shown in FIG. 2 has an absorbance at a wavelength of about 300 to 350 nm and the liquid crystal alignment film obtained in Example 5 shown in FIG. The absorbance at around 350 nm is equivalent. The amount of the polarized ultraviolet ray irradiated in Example 5 was 500 mJ, and the amount of the polarized ultraviolet ray in the liquid crystal alignment film of Comparative Example 2 was 4500 mJ. From this, it was found that the liquid crystal alignment film of Example 5 which was subjected to heat treatment at 240 ° C during the irradiation of the polarized ultraviolet light was subjected to photoreaction with a very high efficiency. In the case of the liquid crystal alignment film of Example 5, the efficiency of photoreaction was 10 times higher than that of Comparative Examples 1 and 2, which was equal to the case where the liquid crystal alignment film which was not subjected to heat treatment at the time of polarized light irradiation was used.
圖3係本發明之實施例9所得之液晶配向膜的紫外線吸收光譜,比較對象為以室溫照射偏光紫外線之比較例3及未加熱或未進行偏光紫外線照射之比較例4之液晶配向膜的紫外線吸收光譜。如圖3所示,將實施例9之液晶配向膜之紫外線吸收光譜(圖3中記載「實施例9」)與比較例3之液晶配向膜之紫外線吸收光譜(圖3中記載「比較例3」)進行比較時,得知實施例9之液晶配向膜中,在波長 310nm附近之吸光度大幅降低。此吸光度之降低係因加熱板上之240℃之加熱與1000mJ之偏光紫外線之照射處理所造成的。實施例9之液晶配向膜在波長300nm~350nm附近之吸收係因來自構成液晶配向膜之聚醯胺酸衍生物所含有之光反應基的吸收,藉由在加熱板上之240℃之加熱與1000mJ之偏光紫外線之照射處理,得知聚醯胺酸衍生物的膜,以高效率進行光交聯反應。偏光之紫外線之照射時,併用240℃之加熱處理之實施例9的液晶配向膜係以非常高效率進行光反應。 3 is an ultraviolet absorption spectrum of a liquid crystal alignment film obtained in Example 9 of the present invention, and the object of comparison is Comparative Example 3 in which polarized ultraviolet light is irradiated at room temperature, and liquid crystal alignment film of Comparative Example 4 which is not heated or not subjected to polarized ultraviolet light. UV absorption spectrum. As shown in FIG. 3, the ultraviolet absorption spectrum of the liquid crystal alignment film of Example 9 ("Example 9" shown in FIG. 3) and the ultraviolet absorption spectrum of the liquid crystal alignment film of Comparative Example 3 are shown in FIG. When comparing, it is known that the liquid crystal alignment film of Example 9 is at a wavelength. The absorbance near 310 nm is greatly reduced. This decrease in absorbance is caused by the heating of 240 ° C on the hot plate and the irradiation of 1000 mJ of polarized ultraviolet light. The liquid crystal alignment film of Example 9 has an absorption in the vicinity of a wavelength of 300 nm to 350 nm due to absorption of a photoreactive group contained in a polyamic acid derivative constituting the liquid crystal alignment film, by heating at 240 ° C on a hot plate. The irradiation treatment of polarized ultraviolet rays of 1000 mJ revealed that the film of the polyproline derivative was subjected to photocrosslinking reaction with high efficiency. In the case of polarized ultraviolet light irradiation, the liquid crystal alignment film of Example 9 which was heat-treated at 240 ° C was used for photoreaction with very high efficiency.
使用實施例6所得之附配向處理後之液晶配向膜的基板,測定液晶配向膜的紫外線吸收光譜。此外,使用實施例4所得之附配向處理前之液晶配向膜的基板,測定紫外線吸收光譜作為比較對象。實施例4所得之液晶配向膜之紫外線吸收光譜中之波長350nm附近之吸收極大的吸光度係1.0,而實施例6之液晶配向膜之紫外線吸收光譜中之波長350nm附近之吸收極大的吸光度為0.76,得知實施例6之液晶配向膜在波長350nm附近之吸光度大幅降低。由該結果得知,偏光紫外線之照射時,併用160℃之加熱處理之實施例6的液晶配向膜係以高效率進行光反應。 The ultraviolet absorption spectrum of the liquid crystal alignment film was measured using the substrate obtained in Example 6 and attached to the treated liquid crystal alignment film. Further, the ultraviolet absorption spectrum was measured using the substrate obtained in the fourth embodiment and attached to the liquid crystal alignment film before the treatment as a comparison object. In the ultraviolet absorption spectrum of the liquid crystal alignment film obtained in Example 4, the absorption maximum at a wavelength of about 350 nm in the ultraviolet absorption spectrum of the liquid crystal alignment film was 1.0, and the absorption in the ultraviolet absorption spectrum of the liquid crystal alignment film of Example 6 at a wavelength of about 350 nm was 0.76. It was found that the liquid crystal alignment film of Example 6 had a large decrease in absorbance at a wavelength of around 350 nm. From the results, it was found that the liquid crystal alignment film of Example 6 which was heat-treated at 160 ° C during the irradiation of the polarized ultraviolet rays was subjected to photoreaction with high efficiency.
同樣,使用實施例7、8所得之附配向處理後之液晶配向膜的基板,測定液晶配向膜的紫外線吸收光譜,評價波長350nm附近之吸收極大的吸光度時,均為0.70。比較實 施例6之液晶配向膜時,吸收極大之吸光度降低的程度稍微大,而實施例7之液晶配向膜與實施例8之液晶配向膜係吸收極大之吸光度之降低程度同等。 In the same manner, the ultraviolet absorption spectrum of the liquid crystal alignment film was measured using the substrates obtained in the examples 7 and 8 attached to the liquid crystal alignment film after the treatment, and the absorption absorbance at a wavelength of around 350 nm was evaluated to be 0.70. More realistic In the liquid crystal alignment film of Example 6, the degree of decrease in the absorbance at the maximum absorption was slightly large, and the liquid crystal alignment film of Example 7 was equivalent to the degree of decrease in the absorbance of the liquid crystal alignment film of Example 8.
由以上的評價結果得知,將偏光紫外線照射於液晶配向膜時,併用加熱處理時,以160℃之加熱溫度,光反應效率之提昇效果充分,即使200℃以上的加熱溫度,光反應效率之提昇效果也幾乎與160℃的情形同等。換言之,液晶配向膜之配向處理中之偏光紫外線照射時之加熱溫度可抑制構成液晶配向膜之聚醯胺酸酯衍生物變成聚醯亞胺的變化,特佳為160~200℃。 From the above evaluation results, when the polarized ultraviolet ray is irradiated onto the liquid crystal alignment film and the heat treatment is performed at 160 ° C, the effect of improving the photoreaction efficiency is sufficient, and even at a heating temperature of 200 ° C or higher, the photoreaction efficiency is high. The lifting effect is almost the same as in the case of 160 °C. In other words, the heating temperature at the time of the polarized ultraviolet ray irradiation in the alignment treatment of the liquid crystal alignment film can suppress the change of the polyamidomate derivative constituting the liquid crystal alignment film to the polyimine, and is particularly preferably 160 to 200 °C.
使用實施例1所得之液晶配向處理劑(I)製作液晶配向膜,製造使用該液晶配向膜的液晶胞。液晶胞係對應液晶配向膜之特性做成平行配向的液晶胞。所得之液晶胞以一對偏光板挟持,可構成液晶顯示元件。 A liquid crystal alignment film was produced using the liquid crystal alignment treatment agent (I) obtained in Example 1, and a liquid crystal cell using the liquid crystal alignment film was produced. The liquid crystal cell corresponds to the characteristics of the liquid crystal alignment film to form a liquid crystal cell which is aligned in parallel. The obtained liquid crystal cell is held by a pair of polarizing plates to constitute a liquid crystal display element.
液晶胞之製造方法係將液晶配向處理劑(I)旋轉塗佈於附ITO電極的玻璃基板(長30mm×寬40mm、厚1,1mm)上,於80℃之加熱板上乾燥5分鐘後,以膜厚40nm之塗膜的形態形成液晶配向膜,得到附配向處理前之液晶配向膜的基板。得知形成於基板上之液晶配向膜均為膜厚之均勻性優異,且液晶配向處理劑(I)顯示優異的塗佈性。 In the method of producing a liquid crystal cell, the liquid crystal alignment treatment agent (I) is spin-coated on a glass substrate (length 30 mm × width 40 mm, thickness 1, 1 mm) with an ITO electrode, and dried on a hot plate at 80 ° C for 5 minutes. A liquid crystal alignment film was formed in the form of a coating film having a film thickness of 40 nm, and a substrate to which a liquid crystal alignment film before treatment was attached was obtained. It is understood that the liquid crystal alignment film formed on the substrate is excellent in uniformity of film thickness, and the liquid crystal alignment treatment agent (I) exhibits excellent coatability.
使用所得之附配向處理前之液晶配向膜的基板,將此 於加熱板上加熱至240℃,維持該加熱狀態下,對於基板上之液晶配向膜面,由一定的方向,介於偏光板,照射偏光的紫外線。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為250mJ。如此得到附配向處理後之液晶配向膜的基板。 Using the obtained substrate attached to the liquid crystal alignment film before the treatment, The plate is heated to 240 ° C on a hot plate, and the liquid crystal alignment film surface on the substrate is irradiated with polarized ultraviolet rays in a predetermined direction with respect to the liquid crystal alignment film surface on the substrate. The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 250 mJ. Thus, a substrate to which the liquid crystal alignment film after the treatment was attached was obtained.
準備2片此附液晶配向膜的基板,於其中之一的液晶配向膜面上灑佈14μm的間隙物(日本觸媒公司製、真球)後,由此上塗佈密封劑(三井化學公司製XN-1500T)。其次,使另一基板與液晶配向膜面對向方式貼合後,將密封劑以150℃加熱150分鐘,硬化製作空晶胞。此空晶胞利用毛細管現象,以液晶之等方相溫度以上的105℃注入向列液晶(Merck公司製ZLI-4792)得到液晶胞。 Two sheets of the substrate with the liquid crystal alignment film were prepared, and a 14 μm spacer (manufactured by Nippon Shokubai Co., Ltd., a real ball) was spread on one of the liquid crystal alignment film surfaces, and then the sealant was applied thereon (Mitsui Chemical Co., Ltd.) System XN-1500T). Next, after the other substrate was bonded to the liquid crystal alignment film in a face-to-face manner, the sealant was heated at 150 ° C for 150 minutes to harden the empty cell. This empty cell was injected into nematic liquid crystal (ZLI-4792 manufactured by Merck Co., Ltd.) at 105 ° C or higher at a temperature equal to or higher than the liquid crystal phase by a capillary phenomenon to obtain a liquid crystal cell.
除偏光之紫外線的照射量設定為500mJ外,與上述實施例10同樣的方法製造液晶胞。 A liquid crystal cell was produced in the same manner as in Example 10 except that the amount of ultraviolet light irradiated by the polarized light was set to 500 mJ.
除偏光之紫外線的照射量設定為50mJ外,與上述實施例10同樣方法製造液晶胞。 A liquid crystal cell was produced in the same manner as in Example 10 except that the amount of ultraviolet light irradiated by the polarized light was set to 50 mJ.
使用實施例1所得之液晶配向處理劑(I)製作液晶配向膜,製造使用該液晶配向膜的液晶胞。液晶胞係與實施 例10同樣作成平行配向的液晶胞。 A liquid crystal alignment film was produced using the liquid crystal alignment treatment agent (I) obtained in Example 1, and a liquid crystal cell using the liquid crystal alignment film was produced. Liquid crystal cell system and implementation Example 10 was also prepared as a liquid crystal cell in parallel alignment.
液晶胞之製造方法係將液晶配向處理劑(I)旋轉塗佈於附ITO電極的玻璃基板上,於80℃之加熱板上乾燥5分鐘後,以膜厚40nm之塗膜的形態形成液晶配向膜,得到附配向處理前之液晶配向膜的基板。 In the method of producing a liquid crystal cell, a liquid crystal alignment treatment agent (I) is spin-coated on a glass substrate with an ITO electrode, and dried on a hot plate at 80 ° C for 5 minutes, and then a liquid crystal alignment is formed in the form of a coating film having a film thickness of 40 nm. The film was obtained by attaching a substrate to the liquid crystal alignment film before the treatment.
使用所得之附配向處理前之液晶配向膜的基板,將此維持室溫狀態下,對於基板上之液晶配向膜面,由一定的方向,介於偏光板,照射偏光的紫外線。偏光後之紫外線的強度係波長365nm下,為14mW,紫外線照射量為50mJ。如此得到附配向處理後之液晶配向膜的基板。 Using the obtained substrate attached to the liquid crystal alignment film before the treatment, the liquid crystal alignment film surface on the substrate is irradiated with polarized ultraviolet rays in a predetermined direction with respect to the liquid crystal alignment film surface on the substrate. The intensity of the ultraviolet light after the polarized light was 14 mW at a wavelength of 365 nm, and the ultraviolet irradiation amount was 50 mJ. Thus, a substrate to which the liquid crystal alignment film after the treatment was attached was obtained.
準備2片此附液晶配向膜的基板,於其中之一的液晶配向膜面上灑佈14μm的間隙物後,由此上塗佈密封劑。其次,使另一基板與液晶配向膜面對向的方式貼合後,將密封劑以150℃加熱150分鐘,硬化製作空晶胞。此空晶胞利用毛細管現象,以液晶之等方相溫度以上的105℃注入向列液晶(Merck公司製ZLI-4792)得到液晶胞。 Two sheets of the liquid crystal alignment film were prepared, and a 14 μm spacer was sprinkled on one of the liquid crystal alignment film faces, and then the sealant was applied thereon. Next, after bonding the other substrate to the liquid crystal alignment film, the sealant was heated at 150 ° C for 150 minutes to harden the empty cell. This empty cell was injected into nematic liquid crystal (ZLI-4792 manufactured by Merck Co., Ltd.) at 105 ° C or higher at a temperature equal to or higher than the liquid crystal phase by a capillary phenomenon to obtain a liquid crystal cell.
除偏光後之紫外線的照射量設定為250mJ外,與比較例10同樣的方法製造液晶胞。 A liquid crystal cell was produced in the same manner as in Comparative Example 10 except that the amount of irradiation of ultraviolet rays after the polarizing was set to 250 mJ.
除偏光後之紫外線的照射量設定為500mJ外,與比較例10同樣的方法製造液晶胞。 The liquid crystal cell was produced in the same manner as in Comparative Example 10 except that the amount of irradiation of ultraviolet rays after the polarizing was set to 500 mJ.
實施例10、11及比較例5~8所製作之液晶胞之液晶配向膜的製作條件如表3所示。 The production conditions of the liquid crystal alignment films of the liquid crystal cells produced in Examples 10 and 11 and Comparative Examples 5 to 8 are shown in Table 3.
實施例10、11及比較例5~8所得之液晶胞的液晶配向膜,使用偏光顯微鏡(Nikon公司製)評價液晶之配向狀態。 In the liquid crystal alignment films of the liquid crystal cells obtained in Examples 10 and 11 and Comparative Examples 5 to 8, the alignment state of the liquid crystals was evaluated using a polarizing microscope (manufactured by Nikon Corporation).
圖4係將實施例10、11及比較例5~8之液晶胞比較偏光顯微鏡相片所示的圖。 Fig. 4 is a view showing comparison of liquid crystal cells of Examples 10 and 11 and Comparative Examples 5 to 8 with a polarizing microscope photograph.
如圖4所示,實施例10、11所得之液晶胞未觀察到缺陷。此外,使偏光顯微鏡之正交偏光下旋轉,確認產生明瞭的明暗,且確認液晶為均勻平行配向。紫外線照射量為250mJ之實施例6的液晶胞也經充分的配向處理。 As shown in Fig. 4, no defects were observed in the liquid crystal cells obtained in Examples 10 and 11. Further, the polarizing microscope was rotated under the orthogonal polarization, and it was confirmed that clear and dark light was generated, and it was confirmed that the liquid crystal was uniformly parallel aligned. The liquid crystal cell of Example 6 having an ultraviolet irradiation amount of 250 mJ was also subjected to sufficient alignment treatment.
而比較例5~8所得之液晶胞觀察到多數的缺陷,得知液晶未均勻配向。紫外線照射量為500mJ之比較例6的液晶胞也未實現液晶之均勻配向,且未充分的配向處理。 On the other hand, the liquid crystal cells obtained in Comparative Examples 5 to 8 were observed to have many defects, and it was found that the liquid crystals were not uniformly aligned. The liquid crystal cell of Comparative Example 6 in which the ultraviolet irradiation amount was 500 mJ did not achieve uniform alignment of the liquid crystal, and was insufficiently aligned.
由以上的觀察結果得知,偏光後之紫外線之照射時併用240℃之加熱處理的實施例10及實施例11的液晶胞,即 使以較少的紫外線照射量也可進行液晶之配向控制。又,偏光紫外線之照射時併用加熱處理時,必要的紫外線照射量係250mJ程度,相較於以往的光配向法,以非常少量即可。 From the above observation results, it was found that the liquid crystal cells of Example 10 and Example 11 which were treated with heat treatment at 240 ° C during the irradiation of the ultraviolet light after the polarization were The alignment control of the liquid crystal can also be performed with a small amount of ultraviolet irradiation. Further, when the polarized ultraviolet ray is irradiated and heat-treated, the amount of ultraviolet ray required is about 250 mJ, which is a very small amount compared to the conventional photo-alignment method.
其次,使用實施例10、11所得之液晶胞,將各自以正交偏光(crossed Nichol)配置之一對偏光板挟持,構成液晶顯示元件。所得之液晶顯示元件係分別將電壓施加於基板上之ITO電極間,確認引起液晶之配向變化,可使光之透過量變化。 Next, using the liquid crystal cells obtained in Examples 10 and 11, each of the polarized plates was held in a crossed Nichol arrangement to constitute a liquid crystal display element. The obtained liquid crystal display elements were each applied with a voltage between the ITO electrodes on the substrate, and it was confirmed that the alignment of the liquid crystal was changed, and the amount of light transmitted was changed.
由以上的評價結果得知,使用本發明之液晶配向膜之製造方法,藉由較少之紫外線照射量所製作的本發明之液晶配向膜可提供液晶顯示元件。 From the above evaluation results, it is known that the liquid crystal display element of the present invention produced by the method of producing a liquid crystal alignment film of the present invention can be provided with a liquid crystal display element which is produced by a small amount of ultraviolet irradiation.
實施例所使用之簡稱的意義如下述。 The meaning of the abbreviations used in the examples is as follows.
CBDA:1,2,3,4-環丁烷四羧酸二酐 CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride
p-PDA:p-苯二胺 p-PDA: p-phenylenediamine
NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone
BCS:丁基賽路蘇 BCS: Butyl Cyrus
APHFP:
二胺[1]~[7]:以下述式表示之二胺[1]~[7]
合成例中之1H-NMR之測定條件係如下述。 The measurement conditions of 1 H-NMR in the synthesis examples are as follows.
裝置:傅里葉轉換型超傳導核磁共振裝置(FT-NMR)INOVA-400(Varian公司製)400MHz Device: Fourier transform type superconducting nuclear magnetic resonance apparatus (FT-NMR) INOVA-400 (manufactured by Varian) 400 MHz
溶劑:氘化二甲基亞碸(DMSO-d6)及氘化氯仿(CDCl3) Solvent: Deuterated dimethyl hydrazine (DMSO-d 6 ) and deuterated chloroform (CDCl 3 )
標準物質:巳甲基矽烷(TMS) Reference material: 巳methyl decane (TMS)
聚合物(聚醯胺酸等)之分子量之測定條件係如下 述。 The measurement conditions of the molecular weight of the polymer (polyproline, etc.) are as follows Said.
裝置:Senshu科學公司製常溫凝膠滲透層析法(GPC)裝置(SSC-7200)、 Device: room temperature gel permeation chromatography (GPC) device (SSC-7200) manufactured by Senshu Scientific Co., Ltd.
管柱:Shodex公司製管柱(KD-803、及KD-805) Column: Shodex pipe column (KD-803, and KD-805)
管柱溫度:50℃ Column temperature: 50 ° C
溶離液:N,N’-二甲基甲醯胺(添加劑為溴化鋰-水合物(LiBr‧H2O)為30 mmol/L、磷酸無水結晶(o-磷酸)為30 mmol/L、四氫呋喃(THF)為10ml/L) Dissolution: N,N'-dimethylformamide (additive lithium bromide-hydrate (LiBr‧H 2 O) 30 mmol / L, anhydrous phosphate crystals (o-phosphoric acid) 30 mmol / L, tetrahydrofuran ( THF) is 10ml/L)
流速:1.0ml/分鐘 Flow rate: 1.0ml/min
校正曲線製作用標準樣品:東曹公司製TSK標準聚環氧乙烷(分子量約900,000、150,000、100,000、及30,000)、及Polymer Laboratories Ltd.製聚乙二醇(分子量約12,000、4,000、及1,000)。 Standard sample for calibration curve preparation: TSK standard polyethylene oxide (molecular weight of about 900,000, 150,000, 100,000, and 30,000) manufactured by Tosoh Corporation, and polyethylene glycol manufactured by Polymer Laboratories Ltd. (molecular weight of about 12,000, 4,000, and 1,000) ).
二胺[1]((E,E)-Bis-(4’-aminophenyl)1,4-benzenediacrylate)之合成 Synthesis of Diamine [1]((E,E)-Bis-(4'-aminophenyl)1,4-benzenediacrylate)
於2L之四口燒瓶中加入對苯二醛(Terephthalaldehyde)[A](40.00g、298 mmol)、吡啶(46g)、及哌啶(7.0g),邊攪拌邊將反應溶液加熱至100℃。其次,丙二酸[B](140.0g、1.34mol)之吡啶溶液(500g)滴下於反應溶液中。以HPLC(高速液體色譜)確認反應終了後,將反應溶液冷卻至40℃,反應溶液注入於蒸餾水(1L)中。接著,添加濃鹽酸直到此反應溶液成為酸性為止,然後將固體過濾。然後,水洗再以甲醇洗淨,減壓乾燥得到化合物[C](收量:60.3g、收率:93%)。所得之化合物[C]之1H-NMR測定結果如下所示。 Terephthalaldehyde [A] (40.00 g, 298 mmol), pyridine (46 g), and piperidine (7.0 g) were placed in a 2-L four-neck flask, and the reaction solution was heated to 100 ° C while stirring. Next, a solution of malonic acid [B] (140.0 g, 1.34 mol) in pyridine (500 g) was dropped into the reaction solution. After confirming the completion of the reaction by HPLC (High Speed Liquid Chromatography), the reaction solution was cooled to 40 ° C, and the reaction solution was poured into distilled water (1 L). Next, concentrated hydrochloric acid was added until the reaction solution became acidic, and then the solid was filtered. Then, it was washed with water, washed with methanol, and dried under reduced pressure to give compound [C] (yield: 60.3 g, yield: 93%). The results of 1 H-NMR measurement of the obtained compound [C] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):12.4(2H,brs),7.74(4H,s),7.60(2H,d),6.61(2H,d)。 1 H-NMR (400 MHz, DMSO-d6, δ ppm): 12.4 (2H, brs), 7.74 (4H, s), 7.60 (2H, d), 6.61 (2H, d).
其次於1L之四口燒瓶中,加入化合物[C](30.00g、138 mmol)、4-硝基酚[D](42.08g、303 mmol)、1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽(以下簡稱 EDC)(68.53g、358 mmol)、4-N,N-二甲基胺基吡啶(以下簡稱DMAP)(3.56g、27.5 mmol)、及四氫呋喃(以下簡稱THF)(600g),於23℃下進行攪拌。以HPLC確認反應終了後,將反應溶液注入乙酸乙酯(500mL)/蒸餾水(1L)混合溶液中,過濾固體。然後,以乙酸乙酯/甲醇1:1混合溶液洗淨,經減壓乾燥得到化合物[E](收量:60.6g、收率:96%)。所得之化合物[E]之1H-NMR測定結果如下所示。 Next, a compound [C] (30.00 g, 138 mmol), 4-nitrophenol [D] (42.08 g, 303 mmol), 1-ethyl-3-(3-dimethyl) was added to a 1 L four-necked flask. Aminopropyl)carbodiimide hydrochloride (hereinafter referred to as EDC) (68.53 g, 358 mmol), 4-N,N-dimethylaminopyridine (hereinafter referred to as DMAP) (3.56 g, 27.5 mmol) And tetrahydrofuran (hereinafter referred to as THF) (600 g), and stirred at 23 °C. After confirming the completion of the reaction by HPLC, the reaction solution was poured into a mixed solution of ethyl acetate (500 mL) / distilled water (1 L), and the solid was filtered. Then, it was washed with a 1:1 mixed solution of ethyl acetate/methanol, and dried under reduced pressure to give compound [E] (yield: 60.6 g, yield: 96%). The results of 1 H-NMR measurement of the obtained compound [E] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):8.36-8.31(4H,m),7.92(2H,d),7.68(4H,s),7.40-7.37(4H,m),6.70(2H,d)。 1 H-NMR (400MHz, DMSO -d6, δppm): 8.36-8.31 (4H, m), 7.92 (2H, d), 7.68 (4H, s), 7.40-7.37 (4H, m), 6.70 (2H, d).
其次,於2L之四口燒瓶中,加入化合物[E](63.30g、138 mmol)、氯化錫(182.5g、962 mmol)、THF(630g)、及蒸餾水(440g),於70℃下進行加熱攪拌。以HPLC確認反應終了後,添加N,N-二甲基乙醯胺(1L)後,使用乙酸乙酯(2.5L)稀釋反應溶液,添加碳酸氫鈉直到副產物之氫氧化錫不會析出為止。然後,過濾上澄液,將濾液分液(separating),除去水層。然後,將有機層分別以1L之飽和碳酸氫鈉水溶液(2次)、及鹽水(2次)依序洗淨,以硫酸鎂使有機層乾燥。過濾後,使用蒸發器餾除溶劑,得到粗產物後,添加甲醇(200mL),於室溫(23℃)下攪拌30分鐘。然後,再度過濾,進行甲醇洗淨,經減壓乾燥得到二胺[1](收量:24.0g、收率:44%)。所得之二胺[1]之1H-NMR測定結果如以下所示。 1H-NMR(400MHz,DMSO-d6,δppm):7.83(4H,s),7.79(2H,d),6.89(2H,d),6.81-6.78(4H,m),6.56-6.53(4H,m),5.04(4H,brs)。 Next, a compound [E] (63.30 g, 138 mmol), tin chloride (182.5 g, 962 mmol), THF (630 g), and distilled water (440 g) were added to a 2-liter four-neck flask, and the mixture was subjected to 70 ° C at 70 ° C. Heat and stir. After confirming the completion of the reaction by HPLC, after adding N,N-dimethylacetamide (1 L), the reaction solution was diluted with ethyl acetate (2.5 L), and sodium hydrogencarbonate was added until the by-product tin hydroxide was not precipitated. . Then, the supernatant was filtered, and the filtrate was separated to remove the aqueous layer. Then, the organic layer was washed successively with 1 L of a saturated aqueous sodium hydrogencarbonate solution (2 times) and brine (2 times), and the organic layer was dried over magnesium sulfate. After filtration, the solvent was evaporated using an evaporator to give a crude product, and methanol (200 mL) was added, and the mixture was stirred at room temperature (23 ° C) for 30 minutes. Then, it was again filtered, washed with methanol, and dried under reduced pressure to give a diamine [1] (yield: 24.0 g, yield: 44%). The results of 1 H-NMR measurement of the obtained diamine [1] are shown below. 1 H-NMR (400MHz, DMSO -d6, δppm): 7.83 (4H, s), 7.79 (2H, d), 6.89 (2H, d), 6.81-6.78 (4H, m), 6.56-6.53 (4H, m), 5.04 (4H, brs).
二胺[2]((E,E)-Bis-(4’-aminophenylethyl)1,4-benzenediacrylate)之合成 Synthesis of Diamine [2]((E,E)-Bis-(4'-aminophenylethyl)1,4-benzenediacrylate)
於1L之四口燒瓶中,加入化合物[C](30.21g、138 mmol)、2-(4-硝基苯基)乙醇[F](50.91g、305 mmol)、EDC(68.98g、360 mmol)、DMAP(3.38g、27.9 mmol)、及THF(600g),於23℃下進行攪拌。以HPLC確認反應終了後,將反應溶液注入乙酸乙酯(1L)/蒸餾水(1L)混合溶液中,過濾固體。然後,以乙酸乙酯/甲醇1:1混合溶液洗淨,經減壓乾燥得到化合物[G](收量:70.9g、收率:99%)。 In a 1 L four-necked flask, compound [C] (30.21 g, 138 mmol), 2-(4-nitrophenyl)ethanol [F] (50.91 g, 305 mmol), EDC (68.98 g, 360 mmol) were added. ), DMAP (3.38 g, 27.9 mmol), and THF (600 g) were stirred at 23 °C. After confirming the completion of the reaction by HPLC, the reaction solution was poured into a mixed solution of ethyl acetate (1 L) / distilled water (1 L), and the solid was filtered. Then, it was washed with a 1:1 mixed solution of ethyl acetate/methanol, and dried under reduced pressure to give compound [G] (yield: 70.9 g, yield: 99%).
其次,於2L之四口燒瓶中,加入化合物[G](71.48g、138 mmol)、氯化錫(183.4g、969 mmol)、THF(715g)、及蒸餾水(500g),於70℃下進行加熱攪拌。以HPLC確認反應終了後,添加N,N-二甲基乙醯胺 (1L)後,使用乙酸乙酯(2.5L)稀釋反應溶液,添加碳酸氫鈉直到副產物之氫氧化錫不會析出為止。然後,過濾上澄液,將濾液分液,除去水層。然後,將有機層分別以1L之飽和碳酸氫鈉水溶液(2次)、及鹽水(2次)依序洗淨,以硫酸鎂使有機層乾燥。過濾後,使用蒸發器餾除溶劑,得到粗產物後,添加甲醇(200mL),於室溫下攪拌30分鐘。然後,再度過濾,進行甲醇洗淨,經減壓乾燥得到二胺[2](收量:30.6g、收率:48%)。所得之二胺[2]之1H-NMR測定結果如以下所示。 Next, a compound [G] (71.48 g, 138 mmol), tin chloride (183.4 g, 969 mmol), THF (715 g), and distilled water (500 g) were added to a 2-liter four-necked flask, and the mixture was subjected to 70 ° C at 70 ° C. Heat and stir. After confirming the completion of the reaction by HPLC, after adding N,N-dimethylacetamide (1 L), the reaction solution was diluted with ethyl acetate (2.5 L), and sodium hydrogencarbonate was added until the by-product tin hydroxide was not precipitated. . Then, the supernatant was filtered, and the filtrate was separated to remove the aqueous layer. Then, the organic layer was washed successively with 1 L of a saturated aqueous sodium hydrogencarbonate solution (2 times) and brine (2 times), and the organic layer was dried over magnesium sulfate. After filtration, the solvent was evaporated using an evaporator to give a crude product, and methanol (200 mL) was added, and the mixture was stirred at room temperature for 30 minutes. Then, it was again filtered, washed with methanol, and dried under reduced pressure to give a diamine [2] (yield: 30.6 g, yield: 48%). The results of 1 H-NMR measurement of the obtained diamine [2] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):7.66(2H,d),7.73(4H,s),7.60(2H,d),6.90-6.88(4H,m),6.66(2H,d),6.45-6.46(4H,m),4.88(4H,brs),4.21(4H,t),2.75(4H,t)。 1 H-NMR (400MHz, DMSO -d6, δppm): 7.66 (2H, d), 7.73 (4H, s), 7.60 (2H, d), 6.90-6.88 (4H, m), 6.66 (2H, d) , 6.45-6.46 (4H, m), 4.88 (4H, brs), 4.21 (4H, t), 2.75 (4H, t).
二胺[3]((E,E)-Bis-(4’-aminophenyl)1,3-benzenediacrylate)之合成 Synthesis of Diamine [3]((E,E)-Bis-(4'-aminophenyl)1,3-benzenediacrylate)
於2L之四口燒瓶中加入對苯二醛(Terephthalaldehyde)[H](50.00g、373mol)、吡啶(78g)、及哌啶(9.5g),邊攪拌邊將反應溶液加熱至100℃。其次,將丙二酸[B](169.5g、1.68mol)之吡啶溶液(600g)滴下於反應溶液中。以HPLC(高速液體色譜)確認反應終了後,將反應溶液冷卻至40℃,反應溶液注入於蒸餾水(1L)中。接著,添加濃鹽酸直到此反應溶液成為酸性為止,然將固體過濾。然後,水洗得到化合物[I]之粗產物。將此粗產物於乙酸乙酯/甲醇1:1混合溶液中,室溫下攪拌30分鐘。然後,過濾以乙酸乙酯洗淨後,經減壓乾燥得到化合物[I](收量:80.2g、收率:99%)。所得之化合物[I]之1H-NMR測定結果如下所示。 Terephthalaldehyde [H] (50.00 g, 373 mol), pyridine (78 g), and piperidine (9.5 g) were placed in a 2-L four-neck flask, and the reaction solution was heated to 100 ° C while stirring. Next, a solution of malonic acid [B] (169.5 g, 1.68 mol) in pyridine (600 g) was dropped into the reaction solution. After confirming the completion of the reaction by HPLC (High Speed Liquid Chromatography), the reaction solution was cooled to 40 ° C, and the reaction solution was poured into distilled water (1 L). Next, concentrated hydrochloric acid was added until the reaction solution became acidic, and then the solid was filtered. Then, it was washed with water to obtain a crude product of the compound [I]. This crude product was stirred in a 1:1 mixture of ethyl acetate / methanol and stirred at room temperature for 30 min. Then, the mixture was washed with ethyl acetate, and dried under reduced pressure to give compound [I] (yield: 80.2 g, yield: 99%). The results of 1 H-NMR measurement of the obtained compound [I] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):12.4(2H,brs),8.07(1H,s),7.72(2H,dd),7.61(2H,d),7.46(1H,t)。 1 H-NMR (400 MHz, DMSO-d6, δ ppm): 12.4 (2H, brs), 8.07 (1H, s), 7.72 (2H, dd), 7.61 (2H, d), 7.46 (1H, t).
其次於1L之四口燒瓶中,加入化合物[I](30.00g、 138 mmol)、4-硝基酚[D](40.17g、289 mmol)、EDC(63.26g、330 mmol)、DMAP(3.36g、27.5 mmol)、及THF(600g),於23℃下進行攪拌。以HPLC確認反應終了後,將反應溶液注入乙酸乙酯(500mL)/蒸餾水(1L)混合溶液中,過濾固體。然後,以乙酸乙酯洗淨,經減壓乾燥得到化合物[J](收量:62.1g、收率:98%)。所得之化合物[J]之1H-NMR測定結果如以下所示。 Next, a compound [I] (30.00 g, 138 mmol), 4-nitrophenol [D] (40.17 g, 289 mmol), EDC (63.26 g, 330 mmol), DMAP (3.36) were added to a 1 L four-necked flask. g, 27.5 mmol), and THF (600 g) were stirred at 23 °C. After confirming the completion of the reaction by HPLC, the reaction solution was poured into a mixed solution of ethyl acetate (500 mL) / distilled water (1 L), and the solid was filtered. Then, it was washed with ethyl acetate and dried under reduced pressure to give compound [J] (yield: 62.1 g, yield: 98%). The results of 1 H-NMR measurement of the obtained compound [J] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):8.37(1H,s),8.32-8.29(4H,m),7.92(2H,d),7.88(2H,dd),7.56-7.51(5H,m),7.08(2H,d)。 1 H-NMR (400MHz, DMSO -d6, δppm): 8.37 (1H, s), 8.32-8.29 (4H, m), 7.92 (2H, d), 7.88 (2H, dd), 7.56-7.51 (5H, m), 7.08 (2H, d).
其次,於2L之四口燒瓶中,加入化合物[J](62.1g、135 mmol)、氯化錫(182.5g、962 mmol)、THF(630g)、及蒸餾水(630g),於70℃下進行加熱攪拌。以HPLC確認反應終了後,使用乙酸乙酯(2L)稀釋反應溶液,添加碳酸氫鈉直到副產物之氫氧化錫不會析出為止。然後,過濾上澄液,將濾液分液,除去水層。然後,將有機層分別以1L之飽和碳酸氫鈉水溶液(2次)、及鹽水(2次)依序洗淨,以硫酸鎂使有機層乾燥。過濾後,使用蒸發器餾除溶劑,得到粗產物後,添加甲醇(200mL),於室溫下攪拌30分鐘。然後,再度過濾,進行甲醇洗淨,經減壓乾燥得到二胺[3](收量:34.1g、收率:54%)。所得之二胺[3]之1H-NMR測定結果如以下所示。 Next, a compound [J] (62.1 g, 135 mmol), tin chloride (182.5 g, 962 mmol), THF (630 g), and distilled water (630 g) were placed in a 2-liter four-neck flask, and the mixture was subjected to 70 ° C at 70 ° C. Heat and stir. After confirming the completion of the reaction by HPLC, the reaction solution was diluted with ethyl acetate (2 L), and sodium hydrogen carbonate was added until the tin hydroxide of the by-product was not precipitated. Then, the supernatant was filtered, and the filtrate was separated to remove the aqueous layer. Then, the organic layer was washed successively with 1 L of a saturated aqueous sodium hydrogencarbonate solution (2 times) and brine (2 times), and the organic layer was dried over magnesium sulfate. After filtration, the solvent was evaporated using an evaporator to give a crude product, and methanol (200 mL) was added, and the mixture was stirred at room temperature for 30 minutes. Then, it was again filtered, washed with methanol, and dried under reduced pressure to give a diamine [3] (yield: 34.1 g, yield: 54%). The results of 1 H-NMR measurement of the obtained diamine [3] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):8.27(1H, s),7.82-7.77(4H,m),7.49(1H,t),6.96(2H,d),6.82-6.78(4H,m),6.56-6.53(4H,m),5.04(4H,brs)。 1 H-NMR (400MHz, DMSO -d6, δppm): 8.27 (1H, s), 7.82-7.77 (4H, m), 7.49 (1H, t), 6.96 (2H, d), 6.82-6.78 (4H, m), 6.56-6.53 (4H, m), 5.04 (4H, brs).
二胺[4]((E,E)-Bis-(4’-aminophenylethyl)1,3-benzenediacrylate)之合成 Synthesis of Diamine [4]((E,E)-Bis-(4'-aminophenylethyl)1,3-benzenediacrylate)
其次於1L之四口燒瓶中,加入化合物[I](54.92g、252 mmol)、2-(4-硝基苯基)乙醇[F](92.58g、554 mmol)、EDC(125.4g、654 mmol)、DMAP(6.15g、50.3 mmol)、及THF(1.1Kg),於23℃下進行攪拌。以HPLC確認反應終了後,反應溶液中添加乙酸乙酯(1L)/己烷(500mL)/蒸餾水(1L),藉由分液操作除去水層。然後,有機層以鹽水(1L)洗淨3次,以硫酸鎂使有機層乾燥。過濾後,使用蒸發器餾除溶劑,得到化合物[K]之粗產物。此粗產物中添加甲醇(300g),於室溫攪拌30分鐘。然後,過濾,經減壓乾燥得到化合物[K](收量:82.2g、收率:63%)。所得之化合物[K]之1H-NMR測定結果如以下所示。 Next, a compound [I] (54.92 g, 252 mmol), 2-(4-nitrophenyl)ethanol [F] (92.58 g, 554 mmol), EDC (125.4 g, 654) were placed in a 1 L four-necked flask. Methyl), DMAP (6.15 g, 50.3 mmol), and THF (1.1 Kg) were stirred at 23 °C. After confirming the completion of the reaction by HPLC, ethyl acetate (1 L) / hexane (500 mL) / distilled water (1 L) was added to the reaction mixture, and the aqueous layer was removed by liquid separation. Then, the organic layer was washed three times with brine (1 L), and the organic layer was dried over magnesium sulfate. After filtration, the solvent was distilled off using an evaporator to obtain a crude product of compound [K]. Methanol (300 g) was added to this crude product, and stirred at room temperature for 30 min. Then, the mixture was filtered and dried under reduced pressure to give Compound [K] (yield: 82.2 g, yield: 63%). The results of 1 H-NMR measurement of the obtained compound [K] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):8.17-8.14(4H,m),8.11(1H,s),7.70(2H,dd),7.62(1H,s),7.59-7.56(5H,m),7.42(1H,t),6.71(2H,d),4.41(4H,t),3.10(4H,t)。 1 H-NMR (400MHz, DMSO -d6, δppm): 8.17-8.14 (4H, m), 8.11 (1H, s), 7.70 (2H, dd), 7.62 (1H, s), 7.59-7.56 (5H, m), 7.42 (1H, t), 6.71 (2H, d), 4.41 (4H, t), 3.10 (4H, t).
其次,於2L之四口燒瓶中,加入化合物[K](82.21g、139 mmol)、氯化錫(211.3g、1.11mol)、THF(820g)、及蒸餾水(820g),於70℃進行加熱攪拌。以HPLC確認反應終了後,使用乙酸乙酯(2.5L)稀釋反應溶液,添加碳酸氫鈉直到副產物之氫氧化錫不會析出為止。然後,過濾上澄液,將濾液分液,除去水層。然後,將有機層分別以1L之飽和碳酸氫鈉水溶液(2次)、及鹽水(2次)依序洗淨,以硫酸鎂使有機層乾燥。過濾後,使用蒸發器餾除溶劑,得到粗產物後,添加甲醇(200mL),於室溫下攪拌30分鐘。然後,再度過濾,進行甲醇洗淨,經減壓乾燥得到二胺[4](收量:46.1g、收率:73%)。所得之二胺[4]之1H-NMR測定結果如以下所示 Next, a compound [K] (82.21 g, 139 mmol), tin chloride (211.3 g, 1.11 mol), THF (820 g), and distilled water (820 g) were added to a 2-liter four-necked flask, and heated at 70 ° C. Stir. After confirming the completion of the reaction by HPLC, the reaction solution was diluted with ethyl acetate (2.5 L), and sodium hydrogen carbonate was added until the tin hydroxide of the by-product was not precipitated. Then, the supernatant was filtered, and the filtrate was separated to remove the aqueous layer. Then, the organic layer was washed successively with 1 L of a saturated aqueous sodium hydrogencarbonate solution (2 times) and brine (2 times), and the organic layer was dried over magnesium sulfate. After filtration, the solvent was evaporated using an evaporator to give a crude product, and methanol (200 mL) was added, and the mixture was stirred at room temperature for 30 minutes. Then, it was again filtered, washed with methanol, and dried under reduced pressure to give a diamine [4] (yield: 46.1 g, yield: 73%). The results of 1 H-NMR measurement of the obtained diamine [4] are shown below.
1H-NMR(400MHz,CDCl3,δppm):7.66(2H,d),7.63(1H,s),7.54-7.39(1H,m),7.07-7.04(4H,m),6.68-6.65(4H,m),6.45(2H,d),5.04(4H,brs),4.37(4H,t),2.91(4H,t)。 1 H-NMR (400MHz, CDCl3 , δppm): 7.66 (2H, d), 7.63 (1H, s), 7.54-7.39 (1H, m), 7.07-7.04 (4H, m), 6.68-6.65 (4H, m), 6.45 (2H, d), 5.04 (4H, brs), 4.37 (4H, t), 2.91 (4H, t).
二胺[5]((E)-4-aminophenethyl 3-(4-aminophenyl) acrylate)之合成 Diamine [5]((E)-4-aminophenethyl 3-(4-aminophenyl) Acrylate synthesis
500mL之反應容器中添加化合物[M](12.7g、65.8 mmol)、2-(4-硝基苯基)乙醇[F](10g、59.8 mmol)、EDC(15g、77.7 mmol)、DMAP(365mg、3 mmol)、及THF200g,進行氮取代後,室溫下攪拌。反應終了後,將反應溶液注入蒸餾水(2L)中,所得之結晶使用異丙醇(100g)進行懸浮洗淨,得到化合物[N](收量:18.4g、收率:90%)。 Compound [M] (12.7 g, 65.8 mmol), 2-(4-nitrophenyl)ethanol [F] (10 g, 59.8 mmol), EDC (15 g, 77.7 mmol), DMAP (365 mg) were added to a 500 mL reaction vessel. 3 mmol) and 200 g of THF were mixed with nitrogen and stirred at room temperature. After the completion of the reaction, the reaction solution was poured into distilled water (2 L), and the obtained crystal was washed with isopropyl alcohol (100 g) to give the compound [N] (yield: 18.4 g, yield: 90%).
接著,於500mL之反應容器中加入上述所得之化合物[N](22.4g、65.5 mmol)、氯化錫(II)(80g、458.7 mmol)、THF200g、及蒸餾水100g,以60℃進行加熱攪拌。反應終了後,反應液中加入碳酸氫鈉進行中和,使用乙酸乙酯萃取。餾除萃取液的溶劑後,使所得之黃色結晶乾燥得到二胺[5](收量:14.0g、收率:76%)。所得之二胺[5]之1H-NMR測定結果如以下所示。 Next, the compound [N] (22.4 g, 65.5 mmol) obtained above, tin (II) chloride (80 g, 458.7 mmol), 200 g of THF, and 100 g of distilled water were added to a 500 mL reaction vessel, and the mixture was stirred under heating at 60 °C. After the completion of the reaction, the reaction solution was neutralized by adding sodium hydrogencarbonate, and extracted with ethyl acetate. After distilling off the solvent of the extract, the obtained yellow crystals were dried to give a diamine [5] (yield: 14.0 g, yield: 76%). The results of 1 H-NMR measurement of the obtained diamine [5] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):7.46(1H,d),7.37(2H,d),6.92(2H,d),6.56-6.47(4H,m),6.20(1H,d),5.78(2H,s),4.89(2H,s),4.18(2H,t),2.74(2H,t)。 1 H-NMR (400MHz, DMSO -d6, δppm): 7.46 (1H, d), 7.37 (2H, d), 6.92 (2H, d), 6.56-6.47 (4H, m), 6.20 (1H, d) , 5.78 (2H, s), 4.89 (2H, s), 4.18 (2H, t), 2.74 (2H, t).
二胺[6]((2E,2’E)-pentane-1,5-diyl bis(3-(4-aminophenyl)acrylate))之合成 Synthesis of diamine [6]((2E,2'E)-pentane-1,5-diyl bis(3-(4-aminophenyl)acrylate)
於500mL之反應容器中加入化合物[M](37.5g、160.2 mmol)、化合物[O](6.4g、61.6 mmol)、EDC(41.6g、172.5 mmol)、DMAP(828mg、6.8 mmol)、及THF300g,室溫下攪拌。反應終了後,將反應溶液注入蒸餾水(2L)中,使結晶析出。將析出之結晶進行減壓乾燥得到化合物[P](30g)。 Compound [M] (37.5 g, 160.2 mmol), compound [O] (6.4 g, 61.6 mmol), EDC (41.6 g, 172.5 mmol), DMAP (828 mg, 6.8 mmol), and THF 300 g were added to a 500 mL reaction vessel. Stir at room temperature. After the completion of the reaction, the reaction solution was poured into distilled water (2 L) to precipitate crystals. The precipitated crystals were dried under reduced pressure to give Compound [P] (30 g).
接著,於500mL之反應容器中加入上述所得之化合物[P](15g、33.0 mmol)、氯化錫(II)(43.8g、231.0 mmol)、THF150g、及蒸餾水150g,以60℃進行加熱攪拌。反應終了後,反應液中加入碳酸氫鈉進行中和,使用乙酸乙酯萃取。餾除萃取液的溶劑後,使所得之黃色結晶以乙酸乙酯及己烷依序懸浮洗淨得到二胺[6](收量:11.9g、收率:91%)。所得之二胺[6]之1H-NMR測定結果如以下所示。 Next, the compound [P] (15 g, 33.0 mmol) obtained above, tin (II) chloride (43.8 g, 231.0 mmol), 150 g of THF, and 150 g of distilled water were added to a 500 mL reaction vessel, and the mixture was stirred under heating at 60 °C. After the completion of the reaction, the reaction solution was neutralized by adding sodium hydrogencarbonate, and extracted with ethyl acetate. After distilling off the solvent of the extract, the obtained yellow crystals were washed successively with ethyl acetate and hexane to obtain a diamine [6] (yield: 11.9 g, yield: 91%). The results of 1 H-NMR measurement of the obtained diamine [6] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):7.47(2H, d),7.36(4H,d),6.55(4H,d),6.22(2H,d),5.76(4H,s),4.10(4H,t),1.99-1.63(4H,m),1.46-1.40(2H,m)。 1 H-NMR (400 MHz, DMSO-d6, δ ppm): 7.47 (2H, d), 7.36 (4H, d), 6.55 (4H, d), 6.22 (2H, d), 5.76 (4H, s), 4.10 (4H, t), 1.99-1.63 (4H, m), 1.46-1.40 (2H, m).
二胺[7]((E)-4-aminophenyl 3-(4-aminophenyl)acrylate)之合成 Synthesis of diamine [7]((E)-4-aminophenyl 3-(4-aminophenyl)acrylate
於500mL之反應容器中加入化合物[M](34g、193.2 mmol)、化合物[D]25.0g、179.7 mmol)、EDC(40.4g、191.7 mmol)、DMAP(2.2g、18 mmol)、及THF300g,室溫下攪拌。反應終了後,將反應溶液注入蒸餾水(3L)中,將析出之白色結晶過濾取得。將所得之粗結晶以異丙醇(200g)進行懸浮洗淨,得到化合物[Q](52g、165.7 mmol)。 Compound [M] (34 g, 193.2 mmol), compound [D] 25.0 g, 179.7 mmol), EDC (40.4 g, 191.7 mmol), DMAP (2.2 g, 18 mmol), and THF 300 g were added to a 500 mL reaction vessel. Stir at room temperature. After the completion of the reaction, the reaction solution was poured into distilled water (3 L), and the precipitated white crystals were obtained by filtration. The obtained crude crystals were washed with isopropyl alcohol (200 g) to give Compound [Q] (52 g, 165.7 mmol).
其次,在2L之反應容器中加入上述所得之化合物[Q](30g、95.5 mmol)、還原鐵(21.0g、382 mmol)、氯化銨氯化物(40.8g、762.8 mmol)、N,N-二甲基甲醛200g、乙酸乙酯200g、及蒸餾水400g,以70℃進行加熱攪拌。反應終了後,使用乙酸乙酯萃取,進行活性碳處理。然後, 過濾再餾除溶劑得到粗結晶。所得之粗結晶使用甲醇、及己烷依序懸浮洗淨、純化得到二胺[7](收量:19.4g、收率:80%)。所得之二胺[7]之1H-NMR測定結果如以下所示。 Next, the above-obtained compound [Q] (30 g, 95.5 mmol), reduced iron (21.0 g, 382 mmol), ammonium chloride chloride (40.8 g, 762.8 mmol), N, N- were added to a 2 L reaction vessel. 200 g of dimethylformaldehyde, 200 g of ethyl acetate, and 400 g of distilled water were heated and stirred at 70 °C. After the reaction was completed, it was extracted with ethyl acetate and subjected to activated carbon treatment. Then, the solvent was distilled off by filtration to obtain a crude crystal. The obtained crude crystals were washed with methanol and hexane, and purified to obtain a diamine [7] (yield: 19.4 g, yield: 80%). The results of 1 H-NMR measurement of the obtained diamine [7] are shown below.
1H-NMR(400MHz,DMSO-d6,δppm):7.60(1H,d),7.43(2H,d),6.78(2H,d),6.77-6.36(4H,m),6.10(1H,d),5.85(2H,s),5.02(2H,s)。 1 H-NMR (400MHz, DMSO -d6, δppm): 7.60 (1H, d), 7.43 (2H, d), 6.78 (2H, d), 6.77-6.36 (4H, m), 6.10 (1H, d) , 5.85 (2H, s), 5.02 (2H, s).
依據日本特公表2001-517719號公報的實施例1,合成二胺DA-1。 According to Example 1 of JP-A-2001-517719, diamine DA-1 was synthesized.
於二胺[1](1.20g、3.0 mmol)中加入NMP(5.0g),以室溫攪拌使完全溶解後,添加CBDA(0.53g、2.8 mmol)與NMP(5.0g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A1。此聚醯胺酸之數平均分子量為6000,重量平均分子量為10500。 After adding NMP (5.0 g) to diamine [1] (1.20 g, 3.0 mmol), and completely dissolving at room temperature, CBDA (0.53 g, 2.8 mmol) and NMP (5.0 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A1. The polyamine has a number average molecular weight of 6,000 and a weight average molecular weight of 10,500.
於二胺[2](1.37g、3.0 mmol)中加入NMP(5.4g),以室溫攪拌使完全溶解後,添加CBDA(0.55g、2.8 mmol)與NMP(5.4g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A2。此聚醯胺酸之數平均分子量為3800,重量平均分子量為5000。 After adding NMP (5.4 g) to diamine [2] (1.37 g, 3.0 mmol), and completely dissolving at room temperature, CBDA (0.55 g, 2.8 mmol) and NMP (5.4 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A2. The polyamine has a number average molecular weight of 3,800 and a weight average molecular weight of 5,000.
於二胺[3](1.20g、3.0 mmol)中加入NMP(5.0g),以室溫攪拌使完全溶解後,添加CBDA(0.55g、2.8 mmol)與NMP(5.0g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A3。此聚醯胺酸之數平均分子量為8100,重量平均分子量為16000。 After adding NMP (5.0 g) to diamine [3] (1.20 g, 3.0 mmol), and completely dissolving at room temperature, CBDA (0.55 g, 2.8 mmol) and NMP (5.0 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A3. The polyamino acid had a number average molecular weight of 8,100 and a weight average molecular weight of 16,000.
於二胺[4](1.37g、3.0 mmol)中加入NMP(5.4g),以室溫攪拌使完全溶解後,添加CBDA(0.55g、2.8 mmol)與NMP(5.4g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A4。此聚醯胺酸之數平均分子量為5200,重量平均分子量 為7600。 After adding NMP (5.4 g) to diamine [4] (1.37 g, 3.0 mmol) and stirring at room temperature to dissolve completely, CBDA (0.55 g, 2.8 mmol) and NMP (5.4 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A4. The polyamino acid has a number average molecular weight of 5,200 and a weight average molecular weight. It is 7600.
於二胺[5](7.06g、25.0 mmol)中加入NMP(32.3g),以室溫攪拌使完全溶解後,添加CBDA(4.51g、23.0 mmol)與NMP(33.2g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(40g)中添加NMP(40.0g)及BCS(20.0g),以室溫攪拌5小時,得到液晶配向處理劑A5。此聚醯胺酸之數平均分子量為10500,重量平均分子量為57000。 After adding NMP (32.3 g) to diamine [5] (7.06 g, 25.0 mmol) and stirring at room temperature to dissolve completely, CBDA (4.51 g, 23.0 mmol) and NMP (33.2 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (40 g), NMP (40.0 g) and BCS (20.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A5. The polyamine has a number average molecular weight of 10,500 and a weight average molecular weight of 57,000.
於二胺[6](1.18g、3.0 mmol)中加入NMP(4.9g),以室溫攪拌使完全溶解後,添加CBDA(0.53g、2.7 mmol)與NMP(4.9g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A6。此聚醯胺酸之數平均分子量為8800,重量平均分子量為35000。 After adding NMP (4.9 g) to diamine [6] (1.18 g, 3.0 mmol), and completely dissolving at room temperature, CBDA (0.53 g, 2.7 mmol) and NMP (4.9 g) were added and reacted at room temperature. A polyaminic acid solution was obtained in 10 hours. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A6. The polyamino acid had a number average molecular weight of 8,800 and a weight average molecular weight of 35,000.
於二胺[7](1.14g、4.5 mmol)中加入NMP(5.6g),以室溫攪拌使完全溶解後,添加CBDA(0.83g、4.2 mmol)與NMP(5.6g),於室溫反應10小時得到聚醯胺酸 溶液。此聚醯胺酸溶液(10g)中添加NMP(10.0g)及BCS(5.0g),以室溫攪拌5小時,得到液晶配向處理劑A7。此聚醯胺酸之數平均分子量為13800,重量平均分子量為35500。 After adding NMP (5.6 g) to diamine [7] (1.14 g, 4.5 mmol) and stirring at room temperature to dissolve completely, CBDA (0.83 g, 4.2 mmol) and NMP (5.6 g) were added and reacted at room temperature. 10 hours to get polylysine Solution. To the polyamic acid solution (10 g), NMP (10.0 g) and BCS (5.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A7. The polyamino acid had a number average molecular weight of 13,800 and a weight average molecular weight of 35,500.
於二胺[5](3.53g、12.5 mmol)及p-PDA(1.35g、12.5 mmol)中加入NMP(27.0g),以室溫攪拌使完全溶解後,添加CBDA(4.66g、23.8 mmol)與NMP(27.0g),於室溫反應10小時得到聚醯胺酸溶液。此聚醯胺酸溶液(40g)中添加NMP(40.0g)及BCS(20.0g),以室溫攪拌5小時,得到液晶配向處理劑A8。此聚醯胺酸之數平均分子量為11500,重量平均分子量為25000。 NMP (27.0 g) was added to the diamine [5] (3.53 g, 12.5 mmol) and p-PDA (1.35 g, 12.5 mmol), and after stirring at room temperature to dissolve completely, CBDA (4.66 g, 23.8 mmol) was added. It was reacted with NMP (27.0 g) at room temperature for 10 hours to obtain a polyaminic acid solution. To the polyamic acid solution (40 g), NMP (40.0 g) and BCS (20.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment agent A8. The polyamine has a number average molecular weight of 1,1,500 and a weight average molecular weight of 25,000.
於DA-1(5.10g、14.0 mmol)中加入NMP(22.0g),以室溫攪拌使完全溶解後,添加CBDA(2.66g、13.6 mmol)與NMP(22.0g),於室溫反應5小時得到聚醯胺酸溶液。此聚醯胺酸溶液(40g)中添加NMP(40.0g)及BCS(20.0g),以室溫攪拌5小時,得到液晶配向處理劑B1。此聚醯胺酸之數平均分子量為6500,重量平均分子量為26000。 After adding NMP (22.0 g) to DA-1 (5.10 g, 14.0 mmol), and completely dissolving at room temperature, CBDA (2.66 g, 13.6 mmol) and NMP (22.0 g) were added and reacted for 5 hours at room temperature. A polylysine solution was obtained. To the polyamic acid solution (40 g), NMP (40.0 g) and BCS (20.0 g) were added, and the mixture was stirred at room temperature for 5 hours to obtain a liquid crystal alignment treatment agent B1. The polyamine has a number average molecular weight of 6,500 and a weight average molecular weight of 26,000.
使用液晶配向處理劑A1,依下述所示順序製作液晶胞。 Using the liquid crystal alignment agent A1, liquid crystal cells were produced in the order shown below.
基板係30mm×40mm之大小,且厚度為0.7mm的玻璃基板,使用配置有將ITO膜進行圖型化形成之梳齒狀的像素電極者。像素電極係具有中央部分彎曲之ㄑ字形狀的電極要素經複數配列所構成的梳齒狀形狀。各電極要素之寬度方向的寬為3μm,電極要素間之間隔為6μm。形成各像素之像素電極係中央部分彎曲之ㄑ字形狀的電極要素經複數配列所構成,因此具備各像素之形狀非長方形狀,係與電極要素同樣在中央部分彎曲,類似粗字ㄑ字的形狀。各像素係以該中央之彎曲部分為界,分割成上下,具有彎曲部分之上側之第1區域與下側之第2區域。比較各像素之第1區域與第2區域時,構成彼等之像素電極之電極要素的形成方向不同。換言之,以後述液晶配向膜之配向處理方向為基準時,像素之第1區域係像素電極之電極要素以+10°之角度(順時針)而形成,像素之第2區域係像素電極之電極要素以-10°之角度(順時針)而形成。換言之,各像素之第1區域與第2區域係藉由在像素電極與對向電極之間施加電壓所引發之液晶在基板面內之旋轉動作(水平配向)的方向互為反方向而構成的。 A glass substrate having a substrate of a size of 30 mm × 40 mm and a thickness of 0.7 mm is provided with a comb-shaped pixel electrode in which an ITO film is patterned. The pixel electrode has a comb-tooth shape in which the electrode elements of the U-shape in which the central portion is curved are arranged in a plurality of rows. The width of each electrode element in the width direction was 3 μm, and the interval between the electrode elements was 6 μm. Since the electrode elements forming the U-shaped portion in which the central portion of the pixel electrode system of each pixel is curved are arranged in a plurality of rows, the shape of each pixel is not rectangular, and is curved in the central portion like the electrode element, similar to the shape of a thick letter. . Each of the pixels is divided into upper and lower sides by a curved portion at the center, and has a first region on the upper side of the curved portion and a second region on the lower side. When the first region and the second region of each pixel are compared, the direction in which the electrode elements constituting the pixel electrodes are formed is different. In other words, when the alignment processing direction of the liquid crystal alignment film described later is the reference, the electrode element of the pixel region of the first region of the pixel is formed at an angle of +10° (clockwise), and the second region of the pixel is the electrode element of the pixel electrode. Formed at an angle of -10° (clockwise). In other words, the first region and the second region of each pixel are configured such that the directions of the rotation (horizontal alignment) of the liquid crystal in the substrate surface caused by the application of a voltage between the pixel electrode and the counter electrode are opposite to each other. .
將液晶配向處理劑A1旋轉塗佈於所準備之上述附電極的基板上。接著,以90℃的加熱板乾燥60秒後,使用200℃之熱風循環式烘箱焙燒30分鐘,形成膜厚100nm的液晶配 向膜。其次,將基板載於240℃的加熱板,對液晶配向膜面介於偏光板照射313nm之紫外線20 mJ/cm2,得到附液晶配向膜的基板。又,對向基板為未形成有電極之高度4μm之具有柱狀間隙物的玻璃基板也與上述同樣,使用液晶配向處理劑A1形成液晶配向膜施予配向處理。 The liquid crystal alignment agent A1 was spin-coated on the substrate on which the above-mentioned electrode was prepared. Subsequently, the film was dried on a hot plate at 90 ° C for 60 seconds, and then fired in a hot air circulating oven at 200 ° C for 30 minutes to form a liquid crystal alignment film having a film thickness of 100 nm. Next, the substrate was placed on a hot plate at 240 ° C, and the liquid crystal alignment film surface was irradiated with ultraviolet rays of 313 nm at 20 mJ/cm 2 on the polarizing plate to obtain a substrate with a liquid crystal alignment film. In the same manner as described above, the liquid crystal alignment treatment agent A1 is used to form the liquid crystal alignment film to be subjected to the alignment treatment in the glass substrate having the columnar spacers having a height of 4 μm in which the electrode is not formed.
其中一方之基板的液晶配向膜上印刷密封劑(協立化學公司製、XN-1500T)。接著,將另一方的基板以液晶配向膜面相對,配向方向成為0°的方式張貼後,使密封劑硬化製作空液晶胞。對此空液晶胞藉由減壓注入法注入液晶MLC-2041(Merck公司製),封閉注入口得到具備IPS(In-Planes Switching)模式液晶顯示元件之構成的液晶胞(IPS模式用液晶胞)。 A sealant (XN-1500T, manufactured by Kyoritsu Chemical Co., Ltd.) was printed on the liquid crystal alignment film of one of the substrates. Next, the other substrate is placed so that the liquid crystal alignment film faces and the alignment direction becomes 0°, and then the sealant is cured to form an empty liquid crystal cell. The liquid crystal cell was injected into the liquid crystal MLC-2041 (manufactured by Merck) by a vacuum injection method, and the liquid crystal cell having an IPS (In-Planes Switching) mode liquid crystal display element was obtained by closing the injection port (liquid crystal cell for IPS mode). .
以偏光顯微鏡觀察上述所得之IPS模式用液晶胞的配向狀態,若無配向缺陷者評價為「良好」,有配向缺陷者評價為「不良」。結果如表4所示。 The alignment state of the liquid crystal cell for IPS mode obtained as described above was observed with a polarizing microscope, and those who had no alignment defects were evaluated as "good", and those who had alignment defects were evaluated as "poor". The results are shown in Table 4.
將上述所得之IPS模式用液晶胞設置於偏光軸成正交配置之2片偏光板之間,電壓無外加的狀態下,使光源亮燈,調整液晶胞之配置角度使透過光的亮度成為最小。其次,使液晶胞由像素之第2區域變得最暗的角度至第1區域變得最暗的角度為止旋轉時之旋轉角度(配向方位角)作 為初期配向方位角計算。其次,室溫環境下,將頻率30Hz,8VPP之交流電壓施加24小時。然後,使液晶胞之像素電極與對向電極之間形成短路狀態,該狀態下,室溫下放置1小時。放置後,同樣測定配向方位角,交流驅動前後之配向方位角之差、即(交流驅動前之配向方位角)-(交流驅動後之配向方位角)以△配向方位角(°)計算得到。結果如表4所示。 The IPS mode liquid crystal cell obtained as described above is disposed between two polarizing plates in which the polarizing axes are arranged orthogonally, and the light source is turned on in a state where the voltage is not applied, and the arrangement angle of the liquid crystal cells is adjusted to minimize the brightness of the transmitted light. . Next, the rotation angle (alignment azimuth angle) when the liquid crystal cell is rotated from the second region of the pixel to the darkest angle to the darkest angle of the first region is calculated as the initial alignment azimuth angle. Next, an alternating voltage of a frequency of 30 Hz and 8 V PP was applied for 24 hours at room temperature. Then, a short-circuit state was formed between the pixel electrode of the liquid crystal cell and the counter electrode, and in this state, it was allowed to stand at room temperature for 1 hour. After the placement, the alignment azimuth angle is also measured, and the difference between the azimuth angles before and after the AC drive, that is, (the azimuth angle before the AC drive) - (the azimuth angle after the AC drive) is calculated by the Δ azimuth angle (°). The results are shown in Table 4.
除了使用液晶配向處理劑A2取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment treatment agent A2 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A3取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment agent A3 was used instead of the liquid crystal alignment agent A1.
除了使用液晶配向處理劑A4取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment treatment agent A4 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A5取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment treatment agent A5 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A6取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment treatment agent A6 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A7取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment agent A7 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A8取代液晶配向處理劑A1外,與實施例1同樣的操作,進行液晶配向性能評價及殘像評價。 The liquid crystal alignment performance evaluation and afterimage evaluation were performed in the same manner as in Example 1 except that the liquid crystal alignment agent A8 was used instead of the liquid crystal alignment agent A1.
此結果得知,如表4所示,即使室溫下、24小時之低溫且短時間的測定條件,以上述式(4)表示之二胺作為原料,將特定之光反應性基導入於聚醯亞胺系聚合物之主鏈骨架中的實施例1~6,相較於比較例1時,交流驅動前後之配向方位角之差較小,明顯提高殘像特性。又,實施例1~6係液晶配向性良好。此外,將其他二胺進行共聚合的實施例7,也顯示良好的液晶配向性能及AC燒焦特性。換言之,藉由使用本發明之液晶配向處理劑,可得到液晶配向性及殘像特性優異的液晶配向膜。又,具有由本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件係液晶配向性及殘像特性優異,因此可得到不易產生顯示不良、對比降低、燒焦等的液晶顯示裝置。 As a result, as shown in Table 4, a specific photoreactive group was introduced into the poly(diamine) represented by the above formula (4) as a raw material even at a low temperature and a short time measurement condition at room temperature for 24 hours. In Examples 1 to 6 of the main chain skeleton of the quinone imine polymer, the difference in the orientation azimuth angle before and after the AC driving was small as compared with Comparative Example 1, and the afterimage characteristics were remarkably improved. Further, in Examples 1 to 6, the liquid crystal alignment property was good. Further, Example 7 in which other diamines were copolymerized also showed good liquid crystal alignment properties and AC charring characteristics. In other words, by using the liquid crystal alignment treatment agent of the present invention, a liquid crystal alignment film having excellent liquid crystal alignment properties and afterimage characteristics can be obtained. In addition, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is excellent in liquid crystal alignment property and afterimage characteristics, and thus a liquid crystal display device which is less likely to cause display failure, contrast reduction, charring, and the like can be obtained.
使用液晶配向處理劑A1,在室溫下,對液晶配向膜面介於偏光板,照射313nm之紫外線20 mJ/cm2外,與實施例1同樣操作進行液晶配向性能評價。 Using the liquid crystal alignment treatment agent A1, liquid crystal alignment performance was evaluated in the same manner as in Example 1 except that the liquid crystal alignment film surface was placed on a polarizing plate at room temperature and irradiated with ultraviolet rays of 313 nm at 20 mJ/cm 2 .
除了使用液晶配向處理劑A2取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9 except that the liquid crystal alignment treatment agent A2 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A3取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9 except that the liquid crystal alignment treatment agent A3 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A4取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9 except that the liquid crystal alignment agent A4 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A5取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9, except that the liquid crystal alignment treatment agent A5 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A7取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9, except that the liquid crystal alignment agent A7 was used instead of the liquid crystal alignment treatment agent A1.
除了使用液晶配向處理劑A8取代液晶配向處理劑A1外,與比較例9同樣的操作,進行液晶配向性能評價。 The liquid crystal alignment performance evaluation was performed in the same manner as in Comparative Example 9 except that the liquid crystal alignment treatment agent A8 was used instead of the liquid crystal alignment treatment agent A1.
其次,上述實施例1~7所得之液晶胞之液晶配向性能與以下的比較例9~15所得之液晶胞之液晶配向性能如表5所示。 Next, the liquid crystal alignment properties of the liquid crystal cells obtained in the above Examples 1 to 7 and the liquid crystal alignment properties of the liquid crystal cells obtained in the following Comparative Examples 9 to 15 are shown in Table 5.
如表5所示,得知邊以240℃進行加熱處理,邊照射偏光紫外線,使液晶配向性變佳。此乃是因邊進行加熱處理,邊照射紫外線,促進肉桂醯基之光二聚化反應所造成的。 As shown in Table 5, it was found that while the heat treatment was performed at 240 ° C, the polarized ultraviolet rays were irradiated to improve the liquid crystal alignment property. This is caused by the fact that the heat treatment is carried out while irradiating ultraviolet rays to promote the photodimerization reaction of the cinnamyl group.
依據本發明時,實現高的光反應效率,可得到可高效率之配向處理的液晶配向膜,藉由使用該液晶配向膜,可提供即使在效率佳,且長期間之使用時,也不易產生液晶之配向狀態變化之不良的液晶顯示元件。 According to the present invention, a high photoreaction efficiency can be achieved, and a liquid crystal alignment film which can be efficiently treated with an alignment can be obtained. By using the liquid crystal alignment film, it is possible to provide a film which is easy to produce even when it is used for a long period of time. A liquid crystal display element in which the alignment state of the liquid crystal changes.
[圖1]係[實施例A]之實施例3所得之配向處理前的液晶配向膜及實施例5所得之液晶配向膜的紫外線吸收光譜。 Fig. 1 is a view showing an ultraviolet absorption spectrum of a liquid crystal alignment film before alignment treatment obtained in Example 3 of Example [A) and a liquid crystal alignment film obtained in Example 5.
[圖2]係[實施例A]之實施例3所得之配向處理前的液晶配向膜、及比較例1、2所得之液晶配向膜的紫外線吸收光譜。 2 is an ultraviolet absorption spectrum of a liquid crystal alignment film before alignment treatment obtained in Example 3 of [Example A] and a liquid crystal alignment film obtained in Comparative Examples 1 and 2.
[圖3]係[實施例A]之實施例9所得之液晶配向膜、及比較例3、4所得之液晶配向膜的紫外線吸收光譜。 3 is an ultraviolet absorption spectrum of a liquid crystal alignment film obtained in Example 9 of [Example A] and a liquid crystal alignment film obtained in Comparative Examples 3 and 4.
[圖4]係[實施例A]之實施例10、11及比較例5~8所得之液晶胞(cell)中之液晶配向膜,使用偏光顯微鏡攝影的顯微鏡相片。 Fig. 4 is a photomicrograph of a liquid crystal alignment film in liquid crystal cells obtained in Examples 10 and 11 and Comparative Examples 5 to 8 of Example A, which was photographed using a polarizing microscope.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011143403 | 2011-06-28 | ||
| JP2012101709 | 2012-04-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201313790A TW201313790A (en) | 2013-04-01 |
| TWI554555B true TWI554555B (en) | 2016-10-21 |
Family
ID=47424231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101123263A TWI554555B (en) | 2011-06-28 | 2012-06-28 | A liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display device |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR101991140B1 (en) |
| CN (1) | CN103827740B (en) |
| TW (1) | TWI554555B (en) |
| WO (1) | WO2013002345A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104395282A (en) * | 2012-04-26 | 2015-03-04 | 日产化学工业株式会社 | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| TWI628209B (en) * | 2013-05-13 | 2018-07-01 | 日產化學工業股份有限公司 | Manufacturing method of substrate with liquid crystal alignment film for lateral electric field drive type liquid crystal display element |
| KR101652922B1 (en) * | 2013-09-30 | 2016-08-31 | 주식회사 엘지화학 | Photoalignment polymer, liquid crystal alignment layer and its preparation method comprising the same |
| JP6372200B2 (en) * | 2013-10-07 | 2018-08-15 | Jsr株式会社 | Method for producing liquid crystal alignment film, photo-alignment agent, and liquid crystal display element |
| JP6243862B2 (en) * | 2015-02-17 | 2017-12-06 | 富士フイルム株式会社 | Method for manufacturing liquid crystal alignment film, method for manufacturing liquid crystal display device, and liquid crystal display device |
| CN107615145B (en) * | 2015-03-24 | 2021-05-07 | 日产化学工业株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| CN105487296B (en) | 2016-01-06 | 2019-01-22 | 京东方科技集团股份有限公司 | Alignment film material and preparation method thereof, alignment film, and preparation method of display substrate |
| KR101989587B1 (en) * | 2016-03-28 | 2019-06-14 | 주식회사 엘지화학 | Liquid crystal photoalignment agent, liquid crystal photoalignment film containing the same and method for preparing liquid crystal photoalignment film |
| WO2017221817A1 (en) * | 2016-06-24 | 2017-12-28 | シャープ株式会社 | Liquid crystal cell, liquid crystal display device and method for producing liquid crystal cell |
| CN109445199B (en) * | 2018-12-30 | 2021-11-23 | 厦门天马微电子有限公司 | Liquid crystal device and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002082336A (en) * | 2000-09-08 | 2002-03-22 | Jsr Corp | Liquid crystal alignment treatment method and liquid crystal display element |
| TW200643575A (en) * | 2005-06-14 | 2006-12-16 | Lg Philips Lcd Co Ltd | Liquid crystal display device and method of fabricating the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3893659B2 (en) | 1996-03-05 | 2007-03-14 | 日産化学工業株式会社 | Liquid crystal alignment treatment method |
| WO1997033191A1 (en) * | 1996-03-05 | 1997-09-12 | Nissan Chemical Industries, Ltd. | Method for liquid crystal alignment |
| TW461980B (en) * | 1997-04-30 | 2001-11-01 | Nissan Chemical Ind Ltd | Liquid crystal orientation processing agent |
| EP1021479B1 (en) | 1997-09-25 | 2002-07-17 | Rolic AG | Photocrosslinkable polyimides |
| US6303742B1 (en) * | 1998-04-01 | 2001-10-16 | Kanekafuchi Kagaku Kogyo Kabushiki Kaisha | Polyimide compositions |
| JP4653421B2 (en) * | 2004-06-08 | 2011-03-16 | 株式会社 日立ディスプレイズ | Liquid crystal display device |
| JP4779974B2 (en) * | 2004-12-22 | 2011-09-28 | 日産化学工業株式会社 | Liquid crystal aligning agent and liquid crystal display element using the same |
| KR100759189B1 (en) * | 2005-12-01 | 2007-09-14 | 주식회사 엘지화학 | Process for preparing of liquid crystal aligning layer, liquid crystal aligning prepared by the same, and liquid crystal display including liquid crystal aligning layer |
| JP4924801B2 (en) * | 2006-03-22 | 2012-04-25 | Jsr株式会社 | Liquid crystal aligning agent, alignment film, liquid crystal display element and optical member |
| US20100060834A1 (en) * | 2007-01-09 | 2010-03-11 | Xing-Zhong Fang | Copolyimide, liquid crystal aligning layer comprising the same , and liquid crystal display comprising the same |
| KR100913605B1 (en) * | 2007-12-07 | 2009-08-26 | 제일모직주식회사 | Liquid crystal photo-alignment agent, liquid crystal photo-alignment layer comprising the same, and liquid crystal display device comprising the same |
-
2012
- 2012-06-28 CN CN201280031708.2A patent/CN103827740B/en active Active
- 2012-06-28 WO PCT/JP2012/066591 patent/WO2013002345A1/en not_active Ceased
- 2012-06-28 KR KR1020137034527A patent/KR101991140B1/en active Active
- 2012-06-28 TW TW101123263A patent/TWI554555B/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002082336A (en) * | 2000-09-08 | 2002-03-22 | Jsr Corp | Liquid crystal alignment treatment method and liquid crystal display element |
| TW200643575A (en) * | 2005-06-14 | 2006-12-16 | Lg Philips Lcd Co Ltd | Liquid crystal display device and method of fabricating the same |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201313790A (en) | 2013-04-01 |
| CN103827740A (en) | 2014-05-28 |
| KR20140048890A (en) | 2014-04-24 |
| WO2013002345A1 (en) | 2013-01-03 |
| KR101991140B1 (en) | 2019-06-19 |
| CN103827740B (en) | 2017-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI554555B (en) | A liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display device | |
| JP7234924B2 (en) | Manufacturing method of zero plane anchoring film and liquid crystal display element | |
| TWI601757B (en) | Liquid crystal display element and liquid crystal alignment agent | |
| TWI586639B (en) | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| TWI669344B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI620769B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI436980B (en) | Diamine, polyimide precursor, polyimide, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| TWI478959B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device and a compound using the same | |
| JPWO2017111117A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| WO2013099804A1 (en) | Liquid crystal orientation agent, liquid crystal orientation membrane, liquid crystal display element, and diamine compound | |
| TW201422677A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP5842581B2 (en) | Novel dicarboxylic acid anhydride and production method, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display device using the same | |
| TWI683857B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| KR102073437B1 (en) | Polymer, liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, and diamine | |
| JP7367673B2 (en) | Manufacturing method of zero-plane anchoring film and liquid crystal display element | |
| JP6057895B2 (en) | Method for producing liquid crystal alignment film, liquid crystal alignment film, and liquid crystal display element | |
| TW202130703A (en) | Method for manufacturing patterned liquid crystal display element | |
| JP7663841B2 (en) | Liquid crystal alignment agent, radical generating film, and method for manufacturing in-plane electric field liquid crystal cell | |
| TWI906242B (en) | Methods for manufacturing liquid crystal alignment agents, free radical generating films, and transverse electric field liquid crystal cells. | |
| JP7367674B2 (en) | Manufacturing method of zero-plane anchoring film and liquid crystal display element | |
| WO2022196565A1 (en) | Liquid-crystal composition, liquid-crystal display element production method, and liquid-crystal display element | |
| TW202513612A (en) | Method for manufacturing liquid crystal alignment film, and method for manufacturing liquid crystal display element |